var title_f33_43_34480="Ketorolac: Pediatric drug information";
var content_f33_43_34480=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ketorolac: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12645342\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/51/43827?source=see_link\">",
"       Ketorolac (ophthalmic): Pediatric drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?1/22/1385?source=see_link\">",
"       Ketorolac (systemic): Pediatric drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13402 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-E9F4F161E5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34480=[""].join("\n");
var outline_f33_43_34480=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/51/43827?source=related_link\">",
"      Ketorolac (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?1/22/1385?source=related_link\">",
"      Ketorolac (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_43_34481="AML FAB M5B";
var content_f33_43_34481=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F63816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F63816&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute monocytic leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blood smear from a patient with acute monocytic leukemia, differentiated (FAB AML M5B). The predominant promonocytes have abundant cytoplasm with scattered myeloperoxidase-negative azurophilic granules. The nuclei have delicate folds and creases. Nucleoli are inconspiruous (Wright-Giemsa stain).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Brunning, RD, McKenna, RW. Tumors of the bone marrow. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 9, 1994, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34481=[""].join("\n");
var outline_f33_43_34481=null;
var title_f33_43_34482="Dermoscopy of scabies";
var content_f33_43_34482=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75431%7EDERM%2F54381&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75431%7EDERM%2F54381&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Scabies mite appearance on dermoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The dark triangular shape in this image represents the head of the scabies mite.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: DermNet NZ. For more information, visit file://dermnetnz.org/. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Scabies mite appearance on dermoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The dark triangular shape in this image represents the head of the scabies mite. This mite is located at the end of a burrow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: DermNet NZ. For more information, visit file://dermnetnz.org/. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34482=[""].join("\n");
var outline_f33_43_34482=null;
var title_f33_43_34483="Chronic paracocci";
var content_f33_43_34483=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clinical aspects of chronic paracoccidioidomycosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 272px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEQAX4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD50vNRmnummWSSN9xI2sQRzRJq+qTSiWXUrxpRjDeacjFVrn/j5m/66N/Oo60Tvuc7bvoav/CSa6RtOt6ljr/r2qSLxV4jjOY9f1RT7XDVjUVPKhqbXU3f+Ex8U9vEmrj6XT/409PG/i6MYTxTraj0F44/rXP0U0kN1JdzoW8ceLm+94p1o/W8f/Gmnxr4sPXxPrB/7e3/AMawKKdkTzy7m6vjPxYoIXxNrAB/6e3/AMaYfFfiVjlvEOqk+puWP9axaM0mkPnl3NN/EGtyNuk1m/ZvUzHNR/2zq4fd/at9u9fOOaoZooSQc8u5qR+I9ej/ANXreor9J2FTDxb4nAIHiLVgD1/0p/8AGsWinZBzs1R4l8QBtw1zUt2MbvtDZ/Oro8d+MREsY8V64I1GFX7bJgfhmudoosg52dCPHXjIAAeKtcAHQC9k/wAaF8eeMlBC+LNdAPb7dJj+dc9RRZBzs2/+Ey8VZJPiXWCfX7W/+Newfs7ajqHiBvEH9uXsl+sMlqqtfETBAwmzjeDg8CvBK9m/ZybWPsXiqLQ7JLqSR7TfuYDZgTYOD1rKulyOx0YWXNVSZ7ZdeF7TVBK8VhpSeZ8oka0jI+oO2oNW8OaLBbpbxaXo0rxY3TtaRYJx/ug1HF4S8XX0Ucd9dPAgQn5ZQgHPsKZc+Djp1vI8nmMWGWYys+4/U1xSV9LHpR5dlYyFsbGylbyINOjll5VYIo1P4YXilspVDwQxyTMyylmUtxjHPFMvbYPZtPblN8OBtbHP4gc/hRpiuuqWgueJXyWCDBxjvmsKl1E6FZK6N+FGaVZBKQvVVzxV77T/AKIDJuZUYgnJ+tZkc22WPCjBO3PYc96kuizWswgPG/7p9jXHuPmT0LauMpJPnH+0TzV3Srq4nu5JXjMNsq7Y/mPze+M1gB5DLC9y2WBwEXoM9zW5p8SpGLt5vuE5Ufxc00tSpNKOxH4j1L7MyDa3zJxg5Yn3rkbjWLTT42a6k8tmGRGwyXPU8/SsDxN4mN1qdy0F4sFtEXAyfvY7e5rz/wAS3d3PJayW4228kbYYvzgjDH14BJrop0HN67ESrKlGy3Oj8QfEK4uNNvYrJbe3ijA8x2fMhzwNuD1rzo203y3c0qbyilVkw7sSTkAYPNXYI9PtL+a8FubiONDJawl8glcDzZARyuc4AxzWdot3JLrFjcB/3z3cZj34AJLdT6DJ7Yr0oUowWh51WrKTN+0ez0+yneYrPqkkCRwxrLtSNyxLK4AGfl29MYNXvBerR6B4qs9Zh8nUzDbu16bpN4kkdsOIx3baQuTx1rkPEKo+v6zLbEtaNfTJFIvzErvPP5Va00x2iG3iWSGbdn5zt8w/w/hgc1bT6Gd31O78O67qGseOL2+0fVLPS5I51ng06ciJY1jOCPQE88Drk10Pxa1Z38Z2OvXmyF33nStQtZC6y7AoK7eyE7vf3rk/CF9Hpml6nGfC737XSJIbkxI0pO7G9c8quARnnmua8Z2+oRa5HYyTymOybybWF33FEBJ4PHrjp2qfUlaM0tX1fOl2GoPZsZ9QWVWMiZi85ZMsFOc/dKkdMEnrVLxFYwSj7VZRTotuFtpp4YiAjqOr8kZPqKwJ5odkEtv5zRhCZI5XyEkPDEdOuAavaZqKWulLPEJZWW4X7XGJSqsnOOOhyDzTtbUuzsLDqN8utf2gl03niMBS4/1gUAY/Eevavb/h/wCIhqsTfbBFFd/88U+VQBwMV8/M0aMwtmmeLdwzjlPT9MVsaT4hfS761uIT5rRlC0eD8/PIOKwr0VNXjudVCry6SZ9LfMshLkDHK7gCTWlpupPb6nFIXKDbtcKMGuT0XUZ9WzdtCkNqAMLv3kMT0+n4VtzlI4jKWG+A55PvjrXlrmg7no3jNeTPUra6hmXzrS4ad3XyiVICofUgnrWTrTx2UVwJMRCNAGkUDL59ug5rmfDOpbr02l0kctlOTuKMuVOMg5rVil0rUYHtpgqRqWEbyH5nPbGDyM8fUV3+29pHY8101SqW3MS8vWvLvTBDMbObft8yUERFRwW3A46jpWToupy6k2q6feHbLBdHZNExMcq+oq7eWMlqtjBqDyzQQzFnBHAJG4Y496lu4hDxb7I1cbyVXHJrnqM9CNinqMjQmByfLjBMbqSSck8HrUWoJLAIWdgdwOAQG4474q/JtnlEUgXEqBQR0Bx1NY16Jt8cfl8Rgrx061hN+6zWPxJHyJNzI5/2j/OmmgdBkEHuDS496+jSuj5FrUSilxRgUNWASiilpAJRS4+tGKYCUUY96KLAFFFLiiwCUUuKSjcAoo4o4osAUUUY96BBXqPwOmKWviOIXLW7O1uVZWIPAl9PrXltes/ASxhu7TxRJPIE8v7MOR1yJf8ACsa6bptI68D/AB4nepJfxMhN1dTRHh83LDj866DSdYcNtN1KUDYKM5bj8ak/skxW9o9qyzwKN7LgHAqlrWnyyRNLpsYlmIAVV4YEnuO/4Yrz4KW7PdUY2DVrdYrwyRtJGrZYoiZUjFUNGu5Bq9sZlxKEkwG4LcZH86ypdQ1aykCakp2OpQqc7kUHGfbmmwuZL+x3ltgBJY8tg9dp+lRNPqS0dfprSXAxKfLWKVgwJ6nHFSNqMAjWJZmabeIypHGfX6Uy2ltbeNpGbbbhmxuHJJ6H8qx7SZrvWYxYBWjhHzFxhcn1NcysrkJcx1NhamPzsRSSqXzwMsR049q4f4k+LtU0mwa3sGtY0ml8sJu/eqCPr/SqnxD8V39lbSacksMEZby3ltnJfBU9DjjpzXltvNHfRExRy3MjoViUoWkxlR5jHt3xXXQw7klKRlWruC5S/DdCCASSMHn2lSHX5UBPXqct7/pWb4kuWl1NhFIJEijMQCHORtGTn19aqbJJYpkiVSYHJO0E5YnoozzUc6eSht1iMd4ZS0jHqAcdu1dyiloji5pS1kTJPD5epx3ExmklsIo1ZF+586HC/QDFZ8SrMkOSVHKfIMsD1/DtViwslvL4WdrNulcAJxtDn+IV2XhTwTcvqrfbNNuZ7Noo545EOFGCM89z1H4GqlJR3ZcIuWyOShRYnliWJo4o1LqrDJOTjPB9qhigl1HUJFiuCBuJWaVsbR0x9cele26B8MUudY1MalMkWjSyof3Yw8ijOVyc4HavVbTwFoqaKkWiWenIsOCFeEOY2xwyk/xfXNYPFdImnsVF3loeKfDrw1p2n+J0tbzU1PmQoRbREtLKR8/LMMIvAG3qc1zXjtLq812y8Q6dp90kT3v2Ymdsl5SdwUDOcYIH4V7KfDstlq1jfhZ7jUrYyjy1VS0xbBLcjHAHFaXhbwhb30UtqulPLGZ/tji6GCkrNnIPt7VzrEPm2uayw8FvI+YNVsrm01G/E9kwaJmkuIV6ISeR/Kmzl7WS6hZUVJYUOH+8oPI6d6+w7v4Y6Ra6o2o3LIti9s63MO0fO+5Spzj2rx3xT8H9SjsvFGqO1srTTia1ZXGyKBELnOfwFdXtXtJWOfli/hdzxMTAwpGJWUD7wHIf5v8ACmW0hVvlXbJ5o2tuwFwc80kMbn/WRSodpbKpuwAMg59OlPtljjuS1ynmQA/Mqnnnv9a1RLVnqdXo/iLUNMvb65bUIwWkWGe3LN86n+JTjGR6813er3N6LzSNO8LS3V9eamgAjDB7fpkkPgd85HY5ryVy0LrdG4CTzMTuwNoGOOB+VdFpmpa5/Y1k+i3d1DIk8ccX2cZJck5JJPy8ewHvWVSlF7FqrOOzPR/Euoan4Wu401G500XQhAdISMJIVGMdc+9dd4a1v/hI9Ng0y/02SC6QGZVyAZ0AGGUgAjnmvPviHbTSozzaJ9nuRbbkvLiVJDKxKh5H28AjOBj9ayVuZ/DOq6brU2oztNEBDIbchiAM8LuPAPHJzXJyqJ0KpzJaan0bobtc6RDZX0zG5icqTJ8xfk4GfXGBVTVbQlGdcGXeYmXOcelVfB+s6dq1uL60F15sifvFkUZLD5g3oevatuSRFeaYLnJy2QOvXsfes5bahdxloclumtpLgyRhhCo3EdD9PesX+1nSRPNSR1dN+FHKnjAP4GuguzJH9tFsEklk+Y7uFAx2/E1x769JoscI1K2EkkikhkOc84GT7AAVk43Wh2wvKS0ueIeOfh54i8J3EU2tW0EMV7I7QbZ1YkZz26cVzUOm3UwDRIrKTgHeOtfQn7TesW15f6PoURRrmEmaZxj5c8BfyryW0EcStC8WwRkFW9a96vPklZHzNCHtI3kc8nh7UXzhYRjs0mKtWng/WbtlWCGHc3TMorrLONr1H/d5C8/KBj8TXV2NusVvgRbGZQwkK/d+lYSrSWx30MHCq/I83T4beKJGCpa22T0DXCj+tXB8IvGpAIsLXB/6fI/8a9h0++MiRrEEkZRyzkYH6VrDUXQ44GFBxn3xWf1mZ3f2ZSS1PCx8H/G5XI023P0u4/8AGqs3wt8XwuFksrZWboPtKH+tfQVxrBjQBS248cdKZNcXBiYi3iGTuEm7J6elJ4mZLy2kj5/m+F/i2H79jbjjP/H0h/rVYfDvxQSAtjEc+k6/417mjltqtJufGXbBAH4miWeaO2mFxvWNRuXyl3HHpnpk1P1uQlltE8Hm8DeIoCwuLOCLA3ZadQMfnVqD4b+KLgI0FtZurjKkXaYP617M6R3ECLLtdnUFVdclQT0IrG1HT9l0Tb3JRF4IX5cH2oWLkyXlkOh5mfhr4pG7daWy465uU/xqBvAHiJFJa3tcYzn7Steky2t2pIlk2qVyC3JanwaeXKLIjM5HAAGMflT+tyQRyyLep5dF4I8Qyuypaw5Ubj++HSlTwJ4jk+5awnPQectexQ2axKdiDI4IxyfapYrRyyqu2I54TOW/IU/rcnsbLKaa1Z483w78UKVDWcALcjNwg/rUr/DLxYjhXsbcbuQTcpj+de2q8EUoj1OZkTbiMMOTzzWtcaLHqUtrExWC0wCZJSWOM4HTHaiOJqNhLLaEFeVz5+i+GHi2WTYtnaZIzzdxgDt1Jr1b4L+Edc8KW3iS317ToFa7WCSOMzqTIiCUMyEZBwWXiuy1fRY7C7/0VSbUIFlhUkpKAc5GaisJgjR+VlrZpDJGU/eGIsv3eeg9vWrlKpJWZnDCU4Pnp9Dbjb7HYx3FnG+xiqCRugOOjL/hinTwOzMJpIlYAfNGCAO/XrUNtPG/mJOphLkt/s5BxnHv1q9FmSVYmUrHtLOuDn256c1ntsXJbWOO8YaZLfuyW7Rwv5XzSMD+874zmuetIJYrS3QKTslwPLYErkHPPpXfaqRtd2jO8HBAbdle2PwxXL6rF9jtHuokXzImJIB2jpxxWNZ8xqm+Wxn6lqPlWQEjO77AVh4+8TV6LV7HwnpR1PUo0kDgkRI2ZCQODt9M8ZrjrCNLu/hLyyQoSMy/eb3wPrxTvFyadqXiayghW+upH/dGRgsYVuAD06dcjFYRgm7Mzb5YnE6nfpen7VrCma7u5vP2vMcCLPyrtAwPwqM6pPp0E8FldJCZiRO0C4wDj5AepGAPTvXQajppPiDVrWS7kuri3G7e6qC0YCqqqoxz1zU/hzSrYS3Au0ljBjxHEAHaaT1J7L7frXo8yUUjzZNydjl7LRUaO9d99tARGIBI/wAwJIGTj2GRS32jCSEyacJ2uJLiO0Adsl3YHPbJ5Gc+hFdhqeiwi4WMs7AxpHkjapxkkY/Gus8F6VbRX3+kxDzYWY2e5gVjDYOT3LYA596znW5VdG1OlJss/D/4eWGjWlhc6lGlxqarvRCeIXJ7+9egWtrH5Btyfs6hRHlTjaBk/T3/ABrmrnUQFnEf3o+SV43HPvS6lrLJAjLGjMSMpvwTgY6d689ylN3Z6Cp+zjodVHcxyadKsaqvyoqkfXtTtO1aXTzdRCNWQyeYgHqD0+leYab4uuPtL2sWnXk0S8Exr0IAxzV+58b2QDxvY3ySo+1sREn8eauKl0Lko25Jao990/VNNlgimlS3jlddxyoyCTg4NUNS8SpEHhsFQ7TjOP54rxqz8d6TIJI/IvSFwuWjIwetaFp4l0yWXKXqRh25VwV5/EetbOvNq1rHHHBxhK8ndHpFldzSzRC4z5LHfIHOc5JJ/kKo+JrjTNQ0KS1kXNvMvlOiHAbceh9sYrh9X8YWUDpGdRRnOM4bpjtUFpr2nXieRFdxPIz7iinOwY4JrLnlaxs8PTunct+KtD02bRLvS9Ft7KDbbCLzSgBKgj5Qx7n8a8bX4d3sWralJqElvaxtmWLBzGGwW25HTjivRfEstveaY0TqJkibcPLJDBvX86yjqyXejXOnXDCG3ZPMeSThlOSSB6f/AF60o1ZrQuvh1y3R4oLGaSKMlVSFgSSMHBI6Dnv2+tdZpGowaLoQN3Yy3vkBRJL5zoPLfkxMgPGGyQe59a3dbsNPvvC91c6RYOqtCrQxpHghweZFPJKgjGOvXmt/wn4GGqeF/EOteJrfM91ZxyQ74dqKVBO8nuDgfma6pVly2Z5ns+bcj1r4l+H7C3ksIreS6V4SY5LiIN5AIDeWSeTkj8hgdqzp9d0vVVgtng0fUYY8zW5VvJeTJ5QnnLccA8Vs2HiO3vDY6PPpWgxpqUULW/mwZjHynG/jOfmx1FZ/jbwjpUkcN5a+HY7CWymRLi505yIigAV96EkqOMhh681nFxelh1acqfukXgbWrqDX/M0vUbeCzBdfs94oEkJ7rxjnjg9PavZGu2NvA/nCVbpPMLFgD/u+5r5jluYYpZLyC5Q27yGIWzodxUHj5upyMc16Xp1jdnTbbVY/DUbxwOssI+3NuH58EentjrWNen1OijU5rJ7npDXBMTrEMHGCnBNcV4ji4jRIPtMisTvI6BuccVuG4ZAlyAlvNcEYG7dhj2zUF7Obe6dpGbYQEJC5BYDJP6muaMtLHek4SutzwTWWbWNQnv7+djdTuZC2eRnoP5VHaWpmuordn3qOWY9hVWeSYMxSMvzgDua6bQLExRnzx+8lG4554Hb2r2Jy5pXZ4sKfLaMToNEthb24y22Hb82Owz6dzW6io5j8oLGCuFZjwB9PWqmlWUvyzMi527hWtNYLKYysJkkUbnGcKB9K5Ju70PZw9NRshBdQ2UQD4Ur1wAQ31quNbBLMYTh1wSyE8D0rQsdHeW7+1pF58MIBeMocbScevUVzE2r3VlqkwtY2+ymQqJp0OFYHhPTGPYU1DmKq1owfc7HT4o7q3Esc3mqwB2kghT9K1f7Eup4DiQKCvG1iAOe4rD067tLxbS+tfLtp5ZjHPbIm1Rgcsp6YPX8a9a0OS2uNOMEqjG4HeBndkZH86ao30M6mIcYqSR5dcaNPbukUQPlLlpd+TnPP5VFJptyEVZ52SEtvQZ4Nep+JLa3htJQyAM64yP4R7iuOvo4gn7tyzKgABIIzj6VlUpchVGsqvQ5e8SYXUSAM6uhI24GDnvxTbm0j2CIouMbyc559K04oI5NmFZGTO5hzk1XaNQCFi2Ss2BnkY9ay6XOyNjPNhsjNwSjYGCAOf1pUiKyRXcwmiR/kAHJ9PSta9hkiRmby2iRMkbuS3pUsVvfW0Nu1xGIhMVZFRg5YHPUfhQrsbkkYwFwzyK0LG36bx8uD261rabDFHfAx/M4T5mZd2Rj2wcdqXypsyyRxLL5inlyQFIx29a1tKtJZXimkRYmZWjbpvIA6jBGRVxWupNSp7tiLTdGhvbqea8Vo7fZsO2I7s57K3J/CtObR5bKfbbSxTW7RkxeUTvXB7KefXNQ3d6Yjbs7vO4k2pHGT5hA4+UkkdunFS2WoogutUcO3lfI4fmQDoBtGCDXoU2noebWlUfXQj17UE8LxiTMV68c8ahHyZPmLHaMcZznNc7pUthrc0+TDYS+eVhMe8AqeQGH9/Jxnp7Vp+ONFutZSN9MktYbiJjONhInOVVl4HUjHXPGTXPaRBYTaFc6jcXd9p2syr5IjEgYTsHJZ8NyCMY69qqcuV6nlOpOL03NcNdwXUlrdJi6hKxSAHKsTxxXS21xJHCqh23ZwOfvAfyri21RrxdH1+GYNGUFszSfeedC3LAeo/TFbtrdGWSGVAJLdlPmMvrjH6VzzSTueqpc8IyRPetG0AleQtO3ybh1wDkf4Vw3jtJX0aS4l4DSIh7HcSev4YrrrxtzR+bnh1QEcZwOP0xXLeOJ1utPntyjpL5yFcHjGSM1zyaui0nYi8BWk8MlzeTqixYUQgrnd3z+dUfEVk8viCVrMwhdpZ5uFPmn5sBj0AGOldN4UiWDSreCZ/NcHA9ieg/Kua8f6RaQu1zuaJlJDeWrPuz1GBwOMVz05XmxVbclupgLpGly+JlstPtW1rWbld8rmfbCjbcgKwwTjPOT2xXSWNs2gaWrXeo2MMkpa38poCzyuOCP9nHQZ60JFpqWmmaPo6LDqcxila7kHlnYB93P97v8AWu30vw14P1OwuhfreXcoDXF/NJLgO33UCsCMHPoOxrp5+aVkc6w8adPnkcFrOg6rp9rZ6w6faY+kcONkqp1LFDnHPf0xWFaa0l1qDKzMjMhG4N09ule029npPg+3tLc6zeXOq3ABWJ2W4ZzjGwcZIA681w/jC28I+aJb+a000u3z3EO4s3rtjU/4U3Do2VSrqL0Rz+qatOtkbiSHeyKELL8oZecfU8VpaH4P1HXItO1LWLsrpsvzLZxMwYnPG4+n0xXJ6rquj3MdudItdTnW1kVmlZflkAPHy+p+taH/AAl2p67qgtrCa8sCqhUMj5UHvuCgAADjgVMYxim30Oh89R7HsyXOg6DYfZpPssbNlNshG4c9Bk5JqHWfEGg6UsMaaXO9xNhlSOLl89yeAK8z8ba/dwx6dpUEGlXNw8e4Tpbnzg2eclycZ5PHtXM6zeWGruZNPs59P1CH5fKW5aR5cY+YZ9eTTVZ2utjL6pzNczPS72e7vrxoZbo6Kky/J9nERBYnA+ds5PtUEXgO7vLiNG8Xyv5b/vPNt426Vzuj+E9WNpBqGqXv2mB4WDWkkrFo/lBJAGPmGc5rMtNH1SQ3kFtqupyrbxNJ5K3Gxto4+8Rye9c7rSk/iOh0Ek1Fnd2k2neF55YNTmsdW0+abLSLGEmhOem3ncO/FXPFPhnw74lhhPhq5gttTmkC21xA2MHP3XAHpya8T8P2lzHam5vZlnt5Wy2G8yWLkj5u46ZHtiuy8FeJrjw7M03h62uNRLHMsU9uCoByAyMCDuwD+VdXtGlyyOadFLWD12Kl9Pq2j3V1a308IihlaM3K5Ecm1iCc9uQa0tH0a6/te3vL2wh1KxuVOQJlZCSOOhHrXS38AvtJn1DSpJFtbtDItrd2he3kzgnD84PJJz3zXA63peo2mlXEtj4ckJhTeslmzPEOepx0rCNSD2epoubl97U96tdF0uwTw15C2aSWwYyM7YWNMZ25zjqvf3rlfjF4t0K00CS1066ll1K8XYqpJlDECVIyOD3Irn7bw3pGvvazLq1/ptlcWEf2m2EjBfP2gNwc8da0NK+HPhTQtWtlutRt1aYHymnm8x3wOeDwoqnLm0DD0oRmp6nC39pr+pabBqV7axLp+mxmUyqwXcjhUjjUDnKjkfnXqngQwRxQ6aZLWBLW0L+dIRM9wQck5yOMjkHNRWXhSK0kuJ7bU0vEHzGJx8sgI+XA9QMD8K5/X/hxfPZvdx7LOeU7bOFCU2buGGT1zyfxqHUkpeR2/VsNVi4uVtdDg/Evh+6e9uvEWnrFqNlcXLxh7NMRxv3TbnAB5r074eXser+DoEhuUea0YW8xwQU+X5QQe46Z6cVW8JfDrX7O1gsL1dHa3jmDRxkqN5BOS+Mbicnk5qx4Jsl03x34q077Hb2qzot3HCjgJvBIIHY8+nrVupzOx58qMaUmou9h2qpi1kEyuohbcC/Qn1BqrI5nRXtYvNlPMgDcDgYrT8WRSXc6PIHjts7HIPTAxn9K44SSQsxkmdwWIHlnbgDgfpXPy6nUn7qbPOdDsWu74Pg4BwMetei6Zo2YJY44tsoO9n9xjg57Y54rC8H2m8NGnEiqCB3J68V6LaW1ysUAkjUKitvJOd2fXFejUlbY4sJTS97qQxooikkZkSKACJUB+ZznrjHSmTusK70k3APt4Uq59uetTJqMMYljjh86YkLv3DKjPbmlm8601FjbySqwG9RMMhBj3z1rOKuei4tPYseH9aeyupbW/hYR3RUb2XGBngMM8VT8V6fokMs4NoP3nRBIcu2724xiq0k8d5cJJfb4ndxtkiIwcetaU8UctsP3Z80SHbhiSo9cVo5u1jKdKLakkcvqWpQyzRxW0QgihQIiQrtCkNg/n1P1rZtPF2rQxNbQOEtyeqEAjHArNuo1guPLaP8AfmT5mCE7hj69adYWU91K0lvA67GwwkAA/lWPNJ6o2VD3fe2On0/xZfKXSR1kDoRJv+YEdufWp2s5tQtUvrFhgxNvjIxhh2HvxXPrakSnyxhCNrFSCBz2rT0m5k00fNNuhds+WoOc56inGfN7sznrYf2T5oEdjcsIdiAoZR82SCR7GrPlBm+TLrkEY6n1xVDxDYPpc/8AaFsxa2uMufUMTyKbpGqrIkjSGRcnZGVXJBrKUXF2ZvCoqi5kbMlvG9syrKFEgwA3JJzz261ZSIGa3inke0Kr8jRje5UZ9utR6cwQQlnYSLu4zgLnpn61q2sCQiEKHkmcEfM2Sp6nn0xVQj1JnK2hQiglkt5IbYTrL8xQTKoMnQcjr0Gc1t6fYm4W4E1v505kbDeWBs+UcBh9KntrGAss8+9pDGwR9gYhT2rZs7W2jVcfu+N7FH2k44GVPtXRGn1Zy1a2lkYWj6PZNNKRBGlxtDOGJ2dOcZ4z79aiubC2S7iumgKCNwjEZOM9DnuK6+BQkZdWQWbNho9uSCf/ANdVbmJo8F5N+5ii/KMEdgR04rp5VbQ5VWdzjprYPZXQkll2o7IZLd/nPfbnsDWPf6Lo+p2VnLf2jqqEkFVLbUCkkFs5LYINdpd2EU7BUA8wNuwqkBivXPrwK5m802O4klhtp5lTzPO+Z8DG3gYHscfhU89laQ/YxqNXOWvNK/sazubWHUVutP8AKVbWMRgCMk7tx77hnGc/hVvwlcxS6XPaws4uY5SHjx99D0ZT25zmmyWS2sVyzTKEOHCA7uemCPrmk0eC6sftLL83nD5MjtnNc9apzWsdkKcadNQRbu5goVZJB5Z6qTlgD0IHrXL+K7hTpMoXH2iKVDgjDOoPJrekhhe6N4zbnzgoegXpiuW8biaOxSQxgrHJ5aSqfmIIBw351y3u9S5K0To7XUo10VzpUaNPGoO2ZuAcA7jjHABqjcqutT27ykJaQKwcIwAZnOCxyDntimeG3Q6ZHbOrM8ziJiEyVBUZGaglmma4ezst5t7Zzu8wDJx24A4rKLSbMX71h2tJf2zweHYzbw3FxcpAJok3sABwyntwRn3qaz+H1teXs2mtfTLaQcXOXKksGO09DyTz+Nc9JLcWfiCx1GSWN5VJym4ggYxmu10PxCPD8bXc1rLHcXx4k3lwy5POM9eKpxcmmio1J04s5qPRTf8AjaW18PyzWVhpcR8yaMl2eQjDBCehPNbX/CtbOy8LXlyjTNchJFceXvLqcElc9GANbngq60yLUWknkEck4N0X2kBmJye/Wum1TVdNmhkisLmcpKrMoQ7QrNkHafXjvmnGm5PVmcsRKNmjk7Gz8LXHg77PGsr+TDmK5WMwsdvbIGC34Vw/gywkvZGm0z7PZ3FxcARxu24sARuDMeOc9MV1PhCO0s9Uf7Nd73KEW9vvLIHJJbrxnPX3zWn/AMIBFNC2o3wQapcKbt4o5Cihwdylcd8IR9PfmsZQk3Y7aFanBNt7nnV7pt5f6zfavf2ExnSRtqSP+6VE+XdkYwBj9KqaK8beIrf+yrfyNQU7Ld1UytOMckE9eD6dq7vwXaJJ4ak2ILq5vraYT2kkh2lsk7QeMDpn6mprGaeG/tS2lRblgiQQ237uW0YnDbGOcDjPXvTi2/dLnOMW9L2Or8H+DgbZ9cu/ObUHWZVilm2FORuO3GM4X8qwtR0KXTmvlvIVbSryc3onSX50TkvGOOORjHpU3jiOXVNIjjiv5bG0k3B2hkYtG4G35uOAckk+tcpolnrPiCePT9QWXUNKt50W5vRMSjIoPyooILEZ5Oeg6d6v2NtlqeZCrZuTejMTQNHl1bUNRuNIsVu7IFJrO1inS3klDDp84+YDJH4VD400S48CSWMNpKjSXrLNCiyBzayAkMGZTyRnjtyetbXizw3peu3WheHvC8sghhvLiCeYHcI0hUO21j04buetcrpEej3uuw2GnWUq6VpwmcXF3gySzEcMSOMAjgVsnFRTe5pS551E47G1ovjzUtKuBZWKyxWiYEpJZ0UE45XIwTirK+N/E3h/UHkvLWEWc5MqpscRumTwOTn09jmuFtrm+XxC9mFDWtwUEgiy3mEEkHGf71ekaIy3+rJaX9vM1sERJYZPubgSSQf4c5yQK56kYQSckdl/easUfDnjHw1qclzPeWc+l3WGk3oS6YxjofftXT6fqd2umxSTWlrqGmMC8V6rANGB/eyDto1LwFpl8l7eQxiCydzCyxOBtAHGOPpzXLXOnab9lSy0e4vZIDKBM9q25SMEEEAc4xXO3Fu8TelPn0Wx6Nb+IZFRbS6+z+dtTakLKsnJA+Xg5HOetaegT2Oo3M1tqVxNc3kTsNkrbjEP4SB615npHiHTfCdhAmpMb3Tr9MRXvlbZEP8AdI6gjsR9a7bw0NMg05dRhE9zduyqjK2GlTd1JPUgH9K1SlzEVqcIxlJadrdzZ8KJLLPPFczXErx3B8mYLgtyeq44x/TNc1e263/j+2i1GDM6iXbLyHLKQRuxx+lehw7IHnitZkWRwfKJHzEj3HcdK4DQJm1nxLqV6smZ7U7Muvytzgkflit1GySRy+0U3KfSxc1aJEt7iG5nXzZG4UDtXmmoh8O0MWZDKQ23jAHA/QA16fqcZkedI0ElzK25W/hUk4OPoK8z1xZzcK8rLnaFJ7EjPaoV22Z0/hIvApCl3lYHYwVcDkE812N6dyTJZFvOKkkg8n8K4DwderZ3EgbhweOM5I/+tXoE17EtvHfW7+aJBg/Lz713yV3cjDy5bIm8ByaPZyyxarFbrK6Fy06HcfbPY+laN1LpN/eabBZZUvMF3RDeRHjkn/8AVWdODc24ubEgSAbgGHBwO9Ojum1K7SW0g+wtHBlmRMEuQATn8K0jO0bNHU6fNP2lyrq2jT6Z4hitmZZBI+VVRwcjIyMcVs6bZi+tpPI3q8bmJ128q/XnjOOfyrN0+3vDeG9W5l+0W/zFpHPI696sad4nm024vn8zfc3R3MWbnJGAQMegFTyxbLnK0d7tWNzTvBnkTtczRSXjBFEaZwWYnkjPp0/CtTT9Bg06O8aRHmO9mK4yc56fhXEwfFiJNkU9/ai5Csqb9wAI9+xp9h4wt7tbiOfWrd2kO4lJxuxk9v8A61X7SMdEjnftZ/HJWLuoW1tPb3b2QKMx+TZwM+9Y0bH7OGd9jRDBbb37/rWk93bQW0MNiyHAycHuTnNYGp3TSNFYQyKj3D7QOu3P8R9s1zys3dHWpKzudTo1s2r+FriOSZZVLMUBXp1/z9a8zXzNM1KS0xLGyHoAeR1/PnFey+E9BudPsktGuVdkUbinAck8/hknFc98TfCZmj+22UpF3EGDbhw/fnHetJ0+aN+p5lKqqdRowrW/aVHiijfkqcMcBv613GlujxJ5mQ4b5In+8MjnFeVaLdtPFCFUFx1YNyCO/wCdd7p2sSjTlcyJ5sLYwVycH3/OuaD5XZnfUbnG6OzsbdbUzZnddq7UMnToDwPxraWKUOu8q20EE4ByuPzzWBbeTLZkBi4BzC7N8wLcsK6CwdSBI+2N0JJUHcTXdB3R5NVstwBWjUw/6ogMwxznFLdXDPasWTC7WZMLzkdP1p1nKoAeN1kUkhWAxnjv9DxWXqzwtdxLIHG4ryG4HfkVcpWRhGLlIxTNJKI3kVlcsN+SQA+PT0rFuLYbw0DorIGwqggbt5P8quaxeSW2qXKrGgtZAHBBJZWzj16Vl3hmWSN5/mRZgw2HbkHjnNck5HqwjomQxQwC2mjliUPLIG+T7xwcnPtmq1wi20G6KUCM7vKGDjJ7Z+uav3/2VnmjiDW86jJlA6Lms66YFAImG2Pkbu+D1I/OsWzTyM6JHtbBvtYjMoHmBN4PFcd4/kU6JLCpMaSOjAk/xHB4NdpfgedJOjxlCcRgDg5rhviP5snha4lkwwSeNNoIBQ7jjH4VC+JDn8IeErqe3+yQzM0S3IBLICTxkHHPtXVpLZrZBLJNpkJYsw5Hu3tmuD8LgXj2hwYyAY0kdjgPjj9c13OmWzTKSQFVY/IIccsFPJP+elZVVaTMoNNJlTVtNgurBI/NjW4lG4MF6qD0rPl067v2tJ5Xd1tgVTHARcniushWGG1dpzEXzuQgYCL6ZPSo01jSxeGP7bBsXarIrghs85P0zRCcjR2WjOT8P6dcwNLDFLceVEcqHIOFJyeceprvdBsGjt8sQ743hcdDk/40sFxpU5lhsLm2eQn5RE4ORWtbzG1YleDsxtx8xJNNuXUzk4vZGJN4fjdVS2hFuYsypJHwQTyfzJNFxAbOL+0bZ7i4vYVAh3SnZ3U5X8624hLcXRjU/vmyPYACrUOnpJFFGqjlSGZjnn8KqLe5NoqykYlo93dwl4TEiRbiFZRtJOAenPb1qnFC8uss2oT3PnzqSqxHbCiqTtI6985zWzpekPZSvsuFeM7yEYZUfX071dtrfyhLEsfmws+xXb7ygdSB25zW0bbjqKL5uXqQC2nurE2Ujwyaev8ArI/vZzyQT6EjOPevO/h+1zZeLddXTNJW40i1kW4aKOUxCOTYA+3npgnj9a9S0ux+zNMVU7GJjO87cg85x61hx+G4bRri5ubJVJnlkM1tIc7W4xjpngVU5PeJyciv5HEeLovDWheEtUu9LvNTtRqN0xSBHKbWIw42HJIPOSTyBXMSSGfTdM0Hw9ptzdRzIBPfLCyrJzvYg+ijI+gr0m98E2HihbV49Ua4FvN576dcqEbk4J8wdcAdBWvdI9rqltJb3TWMemxSW9iqKSjFwE3SJnG0Dj9azik3aXU64VvZq8Vdnj2ha/a+F9Yhi05IpLcy+fJMzAvLEACEDEDaTzXR2viOeWCO5tIrCWGWB55FSUsyfOcKRx8wHFdH8XRo1n4AaI3mnjULdBDFaxW6sSwYLv3fw/KM4rc+Gtv4bj8G2NhNb/ZrhYFke4uI0DMSSx59OfyoxFOLXKmVSmuT6xOLbvaxVt9f0rxJpcOl2CuFmt/KnEo8vErEHYPTOevNZes+Ho/BHhi2u9CmTSL7T8pKJ90iM7n7uehPPpV66vtG17xTcS+H7a1mktVEM5iyoZgflOO+MdRVnx3p1nqfhZ7e7le4lmIuolLMBuTqrDt0rmg+W6saNKHLbS+6MACHUtNksNVura3ltbwXLtDbiTCFQSoyQMHPYVvDxLaWdhBLZXBRbObKLgZaP2GPYfrXCeFIZddv5r+6gxGzbgr/AD7e2BntxXZzaVaz6Qolh+Qy7GZVxsOeBn04Fa+6thtOKtN9RNc1m/8AEssos52giYF0utu0xZXoB9a3NGA0zSo7aOIO6IuXUcvn5mJ+pNRWVlBaS2zxwyMtsSGAX5QDg8iqlxfeVqMESOYg0bM2eQBnGPbgCjn0ujmqJSfLHYjutR/frFBBMrO37wAfcPr9K8/1eFDeOuJ5Qp25xjGB6V3NzOLrU0UFvmG7fjhR6HHUVw+qs6atcDzGSMnOAecjA79uKmGpUVbRHMaarMzOHZQSMOvBB9s12/h+9SUiCb926HK4PDevFcPp85mQHZsGdvHpkkVehNzPEz2NrqE7RsUL29lLIu4dtyqRmvSir6HG5clpHoYuUmbbZ3UbhEGY+nPTk5rVj1C2a1tbW4tUhYBleYoCc9gfWvJZ59WhvI7+PR9Zt5bU7vMbT59hUdc5XpxXWT+IUuNFt9VhZ5WZtywxqNqvnj8DyfxqkuXVnWsRCa0exzfjHWtQm1lPD1hvtAMNdXGMEA4IwB7EV1Hg3w0dt5A939pmhnSS3vpmKbBjoRnoea5a7ydTmv5ljfUL1gEiSXc59Mnpx0rvtBsYtQ8NPb30ZKRq0kjxvypBPbrwKpGT1u29WcHNpNleeF7yS9gHleZLNE8Yy7vwPl9M/wBKl0nwlYQ+HI7zTvN/tVkLSxylf9WD12sOv49K6rTpF0rT5NLNq17uX/Rp1j4CkLtbrwQDTB9gFlbwx2XmXnmFf3ob59xOMEnGOBxUp6myjpr3MK0XVtRuBDYw28EwblWIjJBOBhRxmvWvCPhCHR5pW1KNLy9KorOBuC5POPbpVLwxockq51aK1juFcMqwqVSMEZAUg9ifzJrqryLBVbXLKibpMO3yEcd/pmlFK/Mc9eq5Pli9DVW2jtpH8okxhwj7uG5JII9gMCongNx52UMgK5UMPvMeOB6VmyXUiwP5LrDckiQSTqSHwPujB4Gat295M7RIjZuGRS0oGI1P90fnWnNfQ5ndankPjrw5JpN9LfWf3IyDLEBjjOOMVn6XrVv9qMfmbCQSEAyp6n8+a9l1q1ivbaWGYxZJUbidxbPJyPqTXhfizRrjQtS+22sKG1ikZtq9SDx064rCpTW6O3D1mlaR6j4e1K7S0TcEEP8ArAeCSMYx9a6XTLmJPmR3TeM5HP4V45pOqWtrFDJFcNLBLHlUPGznn8Qciu2sdbWfT2bSmEuwDMRb/P1qYyaNalPm1R2E12qIywTtuL9FXpkVSvJlEIEJaWRmXzC3Xb0z+lU1v7lru3SNfLlKeZIOMAAetF5mZQ6yMZHAJZPl4645onPQzjTs9SG5ihilYqSoVjHuY5PPI/nVENG8BimQz8lRIT0IJxjFEflGd5552eBTyuO9VZg7y7rYbIdpxtODuJ4rn5je9tCSbUfskRaW3eeOQ/N0+6D/AI1kxW7tdz3c/miN8r5R5wDyB09DVsRykRyzltwQhht469c0t80kUGYpnxtGS3T8aTdyb9jHnhK26RWy74wpSPJwcjqT+tcB8QGkTwnd+cFk8m6jQurdcHg13t6PtMkkcc+Ihbkkj7yMeD+HGfxrg/GVgZ/ClwoQRRmSNQinJYAklz7k06a95Cm3yszPDMvmW8IRgxJAxn7hPO6vQLXVPs8rpJdFw7EkY+8cc49AK8l0X/iXyMjjlO3XIrpLm9hj0aa9hkY3CI23A6g8H8qKlP39TCg042ZvQeZ4w1R7c3MlroVuuJzGwLzOAAoxj863ZdC8N6RCkj2hnsIpgsjwgkhTnBPXOT6dMGsv4d2up6Xo2nXekGC9s75iJLdpVRzJgnjP3uDg4xUV94gitvDtxZxWjQXEVzD50Stl0O5icnGAueMDseTWTdnZHdCytqdRpfhiwu4f7Q00fu0OA1qvGAeefyrodLtJII2ieQM2eJGbcRhj0pPhPpN9qFtHd3CGKwlZ9sAwsMZ56BSCR+NVtUupdPuLmxjhjaXf5cbKNoY9c5J461ry81PmZhVn+9cY9DXtd3nSbJhtjZsnoWJGauPdQW1hHINkLAY5O7PQ9Pxrj2vSWSAzAXBYl2UZXd0xU1taXEaz3crSSx8RRKxGST3HHtXPzNClRVTW5sjWXn+0HTg22PK+YU27WyM8HqKV7ma1YiG5e4uA5DMVyG57Yx2rPtbO4kMBubiONZMbjvx168fhWlJZ2otnK3EYuDghoskjn9KpTuN01F2Lsd5cSnYXkeF1Ib5ehx2/Ortvbt9naJ4ZV3FWVjjL8A8fjx+FYdjdSWrukV0CFbLbznHb/wCvTZtUuJrj5I5TvwqTCPlvp6DtVKRnUjd8qNq+8Kpdqs1m7wXXLMN/fGeK5e/GrW3m/breWRJFEUjgfMF4Nbel69PExSQq5jc7g4KgA9cH1rRuNTt723Nt57QxqQXIQueT+oxitJOMrWM1KpB2lqjzdrDQ4r+a7ZZ7q5Z9/lSNuiPy4wVxjFO1nWL2+cwxaejSSxhVzGAoA6Adu2K9Gn0WyyTFEDB0BK7TnPXPaobbRLeO9lMUSeZF8rBwWIB9MYFTZbHRHEQ31ueeR2esW/2d7G3tbCUgq5t4wCCe+e57/jUl5p+q6giJf3swVAy5ztyD1HFdtexSEpGpVAJDgkYzgZNc/PdTtdKokBtwC5U9QM1nJ8uhtTquVpWDQtPFvHHBCQEiHXucdM/hV7VUjSxMb4NuZQ7HfjD9uKWK7giJyw3su4AD24zUZm823L5Oc5KbflPPqayi9dSJtttscFTeGMsk8gGAFGUP+9k+vFQ6yWiNvmGOLLgyqUALjb0z161De6lb2NuHYyRiRhDiNWkLOegCqCSfp6Vmapq0flhbbTtXm+VummTggke6da2hCTWiOaU1F7iXojmnmV5kt1wqoUYkk9fyrjJ0judQnkVl685zW/b6nbSu9jJZXsVxHH5kIubd4TgAcjcozzkZrmpXR0aSTcrM+eG/z61Sg46MuEk1dHH6bc8FwxZD94e/+TXuvgrxSPCP7O/iLWon23Ed1cx2vcmZyqR8d8MQfoDXhbwhL5nUKsRPzdsGvQvBvj6z8O+Gl0LVPC1vrUEV+1/C8tyECvnKnaUOCPXNetKKpzaZ5Sm61NNHcfBXxfea14B8Z6HrOry6vqWlwySJdyhg0sMsJI+8Mnawcfl7V87aREBbwO7SPDgZjWTbnIyR/Wva9Z+NlhcS6lcR+CoY9VvbJrJ7wXo3+WcgBm8sfKCc8mvHNNW2M0ET5URxhmHZiDggd8cUOSsTFWdmd34d0ee7mW50+PzrhU3PGFGOOBtP4ZrqI9cninisp7T7LNBDumkj48xyx/8AZSB+FV/DN5YIS1rPDtuYo/LQOUMbZIYKPoB1z1rR1eXR7jVLRvkhRcxuxbJY9QDXLJ21TO+EU5pNGtb29reRqhtmDrKrowk5Q9QeOoxjitSxsbdYV+1EzFWBYOuOVJ5UVxfh2W4XVWtpEZLVw+wj7wx6GvQ9PEl1NAQm9mTKE87Rj/DFCldXRtWjyuyI45JYLSfddL5BbcuEwUXOBWpYWxmiKebI8m0iRcfLzyDVEJPdholQyMV2tkYyB3I9as6eRHGvmxyvlgnmM2OB7fhVrcxkrrQfcpOsCqzmcpGdqAAFjwOR7f0qLR5BJYzWeMT2sxG2Q7e4IOPyq1cT5WaFJQG5xKi5ZcnOKja1RbiW78krNJH87N/EfWqs9yUl1JYYJUZ/MXLbBI0j4ye3OKxtctI9/kC3EjSJtRgM5B7mtIXfltF5w+ScmPfHlsEDIGOw6VFBdjy2P78SFfmLEEgnsBjpUvbUWx4jrmgvoV7IZo3SylG0spBaM/55rofDlx9msxHayGNQMbmAyw9TXWa/YLqFs9qSfNBBw6AKw79815UZJPD+ttZ3IZ7WTJjYnJB9Kwkmtjrp1G9GeqxXnzFZT5kypuRc4JGKm+3SSxMlxBs4HlsoyOn1rj9PuEmliud6tLn5duc+mDW9DaxJFLMz3CsTnG7OKzcuhtpa5ailMDN5gIjx8yuOc9qjZ2TM0C+eTgGM8bfrTp43miRVPCkElgcn1zUM80m5liQBFcLv7EH0qCd0N1KZnjEbjy4nBB5Py+n51BsU2ccTlhGBnYW4J9+9TcfcugzRsqFWI4Yg4qPVIhKqsihlEnBzyOT36HpQJMzZ7ZVXbAyGdwy5wQmcZ2nuePeuc1S1/wBDELswk5VQP41/H06fhW7eyI0MsskmxQB5j7Ry3Yj6ZA/CsOAONVigcM+wEBj0Hfj86NhOVkcjrGmutu09ouJ4TnaB1Wqsd2ktmybSqEEFcjJyOcfjXd3i+XNlVBC8YI46dK4LX9N+yTvc25xG4JKj+An+la05czszmnBw1XU6XwDdRy6E1p9qhs1t5Hi86WME4bkDeeB9QAa6jS5pLq+s4tTsIZrLzWhjNkwZowRguSRhlI65BPXmvMNFuZNNuEuUija3dh5kUnzIxx94g13Nj4jumtzBClpDtwkboxBJz6fSpnS1Z10qia03NvXYUnurLSZNSu9IsIbnFjEhKoy9ccdM56n1rrL60sdPgtobJ7SK3aUB5HBl8w45wSc5zXnBjFxrEcjzzeZG5RgWBXPbaCOPzrsrGW6uDEhtAY0fajuMbmA3E47Y6fhWfMopxCvUc4xTJ7x8faJI/J8612lmfC9ecAAD1xWpZ/ubQSahGZJlbIhTn5cblwe555rFby5rjN2CRdDz5I3AO0A8cjt3rQd4JtRSeT7RshhbyI1b77YJzWdjKVm9GOutRs/sb74hEzIojLDo/pj8avaeY/K8mSZChVEJjOGZvQDbxj61n22nrdq7zRK0iFJgqnPzNxkj2xXSwWM6zeRZ5gkjhEvmbuGOMtx2IzVwhfUzqVUtiGezsYdMbbaw3qxEzOjvgp6dOT3PNVV1Iyh3gmdEaMsIVQcDPBIPOAMdKvWlrfm0eCONJjcRExy8LxgZJIxuOQcD3qK6LxwS3M9zDEkKmGSJoVbB6bd34Vr7O5zqpzbmXdS2Ukjxl7uV1l+UIhX5e/61HfB3miEVwVaPswO5R1AJ78VmSyXmoXkB0iCbehIZVOVbPQg9cdax5NW1HRdQlt9TtX3u26PeCQ6nnr7ZxUOm0drbidvbS3MkjJueSNADKFfh/Tg9xV06zeR4u4mZFadLZvMUAMG/iBz0AxWPZyJPe+baMsDuitGy8nphkHvxUU88kNvFExy7tukVlBBjPPGf4qSfKzBpTlZEnjDU5bBJ4rkvKkEqIWXBZC56nHXIweK5e4EsFsmGjIlYquHyzn0A7etal1ewNZ3M7yKkqvz5g6gdOO/FVtMtFtZEuJJI2hEBaAMPmSUgfN+Oaio+ZnXT/dxJdMedDCk+0iRQQejFs4AHtxV5rlBcrE7qcvtxng9iPzrHvL6yheRJpGNzGjOT12nAAxjt7VBHPFY2pjI+0GRC67B82WAwSezHk4qFBmcqjZsWk8f/AAkPhaONw3/E2iU7Pu5XcDXLfErxJ4rt/GHxCn0zVdehg0e4tWhkt9Sijt7RCil90DnMuecKvfr1q6t3Lp1zpF3pdv8AbRaXcdy0TSCMZA+5uwfmweTite88RaJrGpS6te/DHQ7y+dwXuJrpHdmUDrmHnAAH4V6WFkoQtJnn4iLnO6E+NuqCXxJoN5aP5kd3owdHZSuVaQEEjtweleV+KbxIore3jYtcZMjAYGFxxyPWt34i+OX8X69b3raUun/ZLU24i+0ebn587vurgdsVx+nQNfSSyFVcn0zinUS5uY1o3UOUnaw1ImRF0y9Yn0gbn9KpLFeREpPZXULZxh4WB/KvbbaCdShJLOx65+7XGeKruU3MqncGi+ba45//AFVz1MxliLJxtYuGAWHTcXe5xNxa3k8LQwwTlsZxtwaoDTtX2Bk0i+lbpvWFm4Hoa9SsrZF0+W7k5aSIfPk5z6CtTSS4gI8weZMgMajPbj19qy+vumtFc6pZeqrTb1OB0satcfZZJNGvbZLdCo22jjew6HJFdJqVhqdz9jtrXTbpYEQNK0cJdgwY8scck9a7yOf7NpV0zllmEJKqw6dM1asS9rKZQwCyRgnHU9+TWH16V9Ym8MKkrp7HIm61KFk8vSdQZowdrtbP8xzyPYYpP7b8VTOgttPvbQR7tmIzjBGDnjNel70CQSrExdjuznI9KV3cuxjbag4AHc47V0+1fQXu9jyi3n8Wj96n9oKEyARbt147/jVlPEXi61na3YTSzICwRrclnGfavRGuZp5HWIuFQ9AcbjgdqyJNN1G2u5tVnnjeeQ4wn8K+nQ9qlYlrYbgutjnLXx54igvY/tei3ARADLtiIbnOD9OlamnePrm4EHm6FfIWVshYXaM5Y8jv+tVr+5W52qDh3YiVsnmME4FW9KK2k9pbE5BU7CO2BxWTx8k0rDeDhON+pLPrtze2bQHTb+P5wEAtnXZ1ywPrx3qtDrU9/PDNfaVe+RAcoViZdy7ep9TnNdNd3TtZEM4zKMLgHhsAVi3+oXUBWytN629piPg/eGOc5/GtKuO5HdrQwhgVP3VuV7S5e5RIwGMzSl41mTACEZwxPNcv4p0177SneGzlhaF98alcljnBwR2rrpLqKb7PdQqFntiC2TgMnQnHc1rRyQ3aXsmXuAAFiA/h4/xrFZjKT5Ui3g1T1kzy3SbO/sL6JIbZ/NdAyopyxJPOR2rpba/ghvZor9o7aQffDuQwPbj6VrBk8OQXWoXYDarMP3Qz82AOK89jaeS8kvJ0L3Mu6aRichaqFdt6ocqagrp3O8TWtP8AOT/S45FwQxOQM445qvJr2lFtj39nE2VypkHJ28AfnXFrqCWwUzOty7fMFAHJI/kOn4VgTTJPdNdz+TtQELGq4Xf0HHtjmvRhQU1qeNVzFwbtE9I/4STRbe2eKbXbFZckbZJgW6/lQ3inwyipGdb05ocB/wDXAMrgn9K+fdciRL3c3LmPfn0yarvGjGMhNpOMj6CrWFj3MVmU7c3Kj2yfxDo0drcwf2pbXYdhhfNUjYW5weOeBUdlr2l3erRSpdR+bMT+6EinHsPwrx1YlK9MZ/xzWp4TCp4n087Rw+aU8MlFu5MM0lKaXLvoe2yeHNS1FmOnxJJu5G58Gsm++H3im48xF01GR12svnLz+teleGZQIIypO4KBXRhjgbia46atqeufN0Pw38bQ+aF0PA3Ls3TIRx689K6e38CeJ4bqSc2scIldH2CVcoCSD044xXs0zyEYDZUetQhpDGDkdcmqnMcKfLqeZ6X4K1aCMxXkHmJJc+YWE4LcDIPSugttJ1G1Dq8EZib52+fBBJwQPQYrqWl2oedr+gqASGSdEMny45FYNXLUL7nIJo2qQXkhijZ4HR44g7ghAWPA46Vp6Xp1/YxKrw/vFiaMkkHrn+WcVuvGRIG6kcYP86a7YkALngdDTG6cTG0S7l06SM3CCDqrEDIccgZrb/tiwtDH9nu5I0aNo2k2btvTqT1zWHfEeaSq8N1x0rKn2K6xOMBz8vPT3rSnK2hy1KCs7HaR6t4fmlX7Fet5wZliZ1IKknBwOn8J/SqZtUutUzqLwnTEcz428yt23DuK5u3MNrqMCz/M7hsOAOB0BraillmmhhkdJCTgEEAAe9b87ehUcLCMU09zU8Q3JSyul0C3QXBEfluF2BEY/PgD07ZzXGX9rr2paNqGnXscd+xDeRMzhZI/mO0E/TFdU0mGLAndESsgznK1lQXXmTO24JGzEhT9axqzadzop4eCWmrKfheOez0i0j1MLFcRJ9wHOGBODn3GKkhiQzW8bO5EErOi54+Ycj1xzSXcmZ0Qjdk7iaihkzcM4U7UcZ/Ks+bmRLpqMjM8T6zovh67huNfRj9qbyg4Xcdqjrjsegrmrjx14VvYji4kQuhX5oH3fhjgdKi+N0YudAsrsKdq3LID9V/+tXj+AMDHTtnjNdtHCwnC7OKVecW0j2B/GHhvyxHBczSiMq0byWxBU45BPfkmoLbxZoyGGKKSVFO5pNwJUMe/r0xXlEZKgjJ5bp61OtwVfsR9BXRHCUjGVeoeht4qitl22oDBSwXKnnPc+/vWDqHiK+njMb3Rt4gCuyMYOD2zWGL2Nhgjp7VFcTK6YHetPq1JbEqvUb1NyzgN9bMLLbJLgA5POK7XwlpsVgsjajw5UABeRXnvh3V/7Ldj8pB6g10H/CaRgH9wSnbafrW7wlKcfeZzyxVenL3EewTalAXYQgqQ2SCOtcv4thmlnN5s2oYykvGcjtiulSzkM4jaMPjGOMd63X8PounXA1CVUV4zwe2CcV8vSvJ2PqqsVys4W0/0uxtYFUbVCsQe+BW5odm02oxbVEaqCOmcdenpXPeFrqN3ltSCzrIwDA9Vz1Fd7Y26wxMyy7flxvHeueSfO4s0hJOLaKviF3+wXEd1EpYKwVlH3h6Gs+C7ju7KOKEsFjCggn26Vqana77JpWn/AHQHCkc5rl18y1vgUGVdd+3HGBwazqJrQ1pWaR25uXjt7VYUwoGDnnvU2orHAqmEneR970J9KwdGnEo85nkAYhypPQDjgfhWo0rXUkjAqy5ynHRcd/euqFTmic86fLKw+CPJzIWyRnfnsBSRiSOBkbdtd8gqxyQR6VZiWOO0Wa4LqhxleCT34p86MMmVtiFvlVF7HkVrGFkYyndnMf2cjwS2xjcvEx5JwxBO7v8AWoLh9kw8uIrJEcgH3ArfmiSSdSsLeauZE35O7HHPtWJci4uPMuWVYwhO4ZyT9K5a0LanZQkm9RRetuKbpFiRdwORgH/9dJPrNppjW02oCOUX2dxzjY/ofasO+kaG3uVUv5g28EY6806OJdT0m9mlUM1r+82kA/N7+2Kw9pJ6HTUoxWvQ6Oe68NanbOuZEfYQNhHBBPTj1qSw1x7O1+y6XbLIxGAxU/rzXnkGll9ewAyw7vvq2AT1x+Vemacbe02xxIJAy5LkHNXThLm5tiMTh4UoJXcrmBqelXU16b7U/nk8rALHgfSsc2IkiK24MazcvID90DtXU61d+fAcOwK5UoTwBXPRMElihB+UgO59ulac/LLQ5fZucbM831Wzkg1F5IjJ5cZ5/wBoE9BWdJPGRvVCyMCUHQDnr9cV22r79P8AtNzI8cjM++MEgDaMgYrjViiZ4oZAXnf5xz0Xb0r3cJUc46nyeY01TnZdTkNRnF7NLMAB5j42r0AHAH6Ukb7pcHqF/Wtez0OeS63RIfs5dsEjoT0rLSHyZZkc5eJip+tdri1ucHMuXQmQZVfpV7w4dniGyOBgNVFPujFW9HIXVrYnoH61E/hZnS/iR9T6Z8KkeWjOTgqMYrrpCMAE8Y4rh/Ck4NtF0+4OtdjG6ADeSTivJTsj61ISYsi44xVbzMKQxxjpT719+NjDYO9Zsjsy8VDZohZ5dzq57dhTA6O3VlkPOQai37QC/Wm3MoDo6px3xUXLSHR6m8L+U43YP3iaLvVEiV38ozBf4O9ULl4CT5w2se4BqDeAgXh4xxkdVouxvUtTzw3EPmWZ/dNzgfwnv+uaxNWmPkrIAAy42nH3ueamUCIN5TkZ7dqzfENybaxjZJNrBwMAdBWlK/MjCb0Zt+MjAbq1lsnDW62q/MowM8FufrntTLC/y8L29xEuGAKAZLAjPWorPUIZo/7NNn+9mhDRXCpkspOCTz65/KqMenSxytDDK73dr5iGU4wwAypxj+tbw96TsOupU6UfM011Ka5uZltklkLybS44Bxx0xUbCSFHaRTk5IP0NaMOprpWnrHpwK3S/PMZlzwxyDjt1rHfXl1Sea2umJvtjYaMAITjI6D0xRKUJe69yo06sI+0a0JROWni+bBMZfjtUlmxeydskB2zXK6HevdThHzuUlZGH8I9Pzrq4sJaRxjr3/OseTkJlPmXMYvxJsjefDq+Ea5e1dZR+Zz+hrwMNlRxX1NJaLf8Ah/VoJB+7a0kz+RI/lXy4g2kqfpXoYSV00edVVmvMQc4/Om9HOBmnr06GjJ3HAxXYZbjDwTkD8KQEEdvbmpACXYdD70oB6YAx7Ub7iskMViAOB3pAdyDd+lS5JAJC8egpOgHGKdwvdH0Yuq61fu1wlkkEURImnkbC4HoOM159eeKtS1m+uFg1G4e2kcxsDwAo9BVHWvFWrazBa2l/dyz30gDfYraP5UU8/MQeTjFQwQRaJKtzNbT21w8bcMysQ3bKjlRjua8uGDUI3lubV809pK1LY7PTYLebTJbyErC8MX7nZ1JHX82zXY+Gb37dDELlWjuNoMgc8dO1eaaet3JO0EDSzM8QkAXABHUjGOT9MV6Jp0K3unCOQeSyoAvzZwx5xxXBiYWaZ6mAnzxaOh1e4W0t5DcFPKkTapPb36da4xvMk+xOSXj8wwmZewPIzWu07NbfZL9GE8S5yzcEfSp9dtUttBsLlZdqNLmRRyp7fnjFck3zNtbJHoU2oJJ9yvEEsXW4APUo+eme34VrWErxWRkZVaWRiBxwT059qpW8IvI5WY/uSAoXocjoalsnkjuN7DEaoeD93dmpptxa7FVbNeZq2dmyBy8jGbb949B+FacwmVFaDKuVDEOAegxUdo0VzFG3zK7Lh1HAFL5zeQVD79vG5hz97FelCzPLqNylcZIZIblM48qVDncOhx2/GsCaDEMwyvlIQQB0ORk/qa6PUbmIhA6gjPlgjtxWVmNreVIhuQAoM/1rOqk1Y2ouUdWcBr6scgS8FgDj0q54UMRtdSRyBGyt5hHcYFQ+I0EFtHlRh3JDD0HH881Q0iZY7BhEd3mkrtzhjzz+FeW3adz2mvaU1YvmMu2nRWZBLTSPKT/DgfKM/TFdVDMZLbCj51GwDr81cjpLm7v9tpE4ZJGd2U5B3YAOe4AGK7hE8mF40XzpVBYlRg5zxmuyN2YVpaLuc3rMM8UIAAV3xuz0HPP6VnMnkrc3UhHkgEA55PNbetiaSIOAxMmA+ekfFcr4im8vT0W2jJCyAN6kYrCS96xKl7t2c9q8kl9A5WFhENwQqv3hnPOazfCVmZteuJ7phuhiZsbgQPQVoapd3N3aLDsYW0CYUfd59/Wubj83SLp4N3zXMZIxxjgH+te5gppJs+YzOndokub2709ZFhIHlkOVx6HIrmb64F5qM11jYZmLsPfvXS6oi3GnzTqxDbAuT3xx/SuRBzhlO412063tUzx8Rh3RkkyZCMYqxY8X0R7bs1UGRgiprUt9oR+4PFW1dMwpr95H1PofwdL5mmwBOoXH6muwDSBQhwSOprg/ArM2nxMFPJxkdOtehrCyx7zgkivHPrYO5UuidgRSQD1NIEUJxlsDtSSmQk8Lj0xUEjSqAQAPpUssbKdy7ghHsahkDyoCpAZe3alneaQsQwx9Krs7BFYttA49zWWzNUtCO5LgYJB+oqk0xEhQrgN1I71LL5jYOCU9apyq+4NkjHQU07hsVzlZSVOFRSTmsXWNS8+NYVCEcDk9ST2/SrOs3LQK47SLj3J9q5u2k33Hmu6mO0jMxAHXHP8AOuijFt3OSs+XVs2dci1Gx17R9V01m+zttspirk7M59sD/GukutRe1VrUeUW1BV8iXdyJIuME+hBryWTxfdN4Wl05ZnE814LoOGIAXk7T+daF14te88OW2nx2cn24FiJRzgnuO/tWkvdbcTqfvUYwk/ejp8mdFrurXep6ibaAJZtMfsshlyVVv4PmHdiDj0q1p1tDo97bW092jg5nM8Sl1LY6OT0x0x7VkweBPErWbKbpBeTRx3X2bzMHPY5/I4rd0XQPEEcqwXcjyT3TsXkiAkUnP8Tc8dewrDlfOmdjrL6u4p9LWIPDDQtcyKgK/vHmctz5nP8ALBFdOoaOT51wXPyZHGKs6fYad4Xtri51CS2nuVyYoYzud3YAEccYGKrG5uLgtPdGFefkUA5PPYegFdVVxvZbnhUYVPZtvZF3U5Rb+HtRTeVMts+SvYbTXy+p3DJ65r6V1dWufDurEAqPsUpUkY6AmvmyIZUAYxk/zrpwsbXZhWd2CtyBk/Sjblicn6U4dCDScZOBiuoyQznOf09KUMQOQaco5OevrRuO2gGITzxkUmSeKcpyp9alghZ1Yhe9UkD03Og03ZaWJ+zQGO9mmaN5idwUEdRjnGMn8at3Mc1qsVnpizJMXC3DNyzEZ2gt+RP1FS+Ho7q/kvbl3ZbWWGQRBF2ndj+XP6CtddIK6LfrtSDUnKuu5jlh5bbsHOOSBXJUqpOxyUsLVlDnS0ZY0HUIbPXUsoJfOTyy8sjNloyo+fn65xjtW/aXwjCTafL5sMshVAqkF2zyea4rTLW4ljcfZIUa3Xy3DgneW64YEZ610PhaOKPULGz891S3BMKtKGXe3TjAI5yTmuGtGEk2elg6lWElFqx3OswC70+zvbnPmNL5TKOC1amrwlvB1vbxsm8XKsg7ADtSS2pnjt1l5wN3mKRtDYxUurXts+gyWhPlz25DqQMmQZ5IrzUlaS7o92TenkxllGWjdm4Ykg7enTrVdAxge2WUGT7w3DqM8gVPaSwyqJoX4ZMlT1HFSKDKY3ZeYwdoI6npzURjdJLoa81rsLaWVIXSV2BB3oBx06DNWRK8kbtI43uBn0qr5JCNuUrn5eemabMdokIZZHQAABgB09Kr2jijPlUnoQXsxRGKyIrZ3Hd1/Cq/2qWdmtInQTyxkAhTgHg5/I1A11Etkj3May3BfaqBucZ71ntJLbSajdW8u+CAKokXs7jgfgBWLnJu51Rgnoyh46niW8jsraQM8KCLju3U/qaLG0uU0dp3MaOivtDAcsQBwfxrCtlm1HxKlzMHKGIS7QBhVJ+Zm5613euW9vD4MuMorTzIBFg/MuT1/GnGKk3JmkKrhFQ87EPgoztp1qjIkc8SKhRfuuPvdfcnmukaC5DtOxPnseV+6Pw9a5rQo7m1stksZYBokOxhk/KCTXU6zMfsUV6pkeRVBEeOeT0H4V0RqNxSOXE+5U02Zi695tvD87s7MQXwMAnt/hXI6tE1uGWWRU8zBYZ3AZ6V2d+JLqeK4MDMUAJhZsBfXPrXE+JXU3flxrkF9xCHIAB71D+O5SfuNM56UPOVi8zzPLPQ8DrXP+L8XGtwCMHMK5yew6f0rdsJVOp30skiqhK726nBJ6DtXOXUjz3UkkcL7JG2h2+9gV20Z8ra6Hk4yCqRVtyQbRa/v8srZK/n6Vyt0BFeOiDBb5h9K6+KJTLGznqSuM9KwvE1k8d0ZUwzqvIHHFdWGmlJruedjaLlTU+xmDGPanocOMfWokyygjGMVJGPnBPSu88iCvOLXc9s+HmptDaJGyFkABwK9JgvhMu4BlB/hbqK8q+H0qmzjP8As9q9FsJUkIJJ3V5E9JNH01Nq/wB5pbg4JPWojIu0g9e1BUqmciolZVJ759ai5q32ITGWPBI9ajYR+apZdwXjB6VYaQE4XHHWkmTzBj5QvqOtZvUtSM64Uxq2GO0nOPSqEs6vxwMDv3rUvI2XAPKYrEuDGs4J4Re5qVvoO/VnMeIrhmBYDAQ/LntXLeaLPwzqV4G2zTyC1QHod3Jro/G08OQInATHX3rAl0CfWr3TdF01lkmkiNzNg5CckDPpxivQo+7BtnDN+0qKJ6H4R8Mafqemi0uYbRNGmthH9qUguZFXkrxkEHPr0q3afDvwp4fspJpvGEIv5UIgkG0lRjP3OTmuB1jwt4h8OLaxPraKjkFY0ZlRD2zxgU6+uNU0fTlFxcw/vjvZWTzPm9Qe1YOdk0j2FhudKrz21PQNafV7Dw1pd/okq6r5G5ZLg/LLznJ2nqBxgVx2kePri3tRHd3htYlVjJFDHhpHJ5OevPesia/kuorS2ge/lgLGQxxDAEp/iqCDQb2WWfUJdEvLiNJB5o3bCB3IBHNRBX9Sqt4p2s9Sfz59amg8qxuVQxsRskK+Ztyd3TjjA966vw5qH9pm3tbWPCQgOVlyXiQ5yM+uazbS+vdV0tYPLj0yC1f92tsjBpQWOUZs8Ejv0rpLOxsNNtLi+06/W5nkjQXODuMQJJxu7kZwfpW9KF5XODF1nClyvdm0zpeC7sYScS2rQ47AspA5r5nZGilkSRdjRuysvoc19IaMmy5jlWJsyKGD56knHT6CvDPHiIvjXVxFgBpycDoK7cO9Wjx5/E2YIOOvWjqaU/eP1NIBzXUJB3pD0pcHJ6UAfKM8UDJ7SEysFAGDXU6dZxRQYcjmuUjlaIDZ1qYXM5HyyEYxwfxqk0YVYSnojutH1OS70uBYUXyYVEXzMAM7Rnjr2rorK6iuZkZdg3gbw44Xbn1rymxvbjTJ/Ps2GNpDIwypB46V22hyS6tEtzY/vHjixKj9wOP6V5uLpJR5jXLcXKclSfY7+xtYLVJZCAJHYPnHDfLgfyrC0O1iS9S+a3WOYg7iOdjZ6/l/OpbjUXjsVjjSV7eXYm8Eb0bJ4xjpWnpHlvY7Yoj8jAOj8MxPOT7YNeUuZJnvVHBtWOjtric2TOZoGjJLGMNyvPTFR2N8kNxI8yRJcOhEKuex4JPtTLeAuhjWSKOQjchCdfanzJm7s/tSRfOCpO3JHbB/nWMk7JnVGz0L9paLjJCs55zGcZ+lWVeHzG2vllIOOnaqtvdfujC8QQpkRPvHQHsKh1K0kN1EYZN2UyEBHXvmnKTivdJjHmlqyzJepcJLv3IOQqY+8eOQaxrwPcXRTTplQodsm7Fa9tpkUkLyzQghEOcMRtJ/HFYmsyQ2arbJGvmSES7uhA5/wrKopSSubUuVS90pzR2cl/bRTYDF9rXGeR64FUPFVyZLc6VpjtHbwZkn3AZkf+E5Htis9muIrIakyqxJfymftjuBWe17JfMJ3hljTdk7uWf/AOtVKfLTtY7eVKSZoaDCbW3yqBpFUjJGckjv9O1aKN9suVjmGAuCxPAyDkVJpGmO8Q8p2bI6ZBIJ56Yqa3tSl7HCR8jNyznliOOPauVqUvQ0jyJO250+jW+0RyOyEs7EKBwc561YtpGUvbEr+5UbcgkDn1ovbyDSrFEhjAkPLEc8VUgldIS8T74nOCMdATn+tdiajZHl8sqrc2tBuqWqlZJpGIkPVg3BGc8D1rhvEkRgTMZ+d3DM5HY9B9a7WeVTMSMNGh3Hbk4Nclqrie7zcEeWcupYYDdvmHtSnK0tDanDmVmeb6jK9nqM8cf3SBk+p6/1rTiskOlRygcjOEB6Nx19uar6nZvcwTSkFSHGRn7uScfnjP41W0y4l+z3AjJdokGQe/ODmutTutDzHT5ZvmNG3tljMm4Kqq2QW5qvrlonmR+YrOTGWPpitrSYUu4o0b5ZskqT6ZPJqLUNzpICAxD7Nw7is1Jp3NpUU1Y8zvYHs7topOFIDKR055psRJdR25/lXU67pwlUhuTjhh2rlQHhm8uUYYDg17WHrKpFHzGIwzoVlba5698N2UwRj/Zr0mCIAb17V5R8NZSBHxwTtr1WCUGPnIyOlefUVptHsQXUus4PVqqOQWY5/KkDDHU0wKPMJBOD2rMsXzlCNmoI7o4xnpS3AGSPWqNwuxHIJ6VNtS7ou3F9GqDzGXbjtXLalqNqsVwN27d91T24rN1SYiYEu23vzxXNapdYySAEPWStoU7sylU0aKGqXAYM0pOByM9K6PwB4g1XSNMuLnTtOBad2El2AFIQLhQCecZBzXneoXDzRSlWyi9a9astVs18L2kFtbtIIIBtUDGWPJ/UmuypSXLykYWSuptXNKfXda8S6NNaTQWyQTRKjx8MQ/qGOT71yUXgzVJb+M3m3asiqBuyNvSumi17TdG06CSdQkmAWiGN3Pf696t6n4v02zWG4t5I7gM0ayDkMqHqw7Vg4Rilqelz1Jx5YKyLsngjT1txFNJN8pOzyZCm3mnWyLoMKmSKa6ijbEUkkp+QNwev3uc8Uk13fvqCy6fcwzW8gUBXYYGevA9veuI8Y6lfvrl3Fa213LZRlSzRAlNy8HGf85oqT5WrGNH37qZ0WsaTpNxfTC8kuLZ5wSA8/lrcEjCbUH3ee/tXPLYR6JczaPblDeTBFuBHIWQKACM/7Rz1rLLTX+pWoMc0+oD7kchwxUjjk8d846+9dJGwGr2lpaQPHcwRIbt9mCdvuepxiiiveuRmc/Z01Tj1OxVo7OOziQr5ixb8dyAM8V866tcG91i/uGJPmSs2T1617JqmplF1TUJBzbWjLu7IzjgfXmvEY87Ax+8eTXfRja7PFbuwySxyKXPHNKARk+tAx079q3Ghg4zilBOOaUHJOAaTtQG4En1ozxy3PtRn2FLjjoOtCEWnHXGcdK7bwXdraaMrvbyRxIx3XA6NknArjG4HFd58LFW+iurGU7lRwdsh/dqG4yeOefpWVWPPBo8fBVvZVVI6YWF1LB55WUGf54IwQTjblTj8av2lkI9GRsTJIsW0gnDK3c4q7ptjcC9Mc8tsYoEZE8osWVQSMjngHjFXBCV8zYzbItqPvPQljnHfpivFqR5fdPrKTTSk+wafDLBHFcR3o4TH71Px5H4irO+5VknKQ5ZirliQNw4GR+FVDdslrcykJJKsiptkPygYyD+WPypur3pUedPMvlKy7fJIO4jp261lKOh0wqK+rJY5fOVIIsRTsSrHOdpLHOfb0FZN1dyw3p23DqyMULY2gkccD3xWFf6tfyRao1mYJ7cyq+M7ZEYcZwOnSs/SLyd78QarKWYt5mHPRuwz9KhwdmdFGopSjFs9F0u5n1Byj3LGBclogRlj71lT2bXl7LNdsBGpxEJGxwPT2zmrWjaxb6Sl0s8aRvKRtBRfmPfBJ5rD8T+JptSsJrdLL7NcZEcbsBk5PUAcdKHTSSdzrlTnFystGc1ql7Nqt1GiLiCI+UFjPBAODj8ua6a1mxuZkjjPYg/oB+lQWmiyWqZeRPNRBu2AAD6VdtpYpnjd1VBGduMD5uOv51hWlzaLY3ozTipPcW11ZLYy7vklIBRUOAw5z+PFJa+ILS6YNc6fcQ3cuJLRiMqwBIPOc54rO1gQ/abCe4cbFuAZMrjC49u1dDFpVqX0+2YQfbJLmNrWdTxsKksPYA1cI32KlKnGLk1qx41H+0bYkxBHHJJPWmafdP57SjeIVI+QnOfpTLmw/svUEhlPmwlsbtp75z3q7FE0WwxRIpkGUJHbvxUST5jO8bWWxbkEyo4tGDAkEKFAAB65OeaxNQt7eS8kUxs8ZGwkHn3/AFq3cyNJc70B3MRlVxkYGP5iq2o3wS0mlSNlmKndkAD3x+lTKSWrCEL6GHdaSht0ZELRllDIOhK84rjL+1ltrl7mBHCykxuo4216fowaLyjcBXADOcHGHbvz6CqWqaOGs1LMG8wMQVHGQetONSUdRToRn7j3OM0WYPbhhIoKH7x9AcEGtmaK3iuiIY5GQbjk9K5WW2/s7XHgd1Ec4IyQeGz1rppo5ZLRQsshLnaXRc555/WtpraXc5FDlvB7mfMiyRBXA3tnk81y3iKxWCGWQBSFAAb613SLFI/yRyMUQhi64G7t+mK53xbBt8OTOQi/vF963ws3Goorqc2LoqdNtrYb8Pp3jkTD9H6V7JCyhBkktivCfBUgW6IU/NuBA7V7XbsyxIxwQRzxXZiY2qM8+nL3UW+uT0FMLhRuZgc9MVFLKSOCNpqnLKsWepPselYKNzRsvSzL5ZZs5A4rKvNQjCHaCxI59qYZzIoOVwDnJ6VjagzbiImBJ67apRI5zO1pvNbJBKH+72rhfEE2xAsbHbnkZ610+p3v2a1keVtuOAvdvpXB3919ruA+Nqr27V3UKet2c856lbB2gyHOecH0rv8Aw/fiSyllupzCqRfu9vtxXEWcaT3yLNIEjB69hXS27WMl/a6Zd6kkWmM+ZZ1XOBjOK1r6O7KoPRiWJ0y+W7k1O6kN8MG1OcxjnkOOp49CK3vB0FnrN3dW08KyxxRN5bnOc54wvsP0rOuPD/hS+voYNAvbu2kYkNHdR7t2M4KleTng9O9V9MsNZ0PxR/xK7e+uZ7VizrBA3K9CMEenrXBKMZr3WexTqVV7so9DovEPg2wsdGuNUiubm5uFYFVgQqgyeSeaXQbzQ00XbcapNZeU7ErIrMZQeoGK623Sz8SboLbUBagEGe0lXY0QH3s5964DxciW2qPa6TPHPFFlQ6RgGTBwQAOvOaiUdVYqhU3U0W/Ea2cL20/hu7BuNmVLghnU9jk8NwcfhWnaeMom8MXN5d3GbyCPyoBJjzW7HOAM9K5/w5qcNjcxJewrHD5haS5Rd00GQMHBGP0qa60HTo/GKRR3MmqtqID2odduFPBZ1AHcHpiuignqzz81qRk0kjH1rVp28Kra7WR764M0pb+Idh9K5fbwOc123xTiji8R2mnWi7Y7SFEwOhJHNYFjol3chCkRAPQ4r0KK92543PGK95mbHESetTpaqTkk11Fp4PvXAZ9orRh8GuvzyyhR6VtZGEsQuhx/2RWHydfrWXNG0bYavQbjSbOyI8wl29Qa5HXYUSU+XwoPApOJVGq5S5WZHSlGMdT1oPTnFNAwvUdag6jS6jFWNIv5NI1OK7QyGIEebGrEb19DVftSFQetJHzKPbtC1Y69M92qowuFC7Y35jVRxv8ATkflitmxhaCeEXZWUzyjcQThTivneF5rVzJZyyW7KMko5H51dl8Q65IuyTVLho8DjPt9PesKmHhJ3PVoZjUhGzPZ9R1qzhuHsjLFHEEaSUSIfvYwqg9wc5rmX1KK3hCx+QJ5lDMZCxSJh02/UCvLJJ7nKl7uZiowCXJ4qncTSSEl55Wz6uayeFj0OqGYzl0PYpbqW4ZorS7sbfz0G5gBkv70f8IlqlxuuJJUndhz5bcbvXH0ryCysJrlwyPIi+u4811Wl6nq2msgs72VyjBiMk59q5asFHY7qWI53aSOkvdM1C4Q273aA2pyIpVw4GccH9at6dplxDextOfPiC4DP/yzx/Wl0/U18VWrWd2n2bW4/mjl6eYBzirmlXRLSW+oF/MUkZcjD/THpXNVjdHrYevJvlb0NiK8h2fvOhJG715pbjTftdvL9lH7wDeJFONpHaqMlq8cTKzb42GVJ6jmrWnPMlubfPyn5zk4AHua4uTXU9OVuW6Oblv31a3uYJEJkiykn8PJ7810Oi65LDbW9kyh4wxKuV5j+UdD9RWJrun5uHnjkjMjhQVClcj1PPWm6deIY0fftkUAFQOlTJuLujoo8taHKzt7t1vYrZ3fI2DOCc7hxVdZJoXe3QDfxgs2eMdjWbaXRlV4oC0aNyB71bKFzswp2Drz35o509SHT5XYtb0QnanlKgwQDlmPXrVC93SXcMsymWMnGzcAPoB6015WSSFWT5M8EHk+wzUd9DvaOIlBsPmLICfkPX86zlqzWmrGm0csErPL89qY+XA+52H41La3imQKS8saRNHjgBCSDk1l3uqTxXdpa7I2trmNd2Thyd5BOenb0qzIR/a88ZyQwX7vQ8f0z+latdRRhfSW5zviux83yz5SgyZ2Pj5t2aTQZna2FrOSjKCBg87s/wAq6+WAajFLFKoDR/cc+3Fc2bBkd2T/AI+V4/3hnkmm5OxzzUW79SZbCRZAsZ38YZs9WPP9a534hQLH4SuSygbZEz35zjtXWWjBwxdW81PlIzj8aw/iOiR+Ar7aPmeWLJ/4FW2Gv7WPqceKf7qSPOvCLiO/U4OTnA+le3aZIz2cbOMblzzXgGkTSQTxugG4evvXoVvql3DHHvkZl28KDXsYmDc2zxIP3EdZqVyYGYE/L/DgVz17fTMxPmbAfQGsLU/FLRnExZVPRR1FYl54lmuFHko+emWqIUJSCVSx00+qBSu+4EcQ6knrWRfeKI1DJahpG6A9BXKTO0vzTMSTz1qMuMYVePaumOGXUxlNvYn1C8nu3JuJDkcqgOQBVQ42kLjaPSnYATpz6mm8DqMKfTtXTFJKyI1ZteG/Ds2tzeZLILPTI2CTXbqSqZ+nU16angDQNI0R5ba5h1e4uYm8khTgkEg7QOQeO9cn8PPGtp4dhSyuop0glkLTOH3LJzgEKRwR0/CvRJY9WubRtT0hIrG1lO2S5dwAjEgg8HnINeViK1RTaa0PfwWHozgpXOW8PxP4Rt/t91pfkXQwbeedt0gU8HHbp0GK1x42mnmu20zzrXzZGYzG4wzM2CB/PrXSfEvwfqOoadpUVx4hsktIFBjhZcM8x7+uMVzNv4QENu+n62trJBbRmWM2c4LXDE8tkckgdj/KudrsbUK3vO60X5Gb4ha61CWe9eVftrShrqLI8wwY6pjG4+o7CuT1a9lu8SWMLxRRHcuMFiRxxjkZrrLq0vfDJn1PTbJJ9Olkxbzug8yNc/3DyOc/Wmal4Lt9ab+1ILmXTrmTDTpEMrjAyQOxPX8a2pWvdnPja86Wi6nD3GoywAR3iK80iBZIFZhvBPysxz157Yr074caFfRa/JqOqhWaK2WGAD+BcDgZrnk8Dabp5TUbi/lnt45N21l4YgcZP1r1LwLa3DaYtxM25piZSD2B6Y9sYrqnKNrxPGlKU5JSOT17Sre68TXF3cKGJ2qM+gAp4ntLVQuUUKMACsvW3uJtZuwGYYfAqiNLkmO6Z2/Ou+CtFHi1VzTZr3PiK3iUhGBI7CsW41+e4YpAG2n2q0mlW0PMgJPfJqzHDCP9XGqjoGNWiUktjmdl3dXG6TOPesvxRaiAL3BGa6qbfHIBgbDyDmud8aOfJiONpzjFDNaN/aKxyIpcZB4zR/OhW684rI9I0fSomniUkNKgI4ILCpB0r2nwLqlp4Z+A1zrKaLp2o6rJqr2lt9rhUr5kjqqlzjO0ZJx7Y4zmlex4GHo+2k1ex4h9og6+bHn/AHhRIcKT1z05619cx+ENU0/QtdbxKfDWpQNp0rxta6SLaSGXYcgcsGX0PBz2r5CtY5JrSFVUkMoH6VLnZG9TCOm1yu5GoaZgEBOe1aVlpWXDTjJ7CtTTtPKhdq/P3btXQ2GmnIYruPcmuCrXfQ9PD4W2pj29ixPICp6Crq2oRP3eFFdGliCcYFLPYqsOFQVxyqN7nqRpRS0OS3TWt1HPC5WeJwysPT0+lbIuV1GbMZ2zqPNTaDw3cH2J5qO5siitkHHaqVtPLpl3HMq/JvAPH50kzSKs7HWaZf8A22IKS7TqhyCMAnJ6VeulLRLKhUPGByOQPXPrWVrlrNYsNRsVYwsAx29Vz6Va0bUEvIFOzeScMMgYrnnHqevRqXXJIgW/FymY3d5d3R04IGelJb28q2z74xHsPqPwqDVECuq+azNuZiwOCFHQcVkfaDvZFkZlf5ixJJz6VjKLaNaTcJ2Okify70YbhU3sv/16uQThizs3lhjnGM/LWGszTKm6Nt3G7b3GMVqWTlY1UAkN8gz/AAisVF2O12epYmjNzG/lFSwJMeTyPw+tUo55I2REjLH7sqSHbj3WrEDZuTGXO4cBu3Wo721kcYBDzhidxHygemfSm1rceie4iXs1lcTJNDb3NvJjY0p5T6evrV+2kkmAup5NrJ+7Axy2BwfyrK094HCpcKguHkKpn59n09u/NbMAe3ljt5PmlUMA+MYpq+zCU4vWO5pWEqFI0aUsXyT2IJ/+vTbu2Z0QqoWdRgsD94Zz+dV4GjKkySYlHys+OTg8VbADyBCokBOd2cce1Vc53G+pRkRmk81Tsk7q38X1rA+Jw/4oC7yuGEkZwO3zf/XrsGtfOPI+cdFJ4xXLfFWIR/D+8MXC+bEDn/erfDP97H1OLE29nL0PFrZzGASemK6BtZhS2+V8zbcAbs4rM0W2S6uYo5ArKcZBNeoaf8O9M1O2WW6JtVx8pgXn8Sc19BWmoyfMfOQTcbHkUrPNK0kzF2xn6UzLbeoya7Txt4Lt/DsKXNlqiTxscNG52uBXFBg3zDoa2hJSjdESVnqBXA6mjkA4J4p2AFGSab1jJ71Qri9qjCNKyohyzsEA+tSgVreDtMfVNfgijU+XCRJI3oAaTdk2OOrsjo5dGjaBlhVWEahCDg9ByfzzVeBp1tjHNFcOkbFkktSSRx3TvXoMdjCZppbWNQytsmjYdR61C+iiKcXEEbRtuG4huQv4VwSkp/FqdEOanrBnn0niMSuk095dfa43LK0xfjjGOcjFbD+K2mtomt8SS2m14EigLRM5PLMeDnn6V2F1BeJKtzFbxzbm5cYKEf7vrUlk8MqyNcWlrcHd8rGMKT7HHWo9lDdI1ljKqaucZZabqXiPUYpLg3SwocySFNqL7YBFej2WmLHbR26tK0adSxwTznnFWNOEQUxJbQwRHnao/GtJ5oxE6DC46H1rKcre6kVbn9+bucx4jshPppt4otwdwpGcbR6iu30WNdP0MOjhljj2ZP0rmLtGuri3SPOA2SK6SeH7PpjgsxBGdgNWr25Wcy0bkeY3MgkvbiUclnNRSO5JCHBoIJeQgY+dv5mnBSQT3r2UtDwLpu5Ua2mkJLyYHpSPb3LIAGwBwKsxhmkw2MVI4ZX64FAzJlthaAzzz7VHHztgVy/jG8tpYIdk8ROeiuDXoOgJFd+NvDcFxGk0TajEHjdQykc9Qa6281HX59S8e3Wi6Z4POn+F7hl+x3emfPcRrHvb94rcNgHHy4zjPFROfQ6aEL2mfNSSo+QrKx9jmnc44GM8816l8fLvTtUn8G6vpNhFYQalo4uvJjjVCNzA4OAMkZxmvLccDk/jSTudl7l8kAV6/wDDjxL4WPwrvPCfi7T9TuIrq6lkYW8BIwWDIyuCMEEA/hXF2XhuG1gM2oyITjgO20GupsLRPskSyRImBwAM1lWnGktdzycupVJycorTuzsdO8VaDpmlasIdQ8dazc3Vi9rF/aqiVYwVOAoAUDJxljknua8m0rRmhsoIZUKOEG4d+nf/AD2rssFTt3DjvTNi72Y5IHcDOa8+dZzPeVFIy7SyCYQDp6Vs2cHICjGaS2iyQdrnPPQj+laMQCYPKn/dNc8u50wXQfb2wiB3AE+9Q3Ea7crwPSrSSqGJJJz6qaZclSmQT/3yayNrWRz96DtfisXyidwfJxnArobpWeTbtJU9wDWdMoRjvDD0wDVJ2IaJtF19rZEsNRGbUjCu3I/Gs/U4IdPu2a2bMLtlAvv1qC6jDh9y5B9jVSK5Zc20q7j/AAsetLkTbOqNVytfodMrQXVudvD4G/jmsW/h8mbIiwh6so/lVrStT+xEB0znhicYFXtQYPG00L+dCByNvP4Vha2jO7njOOu5QhlMkf7t2JC7cJ1/Gt6whP2MbpQTkE4PSuTs2eC5WOOVQHOfmB/Ktgl7YExlG3jGA2Oc1nJdjSnUduW5p31vHsYxyNvDKAE9D3p1tqNtd2d0bJjM9u3lvGzbST75qvbXji4SHYymSPkheEx71OIYDdM8ECKB94KOGPqTjk1CNW3J6lSSGaWRpkQWs4j3bVIzuHA9umK1NI1Jby2S2u3jNyo5mJxtOTwahkjMv7p1zIPmV+Rs9qzbkPCFu4GjSXzPKnixkNjoTxVJESklsdDYGYMhmQJO3zZRgQ6+pzV+EBgXaM55C+hFZ8DI8MREYMyIBuDc49xirtq7Ph/NO1TjYAabiSqlyxbsFy+47hxiue+LKlvh5ekDG+aHj0+aujtv3kTmVWUB8ABTXOfFYGT4dXrgFVSaLAAP96tcOv3sfUwxTXspWPHvDWmXl9dottdxWr5A3sM/pXrth4QneELqXiW7mxgbIF2D9a8p8JTNDqCEgncM/TivZ9Nunk07ezFpAoJyhwOPWvVxV3Nni0orkTOQ8baXounaReW9lbyS3ipve4mcsVH8q8ohZfJUrzkV654m+zrousygEJ5BG8nmR8jgewz+leSRj92uewA4rqwvwHLV1kPyCB2xTB91qdtyF5pFUsuMH610GYM22IseCK9c+G2hNY6S883y3F0oYOB156flivPfCOhza/4gtbGFCU3b5WwSFUV9AGD7NFHaRqVWLgHGOv4Vw4urZ8qOqjC6uY5gu4bozx/vg42SrjBK9Mj3q3FE+NyN5kZ7D09DWgI2bac5ZCCDn2+lBilVWe3VevzA5ri52dPKrGaYowNiS+SwO44zz7VFPapuWQIOe68Vr+QHAwp3n8qQ2brnzSMnoPT9KtVGiHSTM6MMrZyQRjAqzcTZjDYBI/Kn/ZG3ncV49Cf8Kjkt2VABgqT15/wpqSb1JlGSWhZ0KNptQUckAbjWprp22c7oxGE496h8MYjvZmIGfKIwfp9KreI5j/ZbMcLuXHf/AAq1rJWMpLkpts4YOu3J+8etRm4C5AFOSFdoZnz9KVpLaAjeVAxyWb/61exc+dXcg2zTMPJUgDuati1XG64lJb0FZV34jtoEIicH0C1z95rtzccIyop7kGg1UGzsrS5s9J8QaJqmyWWO0vo5ZUgXe2wZyQO9aOva38M5dY1a61K88awRaxN599YRs0VvcHGMMq4JGO2a8+0iWSWVi9wMKctz1rN8cF2vIC7q42nBFRKN9Tpotp8p0Hxr8XaF4t1jRG8MQzw2Gn2JtRHJB5QQBhtVR6ACvOz90Zo6jIPHSjBIyBSWh12P/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Clinical findings associated with chronic paracoccidioidomycosis. A. Cutaneous lesions of the face resulting from hematologic dissemination. The lesions are papular and ulcerating. B. Perioral and chin lesions. C. Cervical and submandibular lymphadenopathy with fistulization. D. Verrucous lesion with irregular borders in the perianal region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shikanai-Yasuda, MA, Queiroz Telles Filho, F, Mendes, RP, et al. Consenso em paracoccidioidomicose [Guidelines in paracoccidioidomycosis]. Revista da Sociedade Brasileira de Medicina Tropical 2006; 39:297-310. Copyright &copy;2006 Sociedade Brasileira de Medicina Tropical.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34483=[""].join("\n");
var outline_f33_43_34483=null;
var title_f33_43_34484="Flunarizine: Drug information";
var content_f33_43_34484=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Flunarizine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/6/8292?source=see_link\">",
"    see \"Flunarizine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F242521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Novo-Flunarizine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F3950243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Calcium Channel Blocker",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F13314906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Migraine prophylaxis:",
"     </b>",
"     Oral: 5-10 mg once daily (Pryse-Phillips, 1997); incidence of adverse effects may be decreased by allowing 2 consecutive medication-free days each week. If no significant improvement is seen after 3 months of therapy,  discontinue use.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13314898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no dosage adjustments provided in manufacturer's labeling. Drug accumulation does not appear to be likely as flunarizine primarily undergoes hepatic metabolism and minimal urinary excretion.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13314899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no dosage adjustments provided in manufacturer's labeling. Flunarizine is hepatically metabolized; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F5950042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule, oral: 5 mg",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11233776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13314907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer at bedtime.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F242519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prophylaxis of migraine (with and without aura)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F3950251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Anxiety, depression, dizziness, drowsiness, fatigue, insomnia, sedation, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Endocrine &amp; metabolic: Galactorrhea, menstrual irregularities, prolactin levels increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Appetite increased, epigastric pain, heartburn, nausea, vomiting, weight gain, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Extrapyramidal symptoms, muscle ache, weakness",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F3950246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to flunarizine or any component of the formulation; history of depression; pre-existing symptoms of Parkinson's disease, or other extrapyramidal disorders",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F3950247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Rarely, progressive fatigue may occur during therapy; monitor for fatigue symptoms. Discontinue therapy with worsening fatigue.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Depression: May precipitate depression; greater risk in younger patients. Monitor for depressive symptoms and discontinue use if depression occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Endocrine effects: Galactorrhea (rare) has been reported in female patients during the first 2 months of therapy; usually resolves with discontinuation of therapy. Mild but significant increase in serum prolactin levels have been observed with use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extrapyramidal symptoms:  May produce extrapyramidal symptoms in individuals with no prior history of neurological deficits; effects are usually reversible upon discontinuation of therapy. Risk is increased in elderly patients; monitor for symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Undergoes hepatic metabolism; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Discontinue use if inadequate response after 3 months of therapy. Closely monitor for adverse effects (eg, CNS effects) in patients treated for &gt;6 months; discontinue therapy with onset of adverse effects. Risk for adverse effects may be decreased by allowing 2 consecutive medication-free days each week. Not indicated for treatment of acute migraine attacks.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F3950257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2D6 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F3950256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May decrease the serum concentration of Flunarizine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of Flunarizine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of Flunarizine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F3950260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3950244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic events have not been observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F3950245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F16570846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if flunarizine is excreted into breast milk. Breast-feeding is not recommended by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F3950273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for extrapyramidal, depressive, and/or fatigue symptoms",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F2869306\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Axilin (MX);",
"     </li>",
"     <li>",
"      Bedriol (UY);",
"     </li>",
"     <li>",
"      Cebrium (TH);",
"     </li>",
"     <li>",
"      Dinegal (CO);",
"     </li>",
"     <li>",
"      Dizine (ID);",
"     </li>",
"     <li>",
"      Flaryzil (PY);",
"     </li>",
"     <li>",
"      Flucilium (TW);",
"     </li>",
"     <li>",
"      Fludan (HK, MY);",
"     </li>",
"     <li>",
"      Fludil (VE);",
"     </li>",
"     <li>",
"      Flumig (PH);",
"     </li>",
"     <li>",
"      Flunariz (PH);",
"     </li>",
"     <li>",
"      Flunatop (BE);",
"     </li>",
"     <li>",
"      Flunavert (DE);",
"     </li>",
"     <li>",
"      Fluzina (CR, DO, EC, GT, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Forknow (MY, SG);",
"     </li>",
"     <li>",
"      Frego (ID);",
"     </li>",
"     <li>",
"      Galium (ID);",
"     </li>",
"     <li>",
"      Gradient (IT);",
"     </li>",
"     <li>",
"      Headache (KP);",
"     </li>",
"     <li>",
"      Irrigor (CN);",
"     </li>",
"     <li>",
"      Liberal (TH);",
"     </li>",
"     <li>",
"      Lunar (PK);",
"     </li>",
"     <li>",
"      MGR (IN);",
"     </li>",
"     <li>",
"      Migon (IN);",
"     </li>",
"     <li>",
"      Natil-N (DE);",
"     </li>",
"     <li>",
"      Poli-Flunarin (SG);",
"     </li>",
"     <li>",
"      Seremig (ID);",
"     </li>",
"     <li>",
"      Sibelium (AR, AT, BE, BG, BR, CH, CL, CN, CO, CZ, DK, ES, FR, GR, ID, IE, IN, IT, KP, MX, NL, PH, PK, PT, PY, TH, TR, UY, VE, ZA);",
"     </li>",
"     <li>",
"      Sinral (ID);",
"     </li>",
"     <li>",
"      Suzin (TW);",
"     </li>",
"     <li>",
"      Vanid (TH);",
"     </li>",
"     <li>",
"      Xepalium (ID);",
"     </li>",
"     <li>",
"      Zinasen (PE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F3950263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Flunarizine is a selective calcium channel blocker that prevents cellular calcium overload by reducing transmembrane calcium influx; also has antihistamine properties. Has greater effect on decreasing the frequency of migraine attacks than on decreasing the severity or duration of attacks.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F3950265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Mean: 43.2 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: 99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic: N-oxidation, aromatic hydroxylation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: ~19 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak, plasma: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Feces (&lt;6%); urine (minimal)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Kariya S, Isozaki S, Uchino K, et al, &ldquo;Oxidative Metabolism of Flunarizine and Cinnarizine by Microsomes From B-Lymphoblastoid Cell Lines Expressing Human Cytochrome P450 Enzymes,&rdquo;",
"      <i>",
"       Biol Pharm Bull",
"      </i>",
"      , 1996, 19(11):1511-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34484/abstract-text/8951176/pubmed\" id=\"8951176\" target=\"_blank\">",
"        8951176",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lavrijsen K, van Houdt J, van Dyck D, et al, &ldquo;Comparative Metabolism of Flunarizine in Rats, Dogs and Man: An",
"      <i>",
"       in vitro",
"      </i>",
"      Study With Subcellular Liver Fractions and Isolated Hepatocytes,&rdquo;",
"      <i>",
"       Xenobiotica",
"      </i>",
"      , 1992, 22(7):815-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34484/abstract-text/1455902/pubmed\" id=\"1455902\" target=\"_blank\">",
"        1455902",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pryse-Phillips WE, Dodick DW, Edmeads JG, et al, &ldquo;Guidelines for the Diagnosis and Management of Migraine in Clinical Practice. Canadian Headache Society,&rdquo;",
"      <i>",
"       CMAJ",
"      </i>",
"      , 1997, 156(9):1273-87; published erratum appears in",
"      <i>",
"       CMAJ",
"      </i>",
"      , 1997, 157(10):1354.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34484/abstract-text/9145054/pubmed\" id=\"9145054\" target=\"_blank\">",
"        9145054",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8869 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-201.211.0.116-7883711FC0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34484=[""].join("\n");
var outline_f33_43_34484=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F242521\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950243\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13314906\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13314898\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13314899\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5950042\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11233776\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13314907\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F242519\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950251\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950246\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950247\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950257\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950256\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950260\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950244\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950245\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570846\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950273\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2869306\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950263\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3950265\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8869\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8869|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/6/8292?source=related_link\">",
"      Flunarizine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_43_34485="Phentolamine: Drug information";
var content_f33_43_34485=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Phentolamine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/46/3812?source=see_link\">",
"    see \"Phentolamine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/36/14917?source=see_link\">",
"    see \"Phentolamine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6534231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      OraVerse&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F209218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Regitine&reg;;",
"     </li>",
"     <li>",
"      Rogitine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F209245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Alpha",
"      <sub>",
"       1",
"      </sub>",
"      Blocker",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F209222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of alpha-adrenergic agonist drug extravasation:",
"     </b>",
"     SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infiltrate area with a small amount (eg, 1 mL) of solution (made by diluting 5-10 mg in 10 mL of NS) within 12 hours of extravasation; in general, do not exceed 0.1-0.2 mg/kg (5 mg total); typically doses of &le;5 mg are effective; a case using 50 mg for a large extravasation has been reported (Cooper, 1989).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     If dose is effective, normal skin color should return to the blanched area within 1 hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Diagnosis of pheochromocytoma:",
"     </b>",
"     I.M., I.V.: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Surgery for pheochromocytoma:",
"     </b>",
"     Hypertension: I.M., I.V.: 5 mg given 1-2 hours before procedure and repeated as needed every 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypertensive crisis:",
"     </b>",
"     I.V.: 5-20 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Reversal of soft tissue (lip, tongue) anesthesia (OraVerse&trade;):",
"     </b>",
"     Infiltration or block technique: Submucosal oral injection:",
"     <b>",
"      Note:",
"     </b>",
"     Dose is based upon the number of cartridges of local anesthetic administered. Infiltration or block injection:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.2 mg if one-half cartridge of anesthesia was administered",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.4 mg if 1 cartridge of anesthesia was administered",
"    </p>",
"    <p style=\"text-indent:-6em;margin-left:8em;text-align:justify;\">",
"     0.8 mg if 2 cartridges of anesthesia were administered",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of pralidoxime-induced hypertension (unlabeled use):",
"     </b>",
"     I.V.: 5 mg",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F209233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/36/14917?source=see_link\">",
"      see \"Phentolamine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of alpha-adrenergic agonist drug extravasation:",
"     </b>",
"     SubQ: Infiltrate area with a small amount (eg, 1 mL) of solution (made by diluting 5-10 mg in 10 mL of NS) within 12 hours of extravasation; do not exceed 0.1-0.2 mg/kg (5 mg total)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Diagnosis of pheochromocytoma:",
"     </b>",
"     I.M., I.V.: 0.05-0.1 mg/kg/dose, maximum single dose: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Surgery for pheochromocytoma:",
"     </b>",
"     Hypertension: I.M., I.V.: 0.05-0.1 mg/kg/dose given 1-2 hours before procedure; repeat as needed every 2-4 hours until hypertension is controlled; maximum single dose: 5 mg.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Treatment of pralidoxime-induced hypertension (unlabeled use):",
"     </b>",
"     I.V.: 1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Reversal of soft tissue (lip, tongue) anesthesia (OraVerse&trade;):",
"     </b>",
"     Infiltration or block technique: Submucosal oral injection:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 15-30 kg: 0.2 mg maximum dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;30 kg and &lt;12 years: 0.4 mg maximum dose",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F209223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F209199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as mesylate: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as mesylate [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     OraVerse&trade;: 0.4 mg/1.7 mL (1.7 mL) [contains edetate disodium; dental cartridge]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F209183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes injection, solution",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F209202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Vasoconstrictor (alpha-adrenergic agonist) extravasation management: SubQ: Infiltrate the area of extravasation with multiple small injections using only 27- or 30-gauge needles and changing the needle between each skin entry. Be careful not to cause so much swelling of the extremity or digit that a compartment syndrome occurs. If infiltration is severe, may also need to consult vascular surgeon.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Pheochromocytoma: I.V.: Inject each 5 mg over 1 minute.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F209250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amiodarone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Papaverine.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F209200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Diagnosis of pheochromocytoma and treatment of hypertension associated with pheochromocytoma or other forms of hypertension caused by excess sympathomimetic amines; prevention and  treatment of dermal necrosis after extravasation of drugs with alpha-adrenergic effects (ie, dopamine, epinephrine, norepinephrine, phenylephrine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OraVerse&trade;: Reversal of soft tissue anesthesia and the associated functional deficits resulting from a local dental anesthetic containing a vasoconstrictor",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F209242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of pralidoxime-induced hypertension",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F209252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Phentolamine may be confused with phentermine, Ventolin&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F209243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not always defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, flushing, hypertension (OraVerse&trade;), hypotension, orthostatic hypotension, tachycardia (OraVerse&trade; &le;6%), bradycardia (OraVerse&trade; &le;4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, headache (OraVerse&trade; &le;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus (OraVerse&trade;)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting, diarrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site pain (OraVerse&trade; 4% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia (OraVerse&trade;), weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Nasal congestion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Pulmonary hypertension",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F209205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to phentolamine or any component of the formulation; renal impairment; coronary or cerebral arteriosclerosis; concurrent use with phosphodiesterase-5 (PDE-5) inhibitors including sildenafil (&gt;25 mg), tadalafil, or vardenafil",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     OraVerse&trade;: There are no contraindications listed in the manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F209187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Angina: Discontinue if symptoms of angina occur or worsen.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vascular events: Following administration myocardial infarction, cerebrovascular spasm and cerebrovascular occlusion have occurred.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiac arrhythmias: Use with caution in patients with tachycardia or a history of cardiac arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal disease: Use with caution in patients with gastritis or peptic ulcer disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: OraVerse&trade;: Efficacy has not been established in children &lt;6 years of age or &lt;15 kg (33 pounds).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F209192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists: Alpha1-Blockers may diminish the hypertensive effect of Alpha-/Beta-Agonists. Similarly, Alpha-/Beta-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha-/Beta-Agonists. Similarly, Alpha-/Beta-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Agonists: Alpha1-Blockers may diminish the hypertensive effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May enhance the antihypertensive effect of other Alpha1-Blockers.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May enhance the orthostatic hypotensive effect of Alpha1-Blockers. The risk associated with ophthalmic products is probably less than systemic products.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Alpha1-Blockers may enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diazoxide: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the hypotensive effect of Alpha1-Blockers. Management: Ensure patient is stable on one agent prior to initiating the other, and always initiate combination using the lowest possible dose of the drug being added. When tadalafil is used for treatment of BPH, concurrent alpha 1-blockers are not recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F209195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13823798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in some oral animal reproduction studies. Diagnosing and treating pheochromocytoma is critical for favorable maternal and fetal outcomes (Schenker, 1971; Schenker, 1982).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F209226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Phentolamine Mesylate Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/mL (1 mL): $125.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Phentolamine Mesylate Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (1): $180.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F209197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, heart rate; area of infiltration; monitor patient for orthostasis; assist patient with ambulation",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Fentanor (IN);",
"     </li>",
"     <li>",
"      Phentolmin (KP);",
"     </li>",
"     <li>",
"      Phentosol (IN);",
"     </li>",
"     <li>",
"      Regitin (CH, CZ, DK, HN);",
"     </li>",
"     <li>",
"      Regitina (AR, BR, VE);",
"     </li>",
"     <li>",
"      Regitine (AU, BE, CL, GR, HK, HU, IL, LU, NL, NZ);",
"     </li>",
"     <li>",
"      Rogitine (GB)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F209186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competitively blocks alpha-adrenergic receptors to produce brief antagonism of circulating epinephrine and norepinephrine to reduce hypertension caused by alpha effects of these catecholamines; also has a positive inotropic and chronotropic effect on the heart",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OraVerse&trade;: Causes vasodilation and increased blood flow in injection area via alpha-adrenergic blockade to accelerate reversal of soft tissue anesthetic",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F209204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: I.M.: 15-20 minutes; I.V.: Immediate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peak effect: OraVerse&trade;: 10-20 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: I.M.: 30-45 minutes; I.V.: 15-30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 19 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (10% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Cooper BE, &ldquo;High-Dose Phentolamine for Extravasation of Pressors,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1989, 8(10):689.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gould L, Reddy CV, Chua W, et al, &ldquo;Electrophysiological Properties of Phentolamine in Man,&rdquo;",
"      <i>",
"       Br Heart J",
"      </i>",
"      , 1977, 39(9):939-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34485/abstract-text/907772/pubmed\" id=\"907772\" target=\"_blank\">",
"        907772",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hollander JE, Carter WA, and Hoffman RS, &ldquo;Use of Phentolamine for Cocaine-Induced Myocardial Ischemia,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1992, 327(5):361.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Medical Management Guidelines (MMGs) for Nerve Agents: Tabun (GA); Sarin (GB); Soman (GD); and VX.&rdquo; Available at: www.atsdr.cdc.gov/MHMI/mmg166.html. Accessed January 8, 2003.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Roberts JR and Krisanda TJ, &ldquo;Accidental Intra-Arterial Injection of Epinephrine Treated With Phentolamine,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1989, 18(4):424-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34485/abstract-text/2705677/pubmed\" id=\"2705677\" target=\"_blank\">",
"        2705677",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schenker JG and Chowers I, \"Pheochromocytoma and Pregnancy. Review of 89 Cases,\"",
"      <i>",
"       Obstet Gynecol Surv",
"      </i>",
"      , 1971, 26(11):739-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34485/abstract-text/5173093/pubmed\" id=\"5173093\" target=\"_blank\">",
"        5173093",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schenker JG and Granat M, \"Phaeochromocytoma and Pregnancy - An Updated Appraisal,\"",
"      <i>",
"       Aust N Z J Obstet Gynaecol",
"      </i>",
"      , 1982, 22(1):1-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34485/abstract-text/6954937/pubmed\" id=\"6954937\" target=\"_blank\">",
"        6954937",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Seino S, Seino Y, Taminato T, et al, &ldquo;Effect of Adrenergic Blocking Agents on Plasma Gastrin and Secretion Levels in Man,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 1980, 73(2):137-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34485/abstract-text/6104918/pubmed\" id=\"6104918\" target=\"_blank\">",
"        6104918",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wespes E, Rondeux C, and Schulman CC, &ldquo;Effect of Phentolamine on Venous Return in Human Erection,&rdquo;",
"      <i>",
"       Br J Urol",
"      </i>",
"      , 1989, 63(1):95-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34485/abstract-text/2920269/pubmed\" id=\"2920269\" target=\"_blank\">",
"        2920269",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9767 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-684EC2BD62-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34485=[""].join("\n");
var outline_f33_43_34485=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6534231\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209218\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209245\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209222\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209233\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209223\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209199\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209183\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209202\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209250\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209200\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209242\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209252\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209243\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209205\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209187\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299867\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209192\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209195\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13823798\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209226\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323680\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209197\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038766\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209186\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209204\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9767\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9767|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/46/3812?source=related_link\">",
"      Phentolamine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/36/14917?source=related_link\">",
"      Phentolamine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_43_34486="Lidocaine and prilocaine: Pediatric drug information";
var content_f33_43_34486=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lidocaine and prilocaine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?31/25/32150?source=see_link\">",
"    see \"Lidocaine and prilocaine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/17/4373?source=see_link\">",
"    see \"Lidocaine and prilocaine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F188755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      EMLA&reg;;",
"     </li>",
"     <li>",
"      Oraqix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F188756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      EMLA&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1048241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antipruritic, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Local Anesthetic, Topical",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11443848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical cream:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     GA &lt;37 weeks:",
"     <b>",
"      Topical anesthetic:",
"     </b>",
"     0.5 g/dose has been most frequently reported (Weise, 2005). One study of 30 preterm neonates (GA: &ge;30 weeks) showed application to the heel for 1 hour resulted in no measurable changes in methemoglobin levels; others have reported similar findings  (Taddio, 1995; Weise, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     GA &ge;37 weeks:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Painful procedures (ie, intramuscular injections):",
"     </b>",
"     Apply 1 g/site 60 minutes prior to procedure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Circumcision:",
"     </b>",
"     Apply 1-2 g to prepuce and cover with occlusive dressing for 60-90 minutes prior to procedure (Weise, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Topical anesthetic:",
"     </b>",
"     Manufacturer labeling: Maximum dose and application area (based on application to intact skin): Weight &lt;5 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maximum total dose: 1 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maximum application area: 10 cm",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maximum application time: 1 hour",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1048234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/25/32150?source=see_link\">",
"      see \"Lidocaine and prilocaine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants and Children:",
"     <b>",
"      Anesthetic:",
"     </b>",
"     Topical cream: Dose should be individualized based on procedure and area to be anesthetized.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Maximum Recommended Dose and Application Area for Infants and Children Based on Application to Intact Skin",
"     </caption>",
"     <col align=\"left\" width=\"173\">",
"     </col>",
"     <col align=\"center\" width=\"95\">",
"     </col>",
"     <col align=\"center\" width=\"106\">",
"     </col>",
"     <col align=\"center\" width=\"106\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Age and Body Weight Requirements",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Maximum Total Dose",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Maximum Application Area",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Maximum Application Time",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         1 to &lt;3 mo or &lt;5 kg",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         1g",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         10 cm",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         1 h",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         3 to &lt;12 mo and &gt;5 kg",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         2 g",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         20 cm",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         4 h",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         1-6 y and &gt;10 kg",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         10 g",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         100 cm",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         4 h",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         7-12 y and &gt;20 kg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         20 g",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         200 cm",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4 h",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adult:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Anesthetic:",
"     </b>",
"     Topical cream: Apply a thick layer to intact skin and cover with an occlusive dressing;",
"     <b>",
"      Note:",
"     </b>",
"     Dermal analgesia can be expected to increase for up to 3 hours under occlusive dressing and persist for 1-2 hours after removal of the cream.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Minor dermal procedures (eg, I.V. cannulation or venipuncture):",
"     </b>",
"     Topical cream: Apply 2.5 g of cream (",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     of the 5 g tube) over 20-25 cm",
"     <sup>",
"      2",
"     </sup>",
"     of skin surface area for at least 1 hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Major dermal procedures (eg, more painful dermatological procedures involving a larger skin area such as split thickness skin graft harvesting):",
"     </b>",
"     Topical cream: Apply 2 g of cream per 10 cm",
"     <sup>",
"      2",
"     </sup>",
"     of skin and allow to remain in contact with the skin for at least 2 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <b>",
"      <i>",
"       Adult male genital skin (eg, pretreatment prior to local anesthetic infiltration):",
"      </i>",
"     </b>",
"     Apply a thick layer of cream (1 g/10 cm",
"     <sup>",
"      2",
"     </sup>",
"     ) to the skin surface for 15 minutes. Local anesthetic infiltration should be performed immediately after removal of cream.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <b>",
"      <i>",
"       Adult female genital mucous membranes:",
"      </i>",
"     </b>",
"     Minor procedures (eg, removal of condylomata acuminata, pretreatment for local anesthetic infiltration): Apply 5-10 g (thick layer) of cream for 5-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Periodontal gel (Oraqix&reg;):",
"     </b>",
"     Apply on gingival margin around selected teeth using the blunt-tipped applicator included in package. Wait 30 seconds, then fill the periodontal pockets using the blunt-tipped applicator until gel becomes visible at the gingival margin. Wait another 30 seconds before starting treatment. May reapply if anesthesia starts to wear off; maximum recommended dose per treatment session: 5 cartridges (8.5 g)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F188738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical: Lidocaine 2.5% and prilocaine 2.5% (5 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     EMLA&reg;: Lidocaine 2.5% and prilocaine 2.5% (5 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, periodontal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oraqix&reg;: Lidocaine 2.5% and prilocaine 2.5% (1.7 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F188725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Cream",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1048244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream: Do not use on open wounds or the eyes; apply a thick layer of cream to intact skin and cover with an occlusive dressing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Periodontal gel: Oraqix&reg; is a viscous liquid;",
"     <b>",
"      <span style=\"text-decoration: underline\">",
"       not for injection",
"      </span>",
"     </b>",
"     ; should be in the liquid form before administration; if gel forms refrigerate until becomes liquid again. Do not use dental cartridge warmers; heat will cause product to gel. Apply slowly and evenly on gingival margin around selected teeth using Oraqix&reg; Dispenser; not intended to be used with standard dental syringes.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1048237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); keep container tightly closed when not in use",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Periodontal gel: Store at 25&deg;C (77&deg;F); excursion permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); do not freeze. May turn opaque at temperature &lt;5&deg;C; opacity will disappear when warmed to room temperature",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1048243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream: Topical anesthetic for use on normal intact skin to provide local analgesia for minor procedures such as I.V. cannulation or venipuncture; topical anesthetic for superficial minor surgery of genital mucous membranes and as an adjunct for local infiltration anesthesia in genital mucous membranes [FDA approved in neonates (full-term), pediatric, and adult patients]; has also been used for painful procedures, such as lumbar puncture and skin graft harvesting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Periodontal gel: Topical anesthetic for use in periodontal pockets during scaling or root planing procedures (FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F188778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Cream/patch:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Angioedema, hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Shock",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Burning, erythema, hyperpigmentation, itching, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Blistering of foreskin (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Burning, edema, stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Bronchospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Alteration in temperature sensation, hypersensitivity reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Periodontal gel:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fatigue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Bitter taste , nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Application site reaction (includes abscess, edema, irritation, numbness, pain, ulceration, vesicles)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, flu-like syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1048248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to lidocaine, prilocaine, amide-type local anesthetics, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1048233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with severe hepatic disease, patients with G-6-PD deficiency, and patients taking drugs associated with drug-induced methemoglobinemia; adjust dosage by using smaller areas for application in small children (especially infants &lt;3 months of age) or patients with impaired renal or hepatic function. Patients who are acutely ill or debilitated may be more sensitive to the systemic effect of lidocaine/prilocaine; use with caution and reduce dosage if necessary. Use with caution in patients receiving class I and class III antiarrhythmic drugs (eg, tocainide, mexiletine, amiodarone, bretylium, sotalol, dofetilide) since systemic absorption occurs and synergistic toxicity is possible. Topical lidocaine and prilocaine cream  has been shown to inhibit bacterial and viral growth; effect on intradermal administration of live vaccines has not been determined. Avoid use near the eyes; severe irritation may occur. In small infants and children, an occlusive bandage may prevent the child from placing the cream in his/her mouth or smearing the cream on the eyes. Oraqix&reg; should only be used with the Oraqix&reg; dispenser; do not use with standard dental syringes; do not inject Oraqix&reg;.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F4805300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Methemoglobinemia has been reported with lidocaine and prilocaine cream; methemoglobinemia is a serious and potentially fatal condition in which the amount of oxygen carried through the blood stream is greatly reduced; signs and symptoms may include pale-, gray-, or blue-colored skin, lips, and nail beds; headache; lightheadedness; shortness of breath; fatigue; and rapid heart rate; symptoms may not develop until hours after exposure; many cases were associated with large doses and/or application areas; very young patients and patients with G-6-PD deficiency are more susceptible to development of methemoglobinemia; do not use in patients with congenital or idiopathic methemoglobinemia, neonates &lt;37 weeks gestation, or in infants &lt;12 months of age who are receiving concurrent treatment with methemoglobin-inducing agents (ie, sulfas, acetaminophen, benzocaine, chloroquine, dapsone, nitrofurantoin, nitroglycerin, nitroprusside, phenobarbital, phenytoin, primaquine, quinine).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Topical use prior to cosmetic procedures can result in high systemic levels and lead to toxic effects (eg, arrhythmias, seizures, coma, respiratory depression, and death). Toxic effects may occur particularly when topical anesthetics are applied in large amounts or to large areas of the skin; left on for long periods of time; used with materials, wraps, or dressings to cover the skin after application; or applied to broken skin, rashes, or areas of skin irritation. These practices may increase the degree of systemic absorption and should be avoided. The FDA recommends that consumers consult their healthcare provider for instructions on safe use, prior to applying topical anesthetics for medical or cosmetic purposes. Use of products with the lowest amount of anesthetic and applying the least amount possible to relieve pain is also recommended.  Do not use if penetration or migration beyond the tympanic membrane is possible; animal data has shown ototoxicity with inner ear instillation.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F188768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F188733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antiarrhythmic Agents (Class III): Lidocaine (Topical) may enhance the arrhythmogenic effect of Antiarrhythmic Agents (Class III). Antiarrhythmic Agents (Class III) may increase the serum concentration of Lidocaine (Topical). This mechanism specifically applies to amiodarone and dronedarone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: May enhance the arrhythmogenic effect of Lidocaine (Topical). Disopyramide may increase the serum concentration of Lidocaine (Topical). Specifically, the unbound/free fraction of lidocaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: May enhance the adverse/toxic effect of Local Anesthetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methemoglobinemia Associated Agents: May enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia. Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F188735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F188746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to Lidocaine (Topical) monograph.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1048232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant local anesthetic action.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1048246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of action: Dermal analgesia: 1 hour; genital mucosal analgesia: 5-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maximum effect: Dermal analgesia: 2-3 hours; genital mucosal analgesia: 15-20 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: 1-2 hours after removal of the cream",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Periodontal gel:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of action: 30 seconds",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: ~20 minutes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1048247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Unless specified, data refers to the topical cream product formulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Related to the duration of application and to the area over which it is applied",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3-hour application: 3.6% lidocaine and 6.1% prilocaine were absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     24-hour application: 16.2% lidocaine and 33.5% prilocaine were absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Both cross the blood-brain barrier",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lidocaine: 1.1-2.1 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Prilocaine: 0.7-4.4 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lidocaine: 70%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prilocaine: 55%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lidocaine: Metabolized by the liver to inactive and active metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prilocaine: Metabolized in both the liver and kidneys",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Cream:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lidocaine: 65-150 minutes, prolonged in cardiac or hepatic dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Prilocaine: 10-150 minutes, prolonged in hepatic or renal dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Periodontal gel:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lidocaine: 2.2-6.5 hours, prolonged in hepatic dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Prilocaine: 2-5.7 hours, prolonged in hepatic dysfunction",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1048239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/17/4373?source=see_link\">",
"      see \"Lidocaine and prilocaine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May experience decreased sensation to pain, heat, or cold in the area until effects wear off; use necessary caution to reduce incidence of possible injury until full sensation returns.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream: Not for ophthalmic use; for external use only; do not apply to open wounds.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Broadman LM, Soliman IE, Hannallah RS, et al, &ldquo;Analgesic Efficacy of Eutectic Mixture of Local Anesthetics (EMLA&reg;) vs Intradermal Infiltration Prior to Venous Cannulation in Children,&rdquo;",
"      <i>",
"       Am J Anaesth",
"      </i>",
"      , 1987, 34:S56.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carbajal R, Biran V, Lenclen R, et al, \"EMLA Cream and Nitrous Oxide to Alleviate Pain Induced by Palivizumab (Synagis) Intramuscular Injections in Infants and Young Children,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008, 121(6):e1591-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34486/abstract-text/18458035/pubmed\" id=\"18458035\" target=\"_blank\">",
"        18458035",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Halperin DL, Koren G, Attias D, et al, &ldquo;Topical Skin Anesthesia for Venous Subcutaneous Drug Reservoir and Lumbar Puncture in Children,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1989, 84(2):281-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34486/abstract-text/2748256/pubmed\" id=\"2748256\" target=\"_blank\">",
"        2748256",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kaur G, Gupta P, and Kumar A, \"A Randomized Trial of Eutectic Mixture of Local Anesthetics During Lumbar Puncture in Newborns,\"",
"      <i>",
"       Arch Pediatr Adolesc Med",
"      </i>",
"      , 2003, 157(11):1065-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34486/abstract-text/14609894/pubmed\" id=\"14609894\" target=\"_blank\">",
"        14609894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robieux I, Kumar R, Radhakrishnan S, et al, &ldquo;Assessing Pain and Analgesia With a Lidocaine-Prilocaine Emulsion in Infants and Toddlers During Venipuncture,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1991, 118(6):971-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34486/abstract-text/2040936/pubmed\" id=\"2040936\" target=\"_blank\">",
"        2040936",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Taddio A, Shennan AT, Stevens B, et al, &ldquo;Safety of Lidocaine-Prilocaine Cream in the Treatment of Preterm Neonates,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1995, 127(6):1002-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34486/abstract-text/8523173/pubmed\" id=\"8523173\" target=\"_blank\">",
"        8523173",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weise KL and Nahata MC, \"EMLA for Painful Procedures in Infants,\"",
"      <i>",
"       J Pediatr Health Care",
"      </i>",
"      , 2005, 19(1):42-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34486/abstract-text/15662361/pubmed\" id=\"15662361\" target=\"_blank\">",
"        15662361",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12553 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-221.179.173.170-312020EB49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34486=[""].join("\n");
var outline_f33_43_34486=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188755\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188756\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048241\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11443848\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048234\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188738\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188725\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048244\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048237\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048243\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188778\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048248\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048233\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4805300\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188768\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188733\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188735\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188746\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048232\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048246\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048247\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048239\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12553\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12553|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/25/32150?source=related_link\">",
"      Lidocaine and prilocaine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/17/4373?source=related_link\">",
"      Lidocaine and prilocaine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_43_34487="Variable decelerations with shoulder pattern";
var content_f33_43_34487=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F86061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F86061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 620px\">",
"   <div class=\"ttl\">",
"    Variable decelerations with shoulder pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 600px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce K Young, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34487=[""].join("\n");
var outline_f33_43_34487=null;
var title_f33_43_34488="Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Drug information";
var content_f33_43_34488=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/35/20017?source=see_link\">",
"    see \"Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?17/13/17624?source=see_link\">",
"    see \"Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F161261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Adacel&reg;;",
"     </li>",
"     <li>",
"      Boostrix&reg;;",
"     </li>",
"     <li>",
"      Daptacel&reg;;",
"     </li>",
"     <li>",
"      Infanrix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F161262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Adacel&reg;;",
"     </li>",
"     <li>",
"      Boostrix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F161272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vaccine, Inactivated (Bacterial)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F161265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Tdap can be administered regardless of the interval between the last tetanus or diphtheria toxoid containing vaccine. Tdap is currently recommended for a single dose only (CDC, 60[1], 2011; CDC, 61[25], 2012), except pregnant females (CDC, 62 [7], 2013).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Booster immunization: ACIP recommendations:",
"     </b>",
"     I.M.: Adults &ge;19 years: 0.5 mL per dose. A single dose of Tdap should be given to replace a single dose of the 10 year Td booster in patients who have not previously received Tdap or for whom vaccine status is not known.  A single dose of Tdap is recommended for health care personnel who have not previously received Tdap and who have direct patient contact (CDC, 55[17], 2006). Tdap should be administered regardless of interval since last tetanus- or diphtheria-containing vaccine (CDC, 61[25], 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Booster immunization: Manufacturer's  recommendations:",
"     </b>",
"     I.M.: Adults &le;64 years (Adacel&reg;, Boostrix&reg;): 0.5 mL as a single dose, administered 5 years after last dose of tetanus toxoid, diphtheria toxoid, and/or pertussis-containing vaccine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Wound management:",
"     </b>",
"     I.M.: Adacel&reg; or Boostrix&reg; may be used as an alternative to Td vaccine when a tetanus toxoid-containing vaccine is needed for wound management, and in whom the pertussis component is also indicated. Tetanus prophylaxis in patients with wounds should consider if the wound is clean or contaminated, the immunization status of the patient, proper use of tetanus toxoid and/or tetanus immune globulin (TIG), wound cleaning, and (if required) surgical debridement and the proper use of antibiotics. Patients with an uncertain or incomplete tetanus immunization status should have additional follow up to ensure a series is completed. Patients with a history of Arthus reaction following a previous dose of a tetanus toxoid-containing vaccine should not receive a tetanus toxoid-containing vaccine until &gt;10 years after the most recent dose even if they have a wound that is neither clean nor minor. See table.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Tetanus Prophylaxis in Wound Management",
"     </caption>",
"     <col align=\"center\" width=\"145\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" rowspan=\"2\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         History of Tetanus Immunization Doses",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Clean, Minor Wounds",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         All Other Wounds",
"         <sup>",
"          1",
"         </sup>",
"        </p>",
"       </th>",
"      </tr>",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Tetanus Toxoid",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         TIG",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Tetanus Toxoid",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         TIG",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"middle\">",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          1",
"         </sup>",
"         Such as, but not limited to, wounds contaminated with dirt, feces, soil, and saliva; puncture wounds; wounds from crushing, tears, burns, and frostbite.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          2",
"         </sup>",
"         Tetanus toxoid in this chart refers to a tetanus toxoid-containing vaccine. For children &lt;7 years of age, DTaP (DT, if pertussis vaccine contraindicated) is preferred to tetanus toxoid alone. For children &ge;7 years and adults, Td preferred to tetanus toxoid alone; Tdap may be preferred if the patient has not previously been vaccinated with Tdap.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          3",
"         </sup>",
"         Yes, if &ge;10 years since last dose.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          4",
"         </sup>",
"         Yes, if &ge;5 years since last dose.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         Adapted from CDC \"Yellow Book\" (",
"         <i>",
"          Health Information for International Travel 2010",
"         </i>",
"         ), \"Routine Vaccine-Preventable Diseases, Tetanus\" (available at",
"         <a href=\"file://www.cdc.gov/yellowbook\" target=\"_blank\">",
"          file://www.cdc.gov/yellowbook",
"         </a>",
"         ) and",
"         <i>",
"          MMWR",
"         </i>",
"         2006, 55(RR-17).",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Abbreviations:",
"         <b>",
"          DT",
"         </b>",
"         = Diphtheria and Tetanus Toxoids (formulation for age &le;6 years);",
"         <b>",
"          DTaP",
"         </b>",
"         = Diphtheria and Tetanus Toxoids, and Acellular Pertussis (formulation for age &le;6 years; Daptacel&reg;, Infanrix&reg;);",
"         <b>",
"          Td",
"         </b>",
"         = Diphtheria and Tetanus Toxoids (formulation for age &ge;7 years; Decavac&reg;,Tenivac&trade;);",
"         <b>",
"          TT",
"         </b>",
"         = Tetanus toxoid (adsorbed [formulation for age &ge;7 years]);",
"         <b>",
"          Tdap",
"         </b>",
"         = Diphtheria and Tetanus Toxoids, and Acellular Pertussis (Adacel&reg; or Boostrix&reg; [formulations for age &ge;7 years]);",
"         <b>",
"          TIG",
"         </b>",
"         = Tetanus Immune Globulin",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"middle\">",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          Uncertain or &lt;3 doses",
"         </b>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Yes",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Yes",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Yes",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          3 or more doses",
"         </b>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"         <sup>",
"          3",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"         <sup>",
"          4",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F161268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?17/13/17624?source=see_link\">",
"      see \"Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Tdap can be administered regardless of the interval between the last tetanus or diphtheria toxoid containing vaccine. Tdap is currently recommended for a single dose only (CDC, 60[1], 2011), except pregnant females (CDC, 62 [7], 2013).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Primary immunization:",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6 weeks to &lt;7 years:",
"     <b>",
"      Note:",
"     </b>",
"     Whenever possible, the same product should be used for all doses. Interruption of recommended schedule does not require starting the series over; a delay between doses should not interfere with final immunity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Daptacel&reg;, Infanrix&reg;: 0.5 mL per dose, total of 5 doses administered as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Three doses, usually given at 2-, 4-, and 6 months of age; may be given as early as 6 weeks of age and repeated every 4-8 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Fourth dose: Given at ~15-20 months of age, but at least 6 months after third dose. The fourth dose may be given as early as 12 months of age, but at least 6 months must have elapsed between the third dose and the fourth dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Fifth dose: Given at 4-6 years of age, prior to starting school or kindergarten; if the fourth dose is given at &ge;4 years of age, the fifth dose may be omitted",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     For children who start primary immunization series &ge;4 months of age, refer to current ACIP \"Catch-up Immunization Schedule\".",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 7-10 years: Not fully vaccinated against pertussis, or never vaccinated against diphtheria, tetanus, or pertussis, or whose vaccination status is not known: Administer a series of 3 vaccinations containing tetanus and diphtheria toxoids; the first dose should be with Tdap (CDC, 60[1], 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Booster immunization: ACIP recommendations:",
"     </b>",
"     I.M.: Adolescents 11-18 years: 0.5 mL per dose. Tdap should be given as a single booster dose at age 11 or 12 years in adolescents who have completed a childhood vaccination series, followed by booster doses of Td every 10 years. Adolescents who have not received Tdap at age 11 or 12 should receive a single dose of Tdap in place of a single Td booster dose (CDC, 55[3], 2006; CDC, 60[1], 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Booster immunization: Manufacturer's  recommendations:",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;10 years (Boostrix&reg;): 0.5 mL as a single dose, administered 5 years after last dose of tetanus toxoid, diphtheria toxoid, and/or pertussis-containing vaccine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;11 years (Adacel&reg;): 0.5 mL as a single dose, administered 5 years after last dose of tetanus toxoid, diphtheria toxoid and/or pertussis-containing vaccine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Wound management:",
"     </b>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3062959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Booster Immunization:",
"     </b>",
"     I.M.: Adults &ge;65 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ACIP recommendations: Refer to adult dosing. In adults &ge;65 years Boostrix&reg; should be used if feasible; however, ACIP has concluded that either Tdap vaccine (Boostrix&reg; or Adacel&reg;) may be used (CDC, 61[25], 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Manufacturer's recommendations: Boostrix&reg;: 0.5 mL as a single dose, administered 5 years after last dose of tetanus toxoid, diphtheria toxoid, and/or pertussis-containing vaccine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Wound Management:",
"     </b>",
"     I.M.: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F161248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, suspension [Tdap, booster formulation]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adacel&reg;: Diphtheria 2 Lf units, tetanus 5 Lf units, and acellular pertussis antigens [detoxified pertussis toxin 2.5 mcg, filamentous hemagglutinin 5 mcg, pertactin 3 mcg, fimbriae (types 2 and 3) 5 mcg] per 0.5 mL (0.5 mL) [contains aluminum; may contain natural rubber/natural latex in prefilled syringe]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Boostrix&reg;: Diphtheria 2.5 Lf units, tetanus 5 Lf units, and acellular pertussis antigens [inactivated pertussis toxin 8 mcg, filamentous hemagglutinin 8 mcg, pertactin 2.5 mcg] per 0.5 mL (0.5 mL) [contains aluminum and polysorbate 80; may contain natural rubber/natural latex in prefilled syringe]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, suspension [DTaP, active immunization formulation]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Daptacel&reg;: Diphtheria 15 Lf units, tetanus 5 Lf units, and acellular pertussis antigens [detoxified pertussis toxin 10 mcg, filamentous hemagglutinin 5 mcg, pertactin 3 mcg, fimbriae (types 2 and 3) 5 mcg] per 0.5 mL (0.5 mL) [preservative free; contains aluminum]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infanrix&reg;: Diphtheria 25 Lf units, tetanus 10 Lf units, and acellular pertussis antigens [inactivated pertussis toxin 25 mcg, filamentous hemagglutinin 25 mcg, pertactin 8 mcg] per 0.5 mL (0.5 mL) [preservative free; contains aluminum and polysorbate 80]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infanrix&reg;: Diphtheria 25 Lf units, tetanus 10 Lf units, and acellular pertussis antigens [inactivated pertussis toxin 25 mcg, filamentous hemagglutinin 25 mcg, pertactin 8 mcg] per 0.5 mL (0.5 mL) [preservative free; contains aluminum and polysorbate 80; prefilled syringes contain natural rubber/natural latex] [DSC]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F161236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F161251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Shake suspension well.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adacel&reg;, Boostrix&reg;: Administer only I.M. in deltoid muscle of upper arm.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Daptacel&reg;, Infanrix&reg;: Administer only I.M. in anterolateral aspect of thigh or deltoid muscle of upper arm.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     If feasible, the same brand of DTaP should be used for all doses in the series (CDC, 60[2], 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     For patients at risk of hemorrhage following intramuscular injection, the ACIP recommends &ldquo;it should be administered intramuscularly if, in the opinion of the physician familiar with the patient's bleeding risk, the vaccine can be administered by this route with reasonable safety.  If the patient receives antihemophilia or other similar therapy, intramuscular vaccination can be scheduled shortly after such therapy is administered. A fine needle (23 gauge or smaller) can be used for the vaccination and firm pressure applied to the site (without rubbing) for at least 2 minutes. The patient should be instructed concerning the risk of hematoma from the injection.&rdquo; Patients on anticoagulant therapy should be considered to have the same bleeding risks and treated as those with clotting factor disorders (CDC, 60[2], 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Simultaneous administration of vaccines helps ensure the patients will be fully vaccinated by the appropriate age. Simultaneous administration of vaccines is defined as administering &gt;1 vaccine on the same day at different anatomic sites. The use of licensed combination vaccines is generally preferred over separate injections of the equivalent components. Separate vaccines should not be combined in the same syringe unless indicated by product specific labeling. Separate needles and syringes should be used for each injection. The ACIP prefers each dose of a specific vaccine in a series come from the same manufacturer when possible. Adolescents and adults should be vaccinated while seated or lying down. In general, preterm infants should be vaccinated at the same chronological age as full-term infants (CDC, 60[2], 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Antipyretics have not been shown to prevent febrile seizures. Antipyretics may be used to treat fever or discomfort following vaccination (CDC, 2011). One study reported that routine prophylactic administration of acetaminophen to prevent fever prior to vaccination decreased the immune response of some vaccines; the clinical significance of this reduction in immune response has not been established (Prymula, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F161249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Daptacel&reg;, Infanrix&reg; (DTaP): Active immunization against diphtheria, tetanus, and pertussis from age 6 weeks through 6 years of age (prior to seventh birthday)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Adacel&reg;, Boostrix&reg; (Tdap): Active booster immunization against diphtheria, tetanus, and pertussis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:2em;text-align:justify;\">",
"     The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for the following:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children 6 weeks to &lt;7 years (DTaP):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; For primary immunization against diphtheria, tetanus and pertussis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Pediatric patients who are wounded in bombings or similar mass casualty events and who have penetrating injuries or nonintact skin exposure, and have an uncertain vaccination history should receive a tetanus booster with DTaP (if no contraindications exist) (CDC, 57[RR6], 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children 7-10 years (Tdap):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Children not fully vaccinated against pertussis should receive a single dose of Tdap (if no contraindications exist) (CDC, 60[1], 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Children never vaccinated against diphtheria, tetanus, or pertussis, or whose vaccination status is not known should receive a series of three vaccinations containing tetanus and diphtheria toxoids and the first dose should be with Tdap (CDC, 60[1], 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Adolescents 11-18 years (Tdap):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; A single dose of Tdap as a booster dose in adolescents who have completed the recommended childhood DTaP vaccination series (preferred age of administration is 11-12 years) (CDC, 60[1], 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Adolescents &ge;11 years and Adults (Tdap):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Persons wounded in bombings or similar mass casualty events and who cannot confirm receipt of a tetanus booster within the previous 5 years and who have penetrating injuries or nonintact skin exposure should receive a single dose of Tdap (CDC, 57 [RR6] 2008; CDC, 61[25], 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Adolescent and Adult females (Tdap): Pregnant females should receive a single dose with each pregnancy, preferably between 27-36 weeks gestation (CDC, 62 [7], 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Adults &ge;19 years (including adults &ge;65 years) (Tdap): A single dose of Tdap should be given to all patients who have not previously received Tdap or for whom their vaccine status is unknown (CDC, 62[1], 2013). Following administration of Tdap, Td vaccine should be used for routine boosters. (CDC, 61[25], 2012). The following patients, who have not yet received Tdap or for whom vaccine status is not known, should receive a single dose of Tdap as soon as feasible:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Close contacts of children &lt;12 months of age; Tdap should ideally be administered at least 2 weeks prior to beginning close contact (CDC, 55[RR17], 2006; CDC, 60[41], 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Healthcare providers with direct patient contact  (CDC, 55[RR17], 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Tdap is currently recommended for a single dose only (all age groups) (CDC, 60[1], 2011; CDC, 61[25], 2012), except pregnant females (CDC, 62 [7], 2013",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2671735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Adacel&reg; (Tdap) may be confused with Daptacel&reg; (DTaP)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Tdap (Adacel&reg;, Boostrix&reg;) may be confused with DTaP (Daptacel&reg;, Infanrix&reg;, Tripedia)",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Carefully review product labeling to prevent inadvertent administration of Tdap when DTaP is indicated. Tdap contains lower amounts of diphtheria toxoid and some pertussis antigens than DTaP.",
"      </p>",
"      <p style=\"text-indent:0em;margin-left:2em;\">",
"       Tdap is not indicated for use in children &lt;10 years of age",
"      </p>",
"      <p style=\"text-indent:0em;margin-left:2em;\">",
"       DTaP is not indicated for use in persons &ge;7 years of age",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Guidelines are available in case of inadvertent administration of these products; refer to ACIP recommendations, February 2006 available at",
"       <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/rr55e223a1.htm\" target=\"_blank\">",
"        file://www.cdc.gov/mmwr/preview/mmwrhtml/rr55e223a1.htm",
"       </a>",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       DTaP: Diphtheria and tetanus toxoids and acellular pertussis vaccine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"       DTP: Diphtheria and tetanus toxoids and pertussis vaccine (unspecified pertussis antigens)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"       DTwP: Diphtheria and tetanus toxoids and whole-cell pertussis vaccine (no longer available on U.S. market)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"       Tdap: Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F161270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      All serious adverse reactions must be reported to the U.S. Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting System (VAERS) 1-800-822-7967 or online at",
"      <a href=\"https://vaers.hhs.gov/esub/index\" target=\"_blank\">",
"       https://vaers.hhs.gov/esub/index",
"      </a>",
"      .",
"     </b>",
"     In Canada, adverse reactions may be reported to local provincial/territorial health agencies or to the Vaccine Safety Section at Public Health Agency of Canada (1-866-844-0018).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Daptacel&reg;, Infanrix&reg;",
"     </b>",
"     (incidence of erythema, swelling, and fever increases with successive doses):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Drowsiness, fever, fussiness, irritability, lethargy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Appetite decreased, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Pain, redness, swelling, tenderness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Prolonged or persistent crying, refusal to play",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Postmarketing and/or case reports: Allergic reaction, anaphylactic reactions, angioedema, apnea, bronchitis, cellulitis, cough, cyanosis, diarrhea, ear pain, encephalopathy, erythema, fatigue, headache, hypersensitivity, hypotonia, hypotonic-hyporesponsive episode, idiopathic thrombocytopenic purpura, infantile spasm, injection site reaction (abscess, cellulitis, induration, mass, nodule, rash), intussusception, limb swelling, lymphadenopathy, nausea, pruritus, rash, respiratory tract infection, seizure, screaming, somnolence, sudden infant death syndrome, thrombocytopenia, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Adacel&reg;, Boostrix&reg;: Note: Ranges presented, actual percent varies by product and age group",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fatigue, tiredness (24% to 37%; grade 3/severe: 1% to 4%), headache (12% to 44%; grade 3/severe: 1% to 4%), chills (8% to 15%; severe: &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Gastrointestinal symptoms, includes abdominal pain, diarrhea, nausea and/or vomiting (3% to 26%; grade 3/severe: &le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site pain (22% to 78%; grade 3/severe: &le;5%), arm circumference increased (28%; &gt;40 mm: 0.5%), redness (11% to 25%; &ge;50 mm: 2% to 4%), swelling (8% to 21%; &ge;50 mm: &le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Body aches/muscle weakness (22% to 30%; severe: 1%), soreness/swollen joints (9% to 11%; severe: &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever &ge;38&deg;C (&ge;100.4��F: 1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (2% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Lymph node swelling (7%; severe: &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Postmarketing and/or case reports: Anaphylactic reaction, arthralgia, back pain, diabetes mellitus, encephalitis, exanthema, facial palsy, GBS, Henoch-Sch&ouml;nlein  purpura, hypersensitivity reactions, hypoesthesia, injection site reaction (bruising, induration, inflammation, mass, nodule, pruritus, sterile abscess, warmth), limb swelling (extensive), lymphadenitis, lymphadenopathy, myalgia, myocarditis, myositis, nerve compression, paresthesia, pruritus, seizure, syncope, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F161253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to diphtheria, tetanus toxoids, pertussis, or any component of the formulation; history of any of the following effects from previous administration of pertussis-containing vaccine - progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy or progressive epilepsy (postpone until condition stabilized);  encephalopathy occurring within 7 days of administration and not attributable to another cause",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F161240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Immediate treatment (including epinephrine 1:1000) for anaphylactoid and/or hypersensitivity reactions should be available during vaccine use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Apnea: Apnea has been reported following I.M. vaccine administration in premature infants; consider risk versus benefit in infants born prematurely",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arthus-type hypersensitivity: Td or Tdap vaccines and emergency doses of Td vaccine should not be given more frequently than every 10 years in patients who have experienced a serious Arthus-type hypersensitivity reaction following a prior use of tetanus toxoid even if using for wound management with wounds that are not clean or minor; these patients generally have high serum antitoxin levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Reactions from previous dose: Carefully consider use in patients with history of any of the following effects from previous administration of any pertussis-containing vaccine: Fever &ge;105&deg;F (40.5&deg;C) within 48 hours of unknown cause; seizures with or without fever occurring within 3 days; persistent, inconsolable crying episodes lasting &ge;3 hours and occurring within 48 hours; shock or collapse within 48 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Syncope: Syncope has been reported with use of injectable vaccines and may be accompanied by transient visual disturbances, weakness, or tonic-clonic movements. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Acute illness: May consider deferring administration in patients with moderate or severe acute illness (with or without fever); may administer to patients with mild acute illness (with or without fever).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding disorders: Use with caution in patients with a history of bleeding disorders (including thrombocytopenia) and/or patients on anticoagulant therapy; bleeding/hematoma may occur from I.M. administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Guillain-Barr&eacute; syndrome: Continue use with caution if Guillain-Barr&eacute; syndrome occurs within 6 weeks of prior tetanus toxoid.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neurologic disorders: Use with caution in patients with history of seizure disorder, progressive neurologic disease, or conditions predisposing to seizures; ACIP and APP guidelines recommend deferring immunization until health status can be assessed and condition stabilized. Antipyretics may be considered at the time of and for 24 hours following vaccination to patients at high risk for seizures to reduce the possibility of postvaccination fever.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vaccines: In order to maximize vaccination rates, the ACIP recommends simultaneous administration of all age-appropriate vaccines (live or inactivated) for which a person is eligible at a single clinic visit, unless contraindications exist. The use of combination vaccines is generally preferred over separate injections, taking into consideration provider assessment, patient preference, and adverse events. When using combination vaccines, the minimum age for administration is the oldest minimum age for any individual component; the minimum interval between dosing is the greatest minimum interval between any individual component.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered immunocompetence: Use with caution in severely immunocompromised patients (eg, patients receiving chemo/radiation therapy or other immunosuppressive therapy (including high dose corticosteroids)); may have a reduced response to vaccination. May be used in patients with HIV infection. In general, household and close contacts of persons with altered immunocompetence may receive all age appropriate vaccines",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy of Adacel&reg; have not been established in children &lt;11 years. Safety and efficacy of Boostrix&reg; have not been established in patients &lt;10 years of age. Safety and efficacy of Daptacel&reg; and Infanrix&reg;  have not been established in children &lt;6 weeks of age or &ge;7 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adacel&reg;: Formulated with the same antigens found in Daptacel&reg;, but with reduced quantities of tetanus and pertussis. Use in the primary immunization series or to complete the primary series has not been evaluated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Boostrix&reg;: Formulated with the same antigens found in Infanrix&reg;, but in reduced quantities. Use in the primary immunization series or to complete the primary series has not been evaluated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gelatin: Products may contain gelatin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Latex: Packaging may contain natural latex rubber.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thimerosal: Products may contain thimerosal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) and may be improved by administering the vaccine at the recommended dose, route, and interval. Vaccines may not be effective if administered during periods of altered immune competence (CDC 60[2], 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F161243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F161245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B/C (manufacturer specific) (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F161256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted with all products; when conducted, adverse effects to the fetus were not observed in developmental toxicity studies. Inactivated bacterial vaccines have not been shown to cause increased risks to the fetus (CDC, 60[2], 2011). Daptacel&reg; and Infanrix&reg; are not recommended for use in a pregnant woman or any patient &ge;7 years of age. Using data collected from 2005-2010 VAERS, there were not any patterns of adverse maternal, fetal, or neonatal outcomes identified following maternal use of the Tdap vaccine (Zheteyeva, 2012). All pregnant females should receive a single dose of Tdap during each pregnancy, regardless of previous vaccination status, preferably between 27-36 weeks gestation. Alternately, administration of Tdap can be given immediately postpartum to all women who have not previously been vaccinated with Tdap in order to protect the mother and infant from pertussis (CDC, 62[7], 2013).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Pregnancy registries have been established for women who may become exposed to Boostrix&reg; (888-452-9622) or Adacel&reg; (800-822-2463) while pregnant.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F6839179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F4043189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if this vaccine is excreted into breast milk. The manufacturer recommends that caution be used if administered to a nursing woman. Breast-feeding is not a contraindication to vaccine administration. Women who have not previously had a dose of Tdap should receive a dose postpartum to help prevent pertussis in infants &lt;12 months of age (CDC, 62[7], 2013). Inactivated vaccines do not affect the safety of breast-feeding for the mother or the infant. Breast-feeding infants should be vaccinated according to the recommended schedules (CDC, 60[2], 2011).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Adacel Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5-2-15.5 (0.5 mL): $48.82",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Boostrix Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5-2.5-18.5 (0.5 mL): $44.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Daptacel Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10-15-5 (0.5 mL): $30.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Infanrix Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25-58-10 (0.5 mL): $24.70",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F6839180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F161257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acelluvax DTP (TH);",
"     </li>",
"     <li>",
"      Adacel (AU, PH);",
"     </li>",
"     <li>",
"      Adsorbed DT COQ (HK, TW);",
"     </li>",
"     <li>",
"      Anatoxal Di Te Per Berna (PE);",
"     </li>",
"     <li>",
"      Boostrix (AT, AU, CO, CZ, DE, FI, HK, IL, NZ, PH);",
"     </li>",
"     <li>",
"      D.T. COQ (MY);",
"     </li>",
"     <li>",
"      Dif per tet all (IT, MY, PH, PK, TH);",
"     </li>",
"     <li>",
"      DiTePer Anatoxal Berna Vaccine (HK, MY, PH);",
"     </li>",
"     <li>",
"      DPT (TW);",
"     </li>",
"     <li>",
"      Infanrix (AT, BB, BE, BG, BM, BS, BZ, GY, IT, JM, MX, NL, SE, SR, TT, TW);",
"     </li>",
"     <li>",
"      P.D.T. Vax Purified (KP);",
"     </li>",
"     <li>",
"      TRIAcelluvax (DE);",
"     </li>",
"     <li>",
"      Tripacel (AU, TW);",
"     </li>",
"     <li>",
"      Tripavac (PH);",
"     </li>",
"     <li>",
"      Tripvac (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F161239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Promotes active immunity to diphtheria, tetanus, and pertussis by inducing production of specific antibodies.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Adults Aged 19 Years and Older - United States, 2013,\"",
"      <i>",
"       MMWR Surveill Summ",
"      </i>",
"      , 2013, 62(1):9-19.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/23364303/pubmed\" id=\"23364303\" target=\"_blank\">",
"        23364303",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine,&rdquo;",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2009, 58(14):374-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/19373199/pubmed\" id=\"19373199\" target=\"_blank\">",
"        19373199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Notice to Readers: Update: Supply of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine,&rdquo;",
"      <i>",
"       MMWR",
"      </i>",
"      , 2002, 50(51):1159.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP),&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2006, 55(RR-3);1-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/16557217/pubmed\" id=\"16557217\" target=\"_blank\">",
"        16557217",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, Supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2006, 55(RR-17):1-37.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/17167397/pubmed\" id=\"17167397\" target=\"_blank\">",
"        17167397",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations for Postexposure Interventions to Prevent Infection With Hepatitis B Virus, Hepatitis C Virus, or Human  Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Other Mass-Casualty Events -- United States, 2008: Recommendations of the Centers For Disease Control and Prevention (CDC),&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2008, 57(RR-6):1-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/18668022/pubmed\" id=\"18668022\" target=\"_blank\">",
"        18668022",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Syncope After Vaccination -- United States, January 2005-July 2007,&rdquo;",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2008, 57(17):457-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/18451756/pubmed\" id=\"18451756\" target=\"_blank\">",
"        18451756",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine From the Advisory Committee on Immunization Practices, 2010,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2011, 60(1):13-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/21228763/pubmed\" id=\"21228763\" target=\"_blank\">",
"        21228763",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older - Advisory Committee on Immunization Practices (ACIP),\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2012, 61(25):468-470. Available at",
"      <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/mm6125a4.htm?s_cid=mm6125a4_e\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/preview/mmwrhtml/mm6125a4.htm?s_cid=mm6125a4_e",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/22739778/pubmed\" id=\"22739778\" target=\"_blank\">",
"        22739778",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC). Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP), 2012,",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2013, 62:131-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/23425962/pubmed\" id=\"23425962\" target=\"_blank\">",
"        23425962",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact With an Infant Aged &lt;12 Months --- Advisory Committee on Immunization Practices (ACIP), 2011&rdquo;,",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2011, 60(41):1424-26.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2000, 49(RR-13):1-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/11106289/pubmed\" id=\"11106289\" target=\"_blank\">",
"        11106289",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cohen V, Jellinek SP, Teperikidis L, et al, &ldquo;Room-Temperature Storage of Medications Labeled for Refrigeration,&rdquo;",
"      <i>",
"       Am J Health-Syst Pharm",
"      </i>",
"      , 2007, 64(16):1711-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/17687059/pubmed\" id=\"17687059\" target=\"_blank\">",
"        17687059",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pichichero ME, Rennels MB, Edwards KM, et al, \"Combined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults,\"",
"      <i>",
"       JAMA",
"      </i>",
"      , 2005, 293:3003-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/15933223/pubmed\" id=\"15933223\" target=\"_blank\">",
"        15933223",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prymula R, Siegrist CA, Chlibek R, et al, &ldquo;Effect of Prophylactic Paracetamol Administration at Time of Vaccination on Febrile Reactions and Antibody Responses in Children: Two Open-Label, Randomised Controlled Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2009, 374(9698):1339-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/19837254/pubmed\" id=\"19837254\" target=\"_blank\">",
"        19837254",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics, &ldquo;Febrile seizures: Clinical Practice Guideline for the Long-Term Management of the Child With Simple Febrile Seizures,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008,  121(6):1281-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/18519501/pubmed\" id=\"18519501\" target=\"_blank\">",
"        18519501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zheteyeva YA, Moro PL, Tepper NK, et al, \"Adverse Event Reports After Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines in Pregnant Women,\"",
"      <i>",
"       Am J Obstet Gynecol",
"      </i>",
"      , 2012, 207(1):59.e1-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/43/34488/abstract-text/22727350/pubmed\" id=\"22727350\" target=\"_blank\">",
"        22727350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9373 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-484BBBCA60-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34488=[""].join("\n");
var outline_f33_43_34488=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161261\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161262\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161272\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161265\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161268\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3062959\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161248\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161236\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161251\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161249\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2671735\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161270\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161253\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161240\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299219\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161243\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161245\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161256\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6839179\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4043189\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323115\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6839180\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161257\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161239\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9373\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9373|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/35/20017?source=related_link\">",
"      Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?17/13/17624?source=related_link\">",
"      Diphtheria, tetanus toxoids, and acellular pertussis vaccine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_43_34489="Squamous intraepithelial lesions";
var content_f33_43_34489=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F82322&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F82322&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 553px\">",
"   <div class=\"ttl\">",
"    Squamous intraepithelial lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 533px; height: 446px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CIN: cervical intraepithelial neoplasia; AIN: anal intraepithelial neoplasia.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Bonnez W. Papilloma virus. In: Clinical Virology, Richman DD, Whitley RJ, Hayden FG (Eds), 3rd Edition, ASM Press, Washington DC 2009, page 623.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34489=[""].join("\n");
var outline_f33_43_34489=null;
var title_f33_43_34490="Criteria for melanocytic lesions";
var content_f33_43_34490=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 616px\">",
"   <div class=\"ttl\">",
"    Dermoscopic criteria for melanocytic lesions: Structures and histopathologic correlation",
"    <sup>",
"     [1-3]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 596px; height: 722px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Argenziano G, Chimenti S, Talamini R, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003; 48:679.",
"       </li>",
"       <li>",
"        Braun RP, Oliviero M, Kopf AW, Saurat JH. Dermoscopy of pigmented skin lesions. J Am Acad Dermatol 2005; 52:109.",
"       </li>",
"       <li>",
"        Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol 1987; 17:571.",
"       </li>",
"       <li>",
"        Jaimes N, Braun RP, Stolz W, et al. White globules correlate with balloon cell nevi nests. J Am Acad Dermatol 2011; 65:e119.",
"       </li>",
"      </ol>",
"      <br>",
"       Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34490=[""].join("\n");
var outline_f33_43_34490=null;
var title_f33_43_34491="Medical treatment of chronic constipation in children";
var content_f33_43_34491=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61175&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61175&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested regimen for recurrent or chronic constipation when a change in diet is not effective or is impossible to achieve",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Step 1",
"       </td>",
"       <td>",
"        Start 2 to 4 teaspoons (3.5 teaspoons = 17 gm) of PEG without electrolytes (Miralax&reg;) once daily (or appropriate dose of other laxative).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Step 2",
"       </td>",
"       <td>",
"        Increase or decrease by 1 to 2 teaspoons every 2 to 3 days until the desired result of daily soft stools is achieved.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Step 3",
"       </td>",
"       <td>",
"        Follow-up by phone or a return visit within 1 month to be sure the laxative is effective.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Step 4",
"       </td>",
"       <td>",
"        Continue to work on adding fiber and extra liquids to the diet each day.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Step 5",
"       </td>",
"       <td>",
"        After 6 to 8 weeks of soft daily bowel movements, begin to taper the laxative dose by 1/2 to 1 teaspoon every 2 weeks, until daily movements continue without the need for a laxative.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Step 6",
"       </td>",
"       <td>",
"        If stools become hard once again, increase the dose slightly and retry weaning off the laxative in another 6 to 8 weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Step 7",
"       </td>",
"       <td>",
"        This process may take from 2 to 4 weeks to six months, but the end result should be resolution of the constipation.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PEG: polyethylene glycol",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34491=[""].join("\n");
var outline_f33_43_34491=null;
var title_f33_43_34492="Chemo skin pigment abnl";
var content_f33_43_34492=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chemotherapy agents causing pigmentation changes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Diffuse",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Methotrexate",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Busulfan",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Liposomal doxorubicin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hydroxyurea",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Procarbazine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Local",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Bleomycin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cyclophosphamide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Busulfan",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Doxorubicin (nonencapsulated)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Ifosfamide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Tegafur",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Mitoxantrone",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Daunorubicin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fluorouracil",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cisplatin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Carmustine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Mechlorethamine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Thiotepa",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Docetaxel",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hydroxyurea",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Hair",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cisplatin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cyclophosphamide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Methotrexate",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Combination regimens",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Special patterns*",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fluorouracil",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Vinorelbine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fotemustine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Vincristine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Bromodeoxyuridine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Docetaxel",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Bleomycin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Imatinib",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Combination regimens",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Supravenous serpentine hyperpigmentation, flagellate hyperpigmentation or hypopigmentation.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34492=[""].join("\n");
var outline_f33_43_34492=null;
var title_f33_43_34493="CRP risk future MI";
var content_f33_43_34493=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69135&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69135&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 482px\">",
"   <div class=\"ttl\">",
"    Increasing concentrations of c-reactive protein predict the risk of myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 462px; height: 319px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In apparently healthy men (left panel) and women (right panel), the adjusted relative risk of future myocardial infarction is associated with increasing quintiles of high sensitivity C-reactive protein (hs-CRP). Risk estimates are adjusted for age, smoking status, body mass index (kg/m2), diabetes, history of hyperlipidemia, history of hypertension, exercise level, and family history of coronary disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Ridker PM, Circulation 2001; 103:1813.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34493=[""].join("\n");
var outline_f33_43_34493=null;
var title_f33_43_34494="Basket CBD stone ERCP";
var content_f33_43_34494=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Basket extraction of common bile duct stone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 291px; height: 288px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEgASMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5xXp0pTn0PPrTlJI9vpTlz0yaAGhcnHXIq3DFg5xziiJOnWtnQdJutXvktrRMu3Vj91B6k0AVNOsJ7y5jt7SJpp5DhI0GSxr1/wAIfDuLTgt3rKpPdjDJCOUjPv8A3j+ldN4H8LWOgWeYR5t4wxLcMOT7L6D2rq4thBHcetOwjlzA27LgDnpT/K2rwABWxqUCgB1H1qiqZIBAxTAbBHsTPrUcsLSvnsKv7MLzUfsKAKqwL3p/lgds1OFzTCyj3oAjCdiM02R0j6nJ9qSaQnhT+ANV3GOQefegB7zHjB2j9apyy7SSuSx7mnup6k1EwPTFAFOffI2WOAOtMEAJU9uv1q4IssQ2ac0QAxQBRu48YwBtPaqk1vhQD371rTxbmHTApGgJQHjjpQBiNaAcmqV1AQTzXQtAcjdziqFzAXcnnGaAOYni5yc1ABtXOPpW7JYyS8qh2+vao3sNnUbsflSAxoo3dxtFaqWq7x1J9amghBcLjFTMCHO05x3oAhNuFkAxg1cmj8u1UKep5qJznkD3qx5iJEu8Fm7A9KYDNM+WXMn3fetO4ghVhJvCjv3NYM+oBG+Xr6DtVee9mmPDYNAHRf2paWeAqEkdya09P1S21aGSzubcSwyqVZHHDCuCUs7/ADHJFdR4QUG7bgjC0Acf448B/Y5ZLrRw0lsfmMHV4x7eo/WvO5Ew3HSvpu4jDPknBFcj4s+Ha6vbSX+kbY74DLRHhZsDt6N/OlYDwto8qCBz9agcYate6tpreV4p43jlQ4ZHXBU+hFU54s5YdcUhjbZN0KkH1/nRUcRIQCigBEXpU0UfqMf4U2JMjOPwrb8PaPc6xfx2lom52PzMeiL3JoAl8M6Bd69qEdrYx5OMu5+7Gvqf8O9e8+G/DFtoditvbqGbq8hHLn1NL4Y0iz0DTxa2SdfmklP3pG9T/hW0Lge/5VSQie2iMZIOMGphHtlJHQ1BHcrnB4q0rZ5HSgCO8TdF9KzwvNakhGOazZsJIelAD3Hy1XJAHbNPd8jrVZfvHNAC788VXlJ/hqVunTBqBs55P0oAI87gTVjy1J55NRKhJwTgZq0qke4oArvCD1FMFplssSBV7b3p+AV96AM57dR93k1XaM7ua0nQg+1IISecfnQBllcNzUiwErgAnmr32Rc5YZ9qsxxhBjGBQBk/YyTyMUi2Ma5yMnNazD5qaUoAx5rZQp2jA9BWVdWnGACfUV1LIF/GqFyFAOwDNAHJvEYVJJ+boBVNnKcHnNbOqKTg7RgDmueuJGaT5RwO9ADprrHy+nWqs91LK3XCjjApkuTkdv50mAFAwaQxjIzZIzx1qwoHk8daZkiMinQN8jbumKAGK20nJ6V13hRwu984JFcLcz/PkHHtXR+Hb3bH8x46YAoEd9bjz5hj7tdHbwlYgEU7BWBoq7o1Yjg88+ldLo5lvb6OCLOOpHYCmBz3jj4U/wDCXaO+p6fsh1xB+7BwFuFH8LHsfQ18039lPZXUttdQvDPExR45FwykdQRX34m22t+m1VHGK8q+MPw2TxZp0mr6Yg/t2Fc+n2lB/Af9odj+FIZ8oRW6mMUVca3kid45I2V0Yqykcgg4INFICnp1lLc3MVvbI0k0hCoi9zXvXg7w1D4esNgxJdygGWXHX/ZHsKw/hZ4ZGn2y6tfL/pUq/uUYcxp6/U/yr0ZfKcZ700hECKScVN5LY6ikcuD8oGKYbhl644pgK0bg8jip4JmQ4YErUAvQcZHNOWYSNxnHrQBpqQyZxxVeaNHJyKha6K/Ko4pUn3feGBQAjWx2/LVdoHVskcetacTq4+U09lyMHvQBhOO3pUbHpxV+8h2NuUVUCZIoASNRnkYq6uOgqusZJ9Ku26j+IE+lADSnAwCaf5PHPFSsQOOgprSAGgCIqBximHkcmpTz0o2ZHFADFWnSRkqMVIiY606Q4GBxQBUxtHJpHz605gfrTSufvHFAFeU8YFVZUwCTzV/ZzxTDHnqKAMG8tvOiwBiub1C12MQvXvXd3EaqvPp0rmtTtmkyy9PTtQBy7xqGO5uRUErqp65NXLu32k7jjFZMgLOQo/E0gCe+ihXBPNVZL7fGTGOPU8Cs++nhimOf3kg9egrNeeSVyzMdvp2oGaMb+fcqu/knmvRfCtou9M5x1rzvQgGuiT2r1Dww2zvwMUITO3tATkL2GK77wdpv2a3NxIMSSj06CuT8Jae15eqzD9zGcsfU+lekk+XGcYB7U2A24ZpZhEnAHJpLzcQsMRGf4hSwIUQyOSW6jPels43LtLJ1akByOs/DrwvqepTXl9pMT3MxDSMCRuOBzx3orr7g/vT17fyopDPFVxx7elOaRl5zVZpgnAqvJMzE881Qi4146nnBFCXZY/MoxWcMknJqxGvSgDQWWMrkL+lP81QuEGKqJ7mpVxgnFAEy88sacXJHHSosk4qRBQA+J2Qgir8U28Cq8UQI5qUIYuR0oAfKm8c1A8IHKjBq0rBhxS7c9RQBQCc81KvBBHanyrhvahMUADZYUm3gDFSEjGBQfm4oAiACn2pSeOBinFBik2nFAC5HHJpsx9BSqMHnpT2UeooArEE01kz9KsFOM5qKQ8cYoAYABUbv6UEnPJzRt7tQBWdC/WqF5GiId3P4cVozyqgxWBrN4qx4ByTQBzusEFiB0rldQumjUhBj3rpL2bzF249elYF1EgJ34PtSA5GXc8jE5OepoQc4bNSalMVmYRL8o71SjLucknH1pDOp8NNDvYuDkHmvSfC81vPfxW8MbtLIQAoPWvLdCiKhnPQ8CvoX4Q+F/sVoNXvF/wBJmXESEfcX1+ppoD0nRLOOxtEiQAEDLEdzWgGMkqjIKjrVUMQoVevSrUKmBRxlz0FAiWQl5VjC5T+KrSjio4gAM+vU1V1jUU020Mrcu3yovqaQylqGtWNveSRSTAOmAQPpRXnt5H51zJIxJZzuJ9zRVWEcmM9zStgdDUYJPrTwPSgCRD6dKmQE9KjiToO9aNva4AZ+PagCBFJHWrKxMFHBqZQicKKmjkAIyKAIEhc9jUsaHoBzV5JEwOas26IxJI60AVILdxgk49qneJiMZFTuQuQMYpplHTj2oAqmNo+eopVfI96nbB6CojEAcjNADXUMOetQY2571OwwPamHmgCPNO3c0wdcU7vQAE+9NLc0pGTzTcUANYmlHUMTmhvpSKhJ6UAK7MevSmbGYZ6VYVBjB5pG460AQbAozVC8uQhO04x61aupPQ8Vzesz7Aefx7UAVtS1DzHKo3A61z99chjg8mor+75ODWTNOTnqT70gLct0ACFx9ax9R8yRG2Nj196kJJOSacVyPWgZyk2S5HvRFFkhQBya0NStxG5YDGfat/4deFLjxPrSQqGSzQ5mmxwB6fU0gO1+Eng1dUukvL1R9gtjkKf+Wren0r39AsaqB8qjjgdKpaXp9tp1nDb2USpDEu1VA/zzV6MF5AAQV7imIs26ZO5iNoHFXIwHIY9+lQxgPhVPyjqKsDKkbRnJ6elAxZpo7aJ5Z2VIoxuZj2rzXXdZfUr55RkRDiNfQVreM9VeeU2VsVEKH94+fvN6fQVyZhcHIYYpoQSXDFjRUUivuNFAGCq9OanhhaToPlHc0kEJZhngVeHK7YhgDjNAEkSRxqMck96l5b2FMjjAAqYAAUAIqgfSpk2kc1GKtQwlwGbpQA6EIOScmrkTYX0NQL5cfpmo5bgdF/OgB005BIU8VCJCOc81AWyad1FAF6GUMPepC1ZykjpVgF8YPH4UASuwA96iJJHFOCHqaRhgUANUYp4GeaYpzUnJHFADG6nFIFLEEVKFAPvTqAItgB9TQ3SnsahnlCDLEZ9KAHGRU57+9ULy6ABOePaql/dsxABwO1Y91dhAQWJoAnu78jPNc/qd152Vyfx7VHdXhfPIArLlkJzzxQBWu15O3n3rOkPUVpSHPeq0sYIz3pDKSjAAqxEKaU7CtLRNMuNVvorS1QvK57Dp7mgA0nw1deIr1LSzQknl37IO5NfQvhPw5YeHtKisbBcgDc8hHzSN6mo/BmiW2g6YtvEh89j++dhyzf4Vt3PybdikseAR2oEPAIYKgxjt2q5GvQL949aht0wvz8setWlUqdw6d80ASxqYiMY5/U1jeK9d+wW5toGH2tx8xX+Af41oapfCzs2l2qZcYjU/zrz2+je5maWeUtI53MTQBmz3DbGbbuPvVSC+Z5NrIR9K0pLZSpG7NQxWu1gRn60wJI5coOGoq9HCQg+UGigDHK9gBT1THQUDinBiaAJO1ApoPFLn05oAePrV15dsI29cVVjQbct19KZNJkYHSgBGY5z3pFY+vFNyaWgB/enDjim9/enA0ATW/wAsqtjIU5xXS6kkd7ZrdwjMgADY7D3rm4OorQtyw+VWIB6j1oAjC1G65HFX2gCoS3Gf0qB1wBjkUAVlTHvT6UrTCcUAKaaaRnAqGSXaMmgBZ5dgrKuJycsx57VLPIXJ54rMupVOeePagCpeXABJPA/nWFdTbidzZ9gat3jF2wD8orNmRTQBSnOaiKgj3qxJHnvUbIR0pAVnQimFM1cKZHIp9paS3U8cNvG0krnCqByaAKlnYT313Hb2sZkmkOFUd6928B+GofDtqyyJuvZAPMm/9lH0qLwR4Yi0BfMmRZL11G98fc9hXYELgMenb3NACsMfOB83YUlqrKCZTlie9EQkLEy4znjHpVgAfjQA9VLH5eDT57iO1tzNMwWMD8zVe4uUtIGmmcCNRye59hXKX+oSajNuk+SIcKvYD1oAm1W+N7IWyQDxj2rGmGRz2q78uzhsmoZVH4GmBRRQMntTgGb6VPtK/SnptycqOKAFiVvLHJop6uuO9FAGEOc1Ii564qFWyfl60krnoDigCf5RwW59qkRV25zxVOFS55/Op3fgKO1AErykjav51EKbmlFAEnYYpRTc+lOoAWlBpo68U/pyxoAsWwJP0rWs9uSD6VhJdLE2B1q5bXO8/SgDclKBAMjjjmqTyLnCjB9ajjkGcljTXYfwigBJnCqT0FZ73SZ61LdP8h5Oa5PVNRFtMVwfUUAb896iLncPpWdNqBJ7VytzqLzNyePQUz7WxOATQBu3GoMV4OOPWsq5upGONxqq1y+cnpUDz9TQBK87Dgmq7v700vu6mmMSTikAvJxQUJ4zSgdKsW8DzSLHGhaRjhQByaAGQWss8qxwozuxwqqM5r17wT4Tj0WJbm5CvqDjnPIj9hR4M8KR6TElxeKHvnGcdo//AK9dggAGSfqaAG7FGXJIA6+9OVSz7iTjsvp/9elYbjk9Owp6/KPmPJoAXp9aZPLHbwPNNII40GWY9qWZ0jieSRwiKMlj2rzPxJq82qy/Z4pH+xp03dZD6mgBuv8AiiW/1RVVttkhwiZ5+p96nWZpEGD8p7Vzi2QDAkc+tbenxkAKOR2pga1tnyxR5oLFTwPanqNqgd6ryDbJxwaAJi3oQaCpC57moMMrcVdhmAGCit/vUARKGCiirRljB+4o/OigDnCFhh96qq2TnvTTIz8mhQc0AXIT8g9Wox60iHAGTz6UUAOpe1NH608DrQAoPA7VIBnmojIiDLNkiq1xe44Q496ALkkyRDrzWZdah6fnVC6ujkjJ571kz3RUHkfjQBovfsZeuAD1roNLuVMAfcDXnsl6ei1a0rVPJfZKx2k8c0AemxS/Lk9DTnlxx3rBs9TH2VC3POODVsXqMM7gR9aALFw+5D61x+vRGUnjBFdBc3QCBoyCK5/V5hIyjPOeRQBzb5Q8npThLgDB5qSSM5OeRnk1XeIjlTmkA9n5IPWmFsmmZPfr706gB24gdBzSDryOaco/OrdpZy3MqpChZmOAAM5oAjto3nlWOJC7scKB1Jr1/wAEeFYtLjW5vQJL1hkLjiMen1p3grwpb6QonuFEl4y55HCf/XrsNgJJ5FACbR1P403BZsnoOgped3PQdBUvAGe9ABjaOetMlZY42eRgqqMlj0FMmdIVaaaQIgHJY4ArgvEmvvqcnkWrbbND16GQ+v0oAreKdefUZvs9uWFpGfp5h9T/AIVRhTcgbFQpBuJJzirsS/KFXqKYDlj+WrNhhJMYzTQMKKSNTvyOtAGoclhxTHjYsCO9ETPjDnip94IANADI4+MMQMetSRWxkkwpGafG+McqfYirUErmQdBj0oArtp82fu/rRWoXbPIGaKAPOF4GafHjpmox06UoJoAsM390n0pyk96rjIGc4pDdJGpCjLe9AFzIUc8e1V5bg9jx7VQluWbktkVCZx0BzQBZnmbGc1UaXscUjONuaoTzZz0xQAXUozirPhfwtqHi3UXtNOeBGjXfI8z4CrnGcdT+ArGllG4cZruPB0X/AAiNtF4s1iSSFmVlsLJG2vdkjBZvSMZznvwfTKA7/R/hj4b8LafNqmusdRe2jMsjTLiJQoycJ3/EmvnvxFq0us6zd38qhGnkLBF6IvRVHsAAPwr1D4j/ABPg8SeEYNO0+Ga2uJ5M3iNyAq8gA9wTg9vu+9eQMueAKBk1pfywEDexXPTNbFvqc3/LOQ4NYBhzx2p8G+JunHp6UAdRBqRICyMc5zkdaknYTrvXJPXNc/HktvGf8KvJKyoVBODTELcn524H4d6h3JkbQeO1E7HcpPUimshP3Rz6UgEdVf7owwpqqSasxR7iMjLVo2WnS3tzHHBGXkY7dqj9aAK1hZPczpHDG0kjnAUDNeweDvDEejx+dcAPeMPThPpU3hHw3FokW6RVe6bq3932FdGcKM9/T1oAayqMuR/9enLzyaUc8mkJCEep6CgBxwOvWoJGECtLK6hepLHAUVJIyxIZJWACjJY9BXC+K9Vm1FxBb/LbL27ufU0AVvFGvPqsot7UlLRD17v7mseKLJA5Cj2pUixjHJq3FH6dKYDo0G0YFTwx8nipI0x2qVVGaAEEYxgVPHEO2Kaq81KmScGgB6IoPNPKr2waUZXnH6U4MB95OPyoAQBMc4zViyhWSYYbAB60yKNZGXCHB681qQQKg4T9aAHNEAcbh+dFTbV/ufrRSA8oyD71HJOqd8U6T93GQOp61jXUvXmmBbmvjyFPFVGnLDJJzVIvxgZNIrEdTQBdExwBngUF/l5NVDIQvBx9ab5pYYHWgCzJL6n8qpzuXGcU4Ang596JI/kNAEWmXSWWo21zJbRXSRSBzDLnY+D0OKta/rF74g1SW+1KXfK/CqOFjXsqjsBVALg08LikAwxgL2NVXKqxA61bnfarE8YrMZix+X86AHkjPPFPUgikihlk7H64qwlltHzNzQAROF+npV61VZD8vP8ASqgs+4Yc1PbRywvvTt3oA07nTy8UUi9BkHFMWBQgHTHatKzvUntzG42yDngdadp2l3WqXwitYi5bq3ZR6mmBX03Tpr+5WC0UvKewH869a8L+HoNEgO077l8b3x09hUvh3QLbRbfZDl5nHzyHv9PatknHyjG7tSAQ4HbmgA9X60BQvzHkml98UAIxx0GT2FRXMyW1vJPOwCIMk0l5cx2dq89wwCKO5xn2rz3XtZuNWlCfctgfljB4+p96AH634me/uTCgMdop+Ve7e5qr5m/BIrOkiIAbBqzbZIwcfSmBYCZOamQHimoPWp16UAPX2p69eRUYzmpFHrQA8Hn6VKn3s1EAd1WbaIyPtHU0AXo13oM556YpjxbJRu5H860FjxHx2AAqKeJSykjkDrmgBIux/wAitC2xnnpVWGPc2c/KB0NWkBDe1ICd0G7iinE5ooA8auuhrGmjLEtW1c9CT0xWRNIuCO9MCk4HOM1XLEZxzU8jblIxURHYUAMBY9eakRSKFXmp0TgfnSAdGmVFSFMIc06IYAxx61MsEk3zKpIpgZU0eGpvPQda05rSRVJZMAVXs4t9ztI68CgCv9m3glgSKg8lVcBQCfpXVraKIGAXtWbBa7rg5XpQBmHcOlII26npW21gqnNC2YyOKAMiOJmPHArWsbdQQGbmpltgg/wrY8O+H7nVbj5FaO2B+eUjgfT1NACaT4fbUrpRaDaAfmfHC16bo+lW+l2wjt0G7HzORy1TabYQafaJBbrtRe56sfU1Z++vynA9aQCPnovfv6UqLtAyct6mlXA4xTgvrQA0gkZ71WvbuKwtmmuGAUdB3Y+gpNTvodNtzNO3P8Kjqx9q8+1DVJdSm3zuePur2WgB+s6ncapODKdsSn5Yx0Hv9aoiP2AqeOPjNO2eopgQlc8YoEZVsgYqxs4zjmgigBPTFSKaYuc04A8UAP3VLGSSAKjjjJP9atxxhRxQAqrzmtDTUBmyQOBxVVELMAOprWhijtVLOee9AE7OQ209O5pOOvXPSq4uUdiAp59asxYYdiMdKQD4xw2aljyWwaIMKTkcHtVj92p9KAGMfm6milYAnIbiigDxqcmVGH86ypYCAe+K1AcijYrL9aYGI0ZwaaISf4eK2Ht+M9aieEjovJoAz1hI6DmpljPQ8VL5bEGrNrbh2A5JzQA+xsTJjcMrmt2C1RFAxxT7SEIoGKtqnFAFKS0iZTlfxrPTTI459yqODW2RnimiP5smgCuIBsII68VW+yKh4Fabr7VEyg0AZrRHOAOKVYF6Grvl5bABJ9q6fRPDYOya/wAjuIv8aAMnQPDT3rLNcDZbZ/F/pXe21vFbQLFCgSNBgKKkVQigKAAOAB2pfekAdevSkII+npSkZ604dDmgBg4YVHdXEdumXPPYetUdY1aKwURph7g9F7D3NYkNzJcTF5WJZuvtQBX1zzLqYyTnPoOwHtXOmAiX2FdlcxedAcjLr+orn7iLbIcd+aYECsAADxUmM0mzJxipUTFAERXikxUzJk8Uvl9M80AQqpJFTrHjGOTShf8A9VSjoKABVwRmplqJmC9aTeW6dKALkMgVsj73Y4q7JGXQuTnPesuM4q/BINm3PTsTQBJHGFPzEZ9hV+HaEBDcfSqaOhbDOo+tWo8Z+Ugj2oAsgKV4bj6U9lJA6VGg9jkVISS3YikAwhwcUVIxG7qKKAPF0fg1IDVdMbcjkGnFxjHSmBOGDCnDBHSq6OB05qeN8g4NADXiXPFXdOhy5YjpUca78L1z2rUt41jTCigCdAAKlXmmD5RzzShyRQBJtFLtHXNQM+KaZDQBK+AMVC2QegpwbIyTzWnomnfbJvMkB8lTjgdTQBb8N6aWlW5nX7vKKf511ROOnWqUaQ2ZKqxMjnPJyTVkEBd2c+9ICYMMDpSjrVRFYSGZySOyenvVsHI6YoAd36Vi65rUdkDDblXuTwfRP/r1Q8Q+JY4S1pp0gebo8g6L7D1NcnA7M5LEnvzTA0jmRy8jFnbkknOat23Drgmq0XKg4qxGcEHvQBuRL8pXnOMZ9ax9ShEc3HOetatpMHAyRurP1Xm4oAzPLyalVAKUAelO4oACgI4ppGDzSg0pGRQBHt5pWbA96CSo45qMnnuaAGMSX5qVBSKgY5FTKmDQA+JCxwK0I7cLHkjJ96i05FMh3E5xxitEIAAARj3oArKiAj5Rn2FWEwpPAprx8gAjNPVcEYI/OkBYQnPBqwnLEHFVFGG5NXYE7hs0ADLz0oqQqc9KKAPAbKTI2nvVoct2NYsMxHStNJ8xZHXFMCwDtJNT253fdHJqkCSvU81p6egABNAGhaRBF/2j1q+hAFVosEcGp1FADiaQn0pScCoWlAoAH6U0vg4HNV5ZzjgVHCcscnn1oA0LeJpnAHNd1bL9hs1VeTt+VOlZPhWBBCSUy5O5mPp2Fas7iW4LFOIuAfWgBg3uwYYMzdfapLOV5piFBMEfG7+8agdJOVgbZcS8tk9BU+qF7exHkMiEDBLHH40gLk11bwxNJNKkcanlmOAK4Lxd4xFxus9MY+T0eYcb/Ye1YvirV5L6dLeJv3MfHB4Y9zWLFCWcAjPvTAu20jOQSa2rUZ5rOtYQhGV5rXgG0ZxQBbg44PFWQcmq1v8AM49KtgYNAEtu5RwQRU+qJtZSeciqo9TVvUAXtoX9sUAZxOBxRmo3JphbjHOaAJs96aZMYqMkn6U1iB05oAlV+eaCwz0qNT604jOKAJUcE1Kp5quvSpVagC3bvslQ5xzWqzgEc81iI2K1XPyqR1IzQA9iGfHrUaITJgHC/wA6hmJK5OeKlswfLBIwe1AGnHBnBJz7VbGBwKq2rfNzUzNh8UgJWbmimk0UAfMyPitK2Ysnesa2YSojqwZGGVYHqK3rY+VEFwORzTAsRfKw3DI/lWnasfMA7GshWLPxwK29ORfLDMxytAGlb8DrVkNtFZqXOGAA4qUy5XqM0AWZH3VSnnCccc+tNuLpY4ic9K5q/vt287vwzQBsS3ibjlxUthdxTXUcKEEuwWuIlu2Y9a2/BWZ/EEBJP7sFx9QOKAPZrG2ktLd2kZUGeAvPAFFtJutd5c5LZ+YVTvr5UtFiRsgoAWPrVeecxWMKrKTuGcEUAdDYqW3SyAeZ2PbFcD8QvEoSX7DbN7u2f0rt4ro/2QZwo+UdB7V8+67qJutTnmc5LOfypAakGofvMvjBPpW3askwBQj6Vw8EwcZFdN4YlJmw33TTA6i1jGcsOauYHHpUXAHFIZBjrmgC/bnawIxV0AMewrHin5FaEMuSKALjREKMVozQg6apOM4NVYGExGOG6VqSxlbMdMHNAHHs+SRSfzqOY4lbGMZ4pqsTQBP1GaRgeM80gPHFKzZ4oAZzuAHSpkPQHpTFGKcR3FAEwAI4NOUY70yI8c1LjjNAD413OoHc1pGYCTB6Dis6ElDuH4U5pD3OaANIbcE7d2elPQnbyB9BVK3mywVjxWjHH+7Pc560ASxPz8vWrT/MyjvWdESsuOeauRviTmkBOz4bFFVpZV8w8CigD408H6qY5Uspm/dn/Vn0PpXexXsicE5X0rxpCyn5WIPqK6vSNeaaNYbknzQMB/731oGem290rqNhyemK29PlxHgnivPtMvDC4ZicGtxtT3QZjbA7imI6b7SiE/MDiobnUo0XjmudjuWZepqtPcEvjPFFwNTUdRaaMAHC+lYV1cnOCeKdJcfLgnHesG7uiszZPHakBomYnnNdX8P5DJq0iK21jCwB964BbngYOa3/AAnqTWWsW1xGMlTnb6+1Az3eG3iubRPOk2jK9uTTNbgZLqC3tkOMZ59KmvGjFmJVR0LYbA7cVDqV8I5YJVDFmG3NMRaLJFpM0GWy67CegBNfPl6MXUqdcMRn8a+hHiF5p7JBiN8A5Y8mvCdfsG03U57eQ5dG6+vegCvZQMXBrrNHiddrZCrnmuYsJdrjdnGa6S0uMkAH5c9qAOhnuliX5WqJbvepIP4Vj31xuAwT9abYyMZAM9RQBu2VwzzKp5reRWKgg9K5iwVluCcnBNdAZSihc0Aa9jdCJwSQa3Z7hRY27E4DAmuI8w5GO9b2pymG2tUzjbECfxoAwph+8bHqaYp9qFfeM+tOA4oAejVJuyKgHWnBu1AFlSMetLxjioVPvUi88d6AJIx82RVuNc4HWq0Y45q7byqmQw69/SgBjqQeRxTSDV9owwDKQR7c5qEonfI57CgCrznitvTZleDY7fMPWs5Y4ckFmDduKs2sKkMFkGfyoA0pPKUfeyajt1knuEiiG52OP/r1mtDMZxFGDIzHACnOa73QNKXT4PMmIM7DLN2UUgGx6LbpGokUs+OT6mivOdb+Ovh+x1a7tLe1uryOCQxefFjY5HBxz0yDzRSGfFSnpUgbaAynBFUb1pY2UJuGRzgVW8259ZOPagDr7LXZIgiyHI9DXU6RqdvdbVjfDHsa85QMUTKPkqM8Gr2mTyW13HIqvjPICmgD1bBjTqDnvVOWTLHFVrbUVmXbhgfQg058lsgHH0pgRXkpVSfaucubw7yCeM1samX8o7VYn2BrmLhZAf8AVv8A98mkBeSbgEmtjw7P/wATOFcgFmwPrXKq8gx+7f8A75NX9MmdLqJwjgqwP3TQB9TqkklrsO9mKAn8qi1S3cQwF1YMpBwag8K67b6kj+UJV2oAxIxyRWpqBE1uhG4qMZqhFrRo5c+ZcINuCADXi3j7f/wk94W7tn9K9k067jtrj5OQQDk9q4T4qWdrNeR3lsCJG4kUD8jQB55btyMmtjTnPmjJNZscYDD5TWhaZMqgcCkBo3WCwK9qksVzMpPX0qvL94etX9KiLzknoKYG7YxbpVC59615oMc+1V9PURupOK1JipUcZoApWkOWG714qTXpykLEsTgbcmrcG3I4Hy1zniK7Ml0lugJXOWPvQA+3mHlKWPale6XO1cc1Qkfy4sc5+lV4X3MTQBsRS5YYq32rNtDgg1fkYEADmgCVDUkf3qgjyQM1YTg0AWl5FLnnFNRs/Wn4zQBNDIUOQT+FW1lRjyQc9c1SQZqQoAM7h+VAFyWOM/MhXPoKhiLi48uJWZn4Cjkk1DDHJcTLFApeRjgAV33hvQU05fPuSr3TDk9kHoKAHeG9DFkonucNcsPwUegrxP4+fFyNornwx4XuAwYGO+vYm4x3iQj8ifwqf46fF4xxT+HvB0zvI2Uu7+EEhB0KRkdT1yR0r5rMc2eIZfT7h/wqRl+xkAtUHHf+ZoqCzSUW6gwydT/yzPqfaigD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Attempted basket extraction of a large common bile duct stone (arrow) via endoscopic retrograde cholangiopancreatography.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34494=[""].join("\n");
var outline_f33_43_34494=null;
var title_f33_43_34495="Edinburgh depression scale 1";
var content_f33_43_34495=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67741&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67741&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Appendix A: Edinburgh postnatal depression scale (EPDS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 499px; background-image: url(data:image/gif;base64,R0lGODlhvQHzAdUAAP///0BAQICAgMDAwPDw8DAwMNDQ0ODg4AAAAKCgoGBgYFBQUCAgILCwsHBwcJCQkBAQEEBm/8DN/4CZ/+Dm/zBZ/yBN//Dz/1Bz/2CA/7DA/9DZ/6Cz/3CN/5Cm/wAz/xBA/wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAC9AfMBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wMGeBgZCBMXCycptARAHAAMBy9PUZQECCtDSBwoBC8UHCQIBCQYLC88A4woE1e7vRgHRB9EAB8UGDNAMAwQMAgQeZHMgAEADafASupM3QEE9AAm6IdAmRB5FCAIyTlTIcZlFctIcKHg28aHFeggGqBzQsaWwkwykBWhgryTCkzIfCEHmsicv/4sAAkjLF8CBzYos6xFYUKDAAp9Qo0qdSnVAxqvirmrdujUrV61ev2YMK5Yr2a9nu5Ytm1btWgFt18bF+nau2ARU8+rdy7ev37+AAwseTLiw4cOIEytezLix48eQI0ueTLmy5cuYM2vezLmnAZU8O4veE0ABtgKhiWwczZoZSwD52jkQSnMAAriwF8wUcqBg699fgAJQoJOmvwMHUho4UOAAgZOrgUvPIjwjtNkQWG58cG2c7+ngqb8e3qAB6qDahWBbmS68+ypAExRQ5wAAgQLa2w1g0A62ve/vBdhEAAUQyI59BTLFkgAF1CcfgbVFJ+CEFFbIiFV1ZajhW27Jxf8hWeNZKOKIJJZo4okopqjiiiy26OKLMMYo44w01mjjjTjmqOOOPPYIDzHGpMaEAfVhYQ5CQgzQnpJRENkEASv52Eozzzz0hJVWMGBAf0IggJBtACbxEJZi/uNAAVwiQaYTwklZyDXZ1KOSekIk0MA5BIyj0wAFjINXbrup01t7EJVW5W1/dunQcKbZ082fAzTQzYL/qHRNADqp401oDxGU5zXtHFmQAJWG46cQswUqQG/7NerbnJF2Y8BB2ahHqJtuyBMAPdJYB8BGRQWE33H7Oaclc85Z5OWqQySwAJT6JDdAaAiYc8AC1vGzFF7j3KOPfEru1w8DBzzw1KxEPET/nKvZQLClTuDSo6U/xRhH7q/XGFDAA+mpM+quBkCA1wJ/poRrHAw51KtvwCZ1k6XqCcBdRtf8asQCrwVQjIQWC4WhAV8+5etRFKEnXzlF7HcaARAM0TIDDvRT8kPWDYBdv+h1GbG/OvN88BwfJbBwzzghRXNGDqlEUjwZ4zzEURmNObTFUiN13T/p4ofMahMFtAAEUH6JUEbmFaPsEEBtZN3IO/8sB0zSPFBfclabBDEAqO3X38ZGyG2fPhYXEZ11YKujE9t8JvnwlgYhWbIQC9T21Gv4JV4yagLUdx/OgRbuKsNtM+u2axVJ409RDZfMEAQE+vZgATRxTIACTdEU/7hqRFhnXgEHsh0UOXabRyCnjoMsVDFMNVh6AgOw3ieC3uB3u/AAPBATtj6rzXCIo/u1ZvetfW9Gbx3exaFZ4Kev/vrst+/++/DHL//89Ndv//3456///vz37///AIyDzMDgJDwUMAmOU0ICErWEAx7BgXNYIBEkSATTFYOCWXCAkKygQUAcpEhK6CD3DGGA24RBfG7YCAp7xgRfMWGFK2yDC332NNjUZ4ZiSuAR2oQFHurhAPxJExI+sgjTAK5xgRJCA14TqUKNBBqvCVM09IQq2hiEiTQ5yDeKUA5+aepAX6zXpqAhKejAJRp5GgJAVEOrOgnFN9x4YxFSZbsh8P/pVHHc4h3JccUk1XEI4RBCpnyzjjTN6QA0CeQAzhHFJC2oIHGsGO4CaR0DAGR2klRjpZx4K4s0AF53Qod9vNMO17UjAYTC1Dme8ak1ohIaxZjTTv5ULkfxUR2OnKMVBcWsQuauUpj0TTCtBklxYCpJ5xAdH8B2ntgEcggHqUgDnAWt7KVMW/eyVzieAgCC3YkAQExTACpFkMYBQCSwKc+zwtmtfNRkWvWQnuWeNjC8yIxgeGNJo4igzXSRi173gI0+ikWvaAbljzVsgDPqUU6DKu6c88kIEJFzL+3xTHr7rGE9JCqwfJ4TQPGi5n6KIA+Fms0BAckGu9DDMrxIKFj/AhnOqLJhndLkzBiFyxwAtIVPi/LzbyS5xgEa6rh4Sa+cRy3I2cR1HGRtrg93qt7cIODFIpALiN3MmCVBl66HXacZLHEGVhdgGlKFCCgY0QgACge5svLDdyqURkSGw8DAWac34xSAvtpmx5t1dWcRCQDJskXRITZEYg8oSFoFIKGJlMYcA0isenRi0YzslYY62+iZ8JIPpDnuIRirSGgwpaW6SaNlQmjZWATwjQQWDbVr1QY35gNbISgAL+QCGTLtKkW/rmax0alHZ7GhsX8QN2ckk4ffbroHBcSkAIDrTYGKIBAH6AQo8vCdHR9WtpxlRLKYWok4X5OSKEUnvCrJ/xNX45ragBlBe0CkSdTGBqDutuloIlna0aqnAOsiQWIBWMqiyitLtCXAAZ/Uh6+sU1kB7Bd3G4VAafm0EuJZjblBYQCaTHu7kuCJHGEqGtdS+4AGIDiB+Yhq1XyqxPOcrUsrCZGcKgdPGpstPXbzlQ/vwFbUIMc+EvIHf6T6NyLT7a/o0elTgXgv1hojlRnLlNn+ZElughOu+hkb1gQXMcuZhmWyAZCSpbddIaBmN3R7yHmErB+E6ksnTKmIlKnr4qHMJyjF8NyoAFK4ckJ4YQHbkrt2kjVBau6ISHnAhosWOWhwk3fVIzPaHNZNyUHOzmHK8GtyqhM9505z0lvNMf/9U2aWIUPQp0au6iKFEHnWlQ5RNTRzCPTq/hqDdrD7G+pS9rD7RO81ZB3CmQgEZWMk71xC2c2wm+M7BsUMIckRIm+Hk6CCyCeZRPC1gtLlvIIQxSjQ6PYQbN3NVzujUMZuCjeH4E6ZqqcpvrGeN/YMEadg7888S4C79NU6kpJjdrUjqT7RVDTjaQxyeDlyBSltcGTEdKcjlA80m3Iged/bGAkK9RCWom4k8/t5H1cqjr16JucuSIeFuBck5poHlSOaI7cVRH9UvgiWQ4LmdmB5LVuCVUE899UBDLrQl/EZJp1zg2iA4BE6yAcMJskISl+D05MOwjRMvQqYTE3U7YP/9CNcnRKlYRBedowG8WF3hHfAoQ5jaAYcSmFNZC/zGtxOBeLYh9eYteESFpxpsLOEAI5lyZFsR0f1jHGYRDAVOcwhykWWRj8DWKBS9ApIBjRKlaL8ohALr442IlG+dTrlM7QYy8gz0JQQ6Y1IgOIbLS7xUpnipzckF9rOB2tSSjx8N8Coxsfe9VE70U3rxygqdWySN5aHJPC7SkVHh/aZgyTCA9KBMqE9UZZhyhzuz2nF6ddJjFusfKNIT5E3tkeRZeSe+bUPFPJDwiIHaJk8nOpJoJornR71c5KwCZCYLoe/6gABDsA80gBpG7cvLAFTA1EQDqVEQPUr9eRMY9cP/x01Ed/ETgLIQPLQUhbTToBjgWgSDkyFc+YBTqh0VRU1MOjgThfIHwtQHKGBTrOSLf2AT+4SEAaxTvxxg/CCH+1xH17EUww0ghRVhBajULxCBOUEZiKlYFzVe97igMdhd2uFSDrIJUAYKVdYDwrgEFyyUQDzcl3YDx6Yg+A0ZI8QdgwwgRPjHV+VHSeDD8bVDUhWNF4zXb4SDV3INBwGXCnjWxETf1W1Wq3VTW6FIUZAiLoFV5Umd23SaIJESJTVNhNBVhnBDwoQObfCVv6iW462UzHTDpZoVjAjM3AneCFTh5EliehhGg8gWZUHEdlQexqjXZSYJDfjTnM1ivywcP+GeIkQg0Mb9YShAzq8iHaJEF79kV1JoyT2lRQOUCk2pooUsS9h4zO2sYZ8mDMoEWP85GL9clcMIg2L9CwgFhT8kl5uV47PIQ7W1DHjYTe+WIzT1jHpKDMRkR24o0YOJjb2YS5gg1794DVgc4oz81kPw3eGE2BkxT0EA45IYYvW9IzoEVoCOV7oKF7DiHcSqZD2KF7vd1YqgYaWBGrT0g4HYWqE5oiUhgCnNDVopI0VZDtFM2qhMWbhuCqstBGQpmgLYmXkcwQ9KT2MiA07IY9qVCvEcGcH51MT4WT2QQ+oAiC3tFVrVUp7YmZWAZSUoxJ3NpOphZWqeFkH92bd9JX/dhQThlZkfqNwt4iThQI4UAlOvjiXSahTf9WRRcI2dhmSvvg6DaBt+CE8zVQgz8OSFJEAMUGHeTgUHTVxMkFpHOcU2ZZxOTlrBfAn+KRwyxaUF5NwTqkzAHcNSHlrBTIq8NYzvtOZ4xhgRGBwDaA7FCeKTVEknZk8RSIUDEQ9u8N7q6YOqZlazyA0R8AAtgNwuXY64JY7oCOYm5YonTmPnVkPs8YTG3k7vFEgVhk40Tl0itBz3nkYMRee5Fme+BNjRmcEswEHPzYFTKcGWbcEX7cEKJc/a4IA+ImffRcUHCMGbjefSDaPamB30lYEM8R2/Qk+doInjvZ4gDIqx+dI/82DAHWlRQwwEZGEUnmScAKQRbqxKEfQoTZlS39ifnbkYLgERfaxe3kSoei4Sm70RK80LSpqDN8BEHH0J68SIkA0fmPUOFs0Q6SCotZHfaWxEYW3RH6EK0VRPefyDDHFg/WWns2CAC/XAAjQJxeqDdiAANnAAC3zABSaAAiALRcnOPUEcdvCKAPkKAVhUS9oEAYQLxWEUjHVhDxjU20iT/MhhPWIcfzSggQgqDMUUs8yUhe4EdpkUEnkI2nzj0whDaWYZUhwoXW1AAjwDIJVJxLRKwhgHmGapbiBBNrjiYuUdzxjUZnYAFWiQ4ymVfNAO7E1QSpVDqnIYlZzjMd4oP8IQYvmYDsq5FcoeDCPao1KAZDXaARk+nL8WRETYRQx4yU1UQAIsJeCVa2k2mX+6HYM1jb5eDe+WA9nt1YldmJG4C4ts2J8ZTUXeZG8emG6Ql4GAZHVFXtS4klP4ZLo1pXztHEQQKGJeBsNsKWCNU3Syp/VIlWRV6ZkxGU8w2n0kYiK1Q6N8hoE0a8c5jf+cGmwcZi/5BsQ62l1CZR2eaB3prH6sIRPaZJ/M2TMc68FcnCKWRrSgJvLkztZegTPYaVbGjBecrBkemcDi5/PUm4OK5u80w7VyZzVcz2oKRTtoJvhajq4ZjsP14tFEG0tlrRNO28ChyqG+QysGWL/VrX/9vFGXWOZtpWb+3kjcXcGRgF0QsCsVKB/amBzfYBz94qMaAABnJi19koF0aC3aEC4eYC35pm4iru4jNu4jvu4kBu5kju5lFu5lnu5mJu5mru5nNu5ucA4XFcF7ZkHW8cEANpAVScGpxtCXUesTFSfTbC6cMB2/9W2S0C7WUB3b4th4AMUD0F+IuhtuoFQc3IQjcp9quJ5srdFD+Bwy9ENW6R45QCjsXJwNOOgR+B4vWNtBuBFvqS97fApulE91BcamKShpERGsuJ5C1q01jFMPSq8gVKOWKtMbhN2xyWozYMt9BcilsUfzwRNDwiw+ARNVxgwefIUAeVOI9h/NBVg/+7FUAxYn/8XUzVFThMMG1C6gOi2hH+bmXK6Uu3UUfjUpPdnHUmVhf3rVGRmMN2DXtzxi2b1EG2YSf4iiCNkM2D1pzLci/KxYbK4qfJ4nQxxWleRoHc4NGh1xJA6XYVDnd9SKzuBlrClWlxVU/L6v56VMzUsMbnJt677UBdJM81IKOI4XRN3Yzx8kUDmG/lFNV5FxBBDYMhorEpMXt5ox4EDWvJhYTWkM80mcoDsYNNoEeuhNDoGxkz6uurAlV9Cksz5Y4D3aQiSk7kDlHhjHjSBZslFae+brjmxkmv0NC+Zp1FGaPpKnNJjUPuRQCzDStdiaYGcM1GVESrpH7uhN/87YVBkZr8/47sIMZ1IApiRbJgM5Jw8DFHEZmv5QAwxAW5D3CvPVRumc2wCxUWLecfpRpkzS4f6QlZIYpxGIDwAk2zFMMsEcjw8E3LzKleGSRMl18KK7LlQQHd9E7hgAJ7iQc96YM8GWqBeMJ5asLv8XNAGfdAIndAKvdAM3dAO/dAQHdESPdEUXdEWfdH8AyU0WkFbcCoklQTvidF+wA0y+cdY4Cx3x2UGKdKAcJ+eB75zyhs6gXhoI1SI95QuinlV8qFtJiv2YEx4oaQN2xssfUI6RMCctcHxJ0jZkFREMIZPVU4TQadoY6fZUMEPfAzpOi9awqgRUtRgcJ87k8T/Rptbc+g4lXTWcMyHxxqpPlPEOzOsYC0GYn1RD3CN0aBbFAYaTLvXNEoyU4s3dy3H+1Wvc03XR70zqYwQMYEXt3yTBfHYVIOWHLbYPMMyl1MMbMYbtnvYUqAvAni01pbNgnRE7MyPU9xvwHJLHNbN0gwh4dZva2tHCerZl/CuVnUrtu0JuN0sUrzbwB3cjvt/SQLQUNBBsAu7SXAMwu0GA+tG+/xS8uoEG1G6zW0NuAV+ms2iSCA0kvRiyNconzqimpcuiIJ+6zuiNH3dWxB/DlAfghqnDYB09zSB2JmFEGi0RJV4ygGG90DCeOHU7M0FpCKKh7iqug1I44A14H1h/xblh/t4naWq1gO+BSZxj6ekAPpoBPFlyth5UxZFxw4r4V02jRUusWuBdjTDlVPZsHZ0Z5fnNAelmko1Z6pBqYEs2SeeBVbCmjErinVFO17b4O08bZO5bu/2bO9YSYbZ2QNO3BqsBXS743/QPKHyt6KLz1QOCEYpaVv+CU6Rul/eCVia4Oy2JMbNBh/0QGLOBKN73f4Qw0nw3Oh2BrsbTl/oj03gK7I713F6pvGQ3UC63dirrKH0KZlSjlG0KfHLRYZifCiqHpUyRTY5vP62KnPSvogefMdL0XJ+y0fg3vB9hfKNdDA1LChYhPc3K/jdLIf6LT7YLD5IhP371F5YU/92iurI0RzPMc9zXeA93BCaiECUhh6wKDFxeGFD4KtkUjXG3h02rJBF8+wU4+RzfeEg+a2GtWoKaTMMrn5N0+x6zozswbQenmNlXNEcouJjw+If5eKTtmpkSQwoKRMIhbKPkyR3Zje6TGrqsZeCzO+QPOA9HratCeRfK48M8jyEWS9obJq5BnfA41XEDEjaicW/WfFjXqkbHwo71/EgH/JBByShGwjxKfJSQCX5fgUEnQV214AoPyBG+RBFmgQiWis5ag/JJ33lW94qsUDeBxGhkfPxO6QsAbzGpOUgrytJiKekmqZC2Oq2lSnOsN8CkIEenCZRj4Dxor/YZOYbnzD/9eCr2dqJqchDutguTOwrWIW3pvoU036MpYnyQROZyi7aVeND8hBaIu5CD+nH4lrsY+xVwr3ubK2W+C70on2VhjPjjg44NklDrXyuYnkSd2aXcy/y2EW1AVeFi9+bKPnwLvMnR45Z4lwEoH9TUivMdx/zDYTk4zPlrm8GQo0GAj37uJ/7IkLyzF0HyK37PXRuuDsgisx2RA78KT/zCFHz/+V5RL/zgAS95+yi3u0bx4/8UMD09eD0R4DUakowUm8PcjilhFLfqob9VCD2NatVZW9ZZx9xErHy/5FX54/+KZ+AxDmu3a+tYgwEA8Bw6FAcAAjAIEAcHhgNgEAACAiV/07tltv1fsFh8ZhcNp/RafWa3Xa/y1T5XC7UXpeM5sMBIDCGEgy0sqgAIAimHqyknAKkDpQGCrQmhxSq8LLgODs9P0FDRUdJS+HwrJoIFAoKGiGQnAqrGloVEmubiAz0HLICAhKcWAMWMrFMk5WXmZudn6HLDBaiq62vsbO1t5Mb7LjBw8XHycvNz9HT1dfZ293f4ePl5+nr7e/x8/X3+fv9/wEGFDiQYEGDBxEmVLiQYUOHDyFGlDiRYkWLFzFm1LiRY0ePH0GGFDmSZEmTFg0MUKmSQAJhRAgM6mSgz66aomjSXKJSiwOZbRoEuEnEZxeX61YF+OmkqJlvanR9if+p5qi4pkOaRDWXQIACBlQOGLLpiYmTsqOYlBWAoIqjp2qgEEh0B5kWsdjOflGwaK4VO6jCbNKaZpMXnXHa3uWUlw3gJI/V5RVgBM8BYdMCtH3yctEUPwIyJ0qAxPISVaAXDE7QYMECAqA7Y27kAFgjAUEVbKnStjDWB62RDEh96zURAXIVZLb7dUDStlcGsH05ZHJyIQeSLxhkGfTL20IBGHh5oPPm7tMWkE7+EvNu5mZbX2eAiQgU+gF+p6ce4JZZ6Z65CwY9JJzbIgH+lCgNgNF2cqm0ARqwLhD+NMMqs7AosyMo7bRYrbVEhOMvkfameG8Ing6ARJgC/UjuOSH/Glhkt3UkC+AAXkw7xAACyhtCiQZgKYu+rvzKsSwHqjjwDgd4LKA5Bg44oIADCMBDij+QQECYBabjojcrmHwgNwOQEBMABgbB0UkAkHQiASelFKLNKyIZYCnQbgTkxvAAGQDNPwZBQIoFHiAAkSmG8vPJ48xkoDkudeRxQTjrgxIKKgt44BsCMhVCKB5zazMoJ+oMNI9FQQVgzTaJYI2ASHIsUgAIHEhALRtxdBXWYRRoDs9cXYvLkT5+C6/M3CDYcZE3B4glRwcoMWTVKqb1C8ilaIxKLEmaYMCB5ujC5IEHqoCACHPxKKusQxkr8qwrHsgMtCoGoA2CuhTb4st0/1X5rYA9clNAkK+60qosXqhIrsgvtw0kOW6pqyILIYWB0ixd+DVAF+HO/BbEwcilbhHHinS3CQjk6G0TiE1GuGAnFmiEZTzEUos3AGL20a7Ebl4AEwEcdUtnHhf4t2Nw232Mv2nsJDg5lxXGD014JLu5LKIPNS5eAnyuS2kh1G1i4sH4xWqArlZKsYBBNIn4i33BbiJTAq5m4A+6nVRpKXXztnNh3W42IstYDRmbT9YqwTjus67+DZF2xTKEZFTKRmClt1aOld9JVloKlZmFqLmJhj/f2W2lNWVJ6MfmbnyBxwezIgEHYuyz75Rut4KBAvpqp2qd1R1izV0yxZkSnP+l4DhnJctac1Sh31XJ7iEMmMyPNWd5e4vKRdMludwMlWlvVZKlfuHep7j5EQBgPWttyBzoLICgLzY7x0MFWMSOvI8nHiu237I+k1khNoSYC+hMEz7zEaUKBFCCASjBqdC1xWY6a5MD7VKThgmAGn5wVpEQh4DuLUF4KukfER7wPmD4oXzhUWB4/JJC9E3hg+P43WPKUrQCDGUIsFiQLjQGjEH4iT9NOFgBfEa2uNnvTQFwBaeKgb3TcSEACFBijhKgB4WFBwGxgKATK3SWLxbgGFPYoRMaxguhSAICYPSRE/szqS1EL0e1KEB/dFgTYHRJAK14kRZyMUCutaKDxjn/IwKP6EaYAGMtQyha0SZ4otHdrEpr1IKUlNIwNv1rSo74l1IWpMUm5NFCXcIRAOgTHk5WYYxlZAX6LHeSg7TrSwL7yFyg4AaSyZKXZaDlJQHxETW+rw277OUxkZlMZS6Tme9ISbOKgK1rxA4N1OxCUHi4IGFcJQw7csZU4FLDL1izmfagUAGEYcxqfClW2tOZGOIyQ8m95QvcJIUYs1mGqnghc+XkBx4wiAfZFKE2++EQi5ywoeTFhzrYTMp1uBKMd25oEEATAIyKsbf/CIo/Q0AodZiDHYmmz10MRZGKFoSE7+SGfS56i3CModIT2QE0/SGRRZu1onmBKEIA/V7v/3jiIf0QIToCEAZHWToFETkhKf2hjQC/wyQJAYCipOIMdX6oHPE8oUf+LENl0NWsKVUJRn6AUrEMIIVqtYp3lrnUpZKwpfTgyE87mtqPgmU3ZqUor30pVVxxJoy1BgJOjuKaMOb5VigdKVpl1FJgVSWEVD4BShKEjCFEdTJlTapZQtpNbn4FCEJR9U6ZCFNS2We5QG1pm7TQymgbMIgrWeyxwAHWq6ZHhB8FyYiJ4JKhEmE9r56BQgxI5wDiRQXl1CsA93qTIPiUsNc2AgAhU8RlraaLwuHsZ446i8+oQL93YhdqBmuCxk5EjXlaN39KUwDT/pY+CE6xunrEV7lSdv+0j0nyEOci6WMUELMazrOd480eyqhQmAA3IBbMvRd2dQZeoD3lCuIKWVjmVwVbWmy4ZsAPuPyCNpWoDYBLcABzckcEwEROYqdj2XY/zJJ3pQ7EBo4Y5/RWP8ZNMsQ8kx3tHhDMtqXvLIoRy5ALdzk/OI5uGxObbv+bhQQo4MHGKeMv35nklXSIyhBS4X11FuMaKyIAXOsVFKRgCF4grsMeprD05lK9PkjQm0F54Z1YaoD5WsFUUY7V+5TAQY8ewBJT6OCrZHHAiN25focIroyOsWdQppBtisMucNlUoeet6VD3KeD+TMjfnHGsYXZgldvKlugsZ6KARC0CFeYsRT//C9qDToDgIoq2hOOlcn5g61Kbx/nmSTmxAVCEZC7e10qmEmM3flw18NpIxndCy4lI2OMmq43GQ7pN2UTVhR37Q+A+SptPl/hj9t6Umgpt0itCCHIxGqhDapAyFbY6LzBAucFP9o7AkNs2SQeJRG0DQy7/giSE4cfJGvpQSag0eFvetB9g+46c9JiLLalIT49gfOLuSNo9WHHGLqhzI7ns+MlRnnKVr5zlLXf5y2Eec5nPnOY1t/nNcZ5zne+c5z33+c+BHnShD53oRTf60ZGedKUv3Z8XkIAENkCGDkS9FE5/OtS7MHWmbx0AFMiABTgAhglMYAgRkMAnxq4FCox9/wIZiEAXzM71rUvg7QCQgAbcfnYnRCACE6BABDyAAQxQYAgaiAAGqE4EDmhA8BcAAAf4TnYAGD4CGgBA5Am/hQyE3QkSELwFzg75vk9e73cHwAQOT3W/y/3mdB8C6imwAQtoIQMZkMAFItCBC3ggA5PHwAUoYAHHEyH3AAi83R2PAQ7IHvhhr/3ttyCB2TuBAhWgwAUqcHboK9/wZdfA8TdgeQB8QO+sp7nrTy/5D2gh7ZfX/tsxkIGxg37vel//2iNgAb+DwAN6b/8WIoDziMADOqDszg7/9A8ALIACgu/xKmD5zE/n0K/91s8J2i/uXA/wrm74DHAIPiD4LC/t1v+uAt7u/zpv+ixQ8swOBNPP+DKgAzxgCCSgAxIwAluv7iiQ/QrQ/eyuBDFgCICv/nxPAipgCOSPAQHgAtZvAnZQCwJwC7oPALKPCI2Q7C7AAoQPADbA8aJw9Www5jagAkCgAHOQ+khwAzCw7jqABK1v70gwAqIuA0gQA/yODcOu+uDwBLOuAuTw7OTw8CTvBQuPDamO/L7wC+PuGRbwEBkR7sqPGTig9xqR56RpEi2xGSyDnS5xE03hbDSRqXLMEd5gnzqBFA9jDUjxq9rAntogFb0gKSrxDbyJKGLRC7CJC07xRGDuE+vDK36NFxEDFBTj42QhDPKFDIBRDEguGP//Kwz2wg9CgZuWcQviydv4SxRfLhkLzEdwI71EZKvYhy9cxC4U4GmGoKqoKqPYJ6K6KkTCrRxBqciWiqj+A6bewhAORDk8YycmJJWQ6pKyYzvYMb0WQLxaZKkGKjxSg7osRAAwZKrQkbIwgSf2caUCgTXSoziog9/UkUFgKmg+qh9VykRK5KKYADawKkA6Q6QuKh0FiJm0MWlq6zKO5QDMpbpyY7AMLSbMRVfsxifpxrA4jHqOZScNwFyOxLVIRbUU64MMAVwgJXt0JQtmklTSpE+EMkrGangcaRFiS0qohE7GyjHK0VdwBRCAEiY6RZOq8lPMZE0KbQjQSgrEElOE/0AnE8A1/ISznGWvFAVLcCgrIwuVBIAXXuXXkqkwHJILZNJtiMZoIAVKyguNXkTCHMUyVcLSYMJfeMwv1iW/irG6EqNHDAHDvgLCcgYyssdNHkZzkMu+hkHAqkteMiO55oUyXYy7wkvY2BLVlmjKUKlLnksm4MW+JpMIFuAvUmIwdsx+QGfPwAICNKWZDsSKXiKW5ih2sqd1jEgpjCjFTucKxKxKaKzJ7IcIuPO/oENslCw0WYwy0Yyksqd0EK4IjgCHFOfI3mLK7kXEmsU/ndLHUGcleodmbgbCUi1ZbtIsTuwY9BPH/EbF/iIzE+ca2yZ6iqwKwsJoVq4x5XOEzv9EohjNyljI0AaN1l6FjnRrhAzBUHIEPxZoRVXpfyiz0Oij06rggqiSvtanfRRn057C1C4qt1KCSNFIg24GRT8ID/ggtZ4t1SxKC+osKyBEF5xkROVyzvqEOY+HjkAH05AkSvxAG8sJgmiFENwmi4pILoNJlRQJpIitCBQO26ZERQNBlEokTq9G3uzijMZt3QyBGIyhuvRgUCvJF55tF3oBgaCFFZ6ijwhu2FxBUhkSk6rnQKmtkyTUrCwJQZcotdAH2UqsUdek2zwq5JIndvbIS11zUtQNk9CJE9kBl9rUIIDTHC4OMWVVHYapFgFiKMkh5PJpV4m1WI2V5bhC4/r/Ycw6gRWlQXW8wBWXgRSl9Vh1o1e48h8MgC1CYRrBIIvu0wuOcRmMbN2slQs6aXYEAhPaNChesqE+RUIYREEwY2Tyo4aeyjbUcXWIajiCyyGvyjPykZXGwysLKqGKYaGSE6v4sTSTQx/PlZ+uESAQIdnsRkF0S67yZICgYLPcErWoyqzIgxrSii6ktCi3C0gIrbcCC9MmwzAxlqraajQshbbcRloky1wjNjSJMR8Qp0ltcjrR1M/Kpkk3tV0cbACGc3ve4jF5rMLy58JA4zQ3LEqk8y1SUzRFBsKoADp1dmd7KL0CwiucKJg2dDBWUwnKRjFS7Ry/zMROk1+Fp1Aq/yh/yqxr4lPNoqCDzpZf3zN7qCBDwbYLciZ+1oEOELcluyBr1kZMMcg9e0YKmCeYSowxrIfOcOGKVE1J1Kx4cs1GnyNoHFcx80zSBgFH0wdMvxZsv6jMAILN6gtWfzE3iWiLIJUa2vZ6osjLnGgpHAACiOlO11QsGM57Ho6wnoCTumQV/qXZyO3dBhUfkWhQB/cQOa56sTcMTC57ubd7vfd7zcFX9UHPPEp8nQIbKg58QyETCaK5gsOayPQOtrEZ4ld94cAT25dIzuJA7rOouoQlhWBevaMkQ2cejUMdRerXAkQQgCOl1pF6UmMR/tEuurGlJEpBOmN17Vdf2pcJVv92QfRST1TLCYLmPj5VCfYqs5xgLs/kUbrkL78iVcqmYyWlKmWBtVr4sB5DZXt2g4dWIKCjV0ZJOSHDf0gq1VgGwRqJCJYWvZagkFq1LIp2KFYTyuRrY3B3ACxMg33YioHYU5SEcrzmGvtNF1jGcraMQZnDyRqtbNa2Qqp41ZrTbs1MWbs4NA83cefAjt1FD+rLrHykd1QXeX4IeI4HRmFoFzLX0a7LGgdoeYyIcuvz2fBnEW7NeO74C6pzpACCclQBValD5AhL3fJgTSFjjwIOikVVZu8IqCxNXfDUjIphkiEM3OaieDNZlsY1l891l3n5l4E5mIUZG8ijMAXimXz/FTPElBrFqSfMdxucdZjZZDUMsh8ohBVi8U+k9SjUyVu/oIdBwZuD2ZfxARUMUyHXx3+DCiODo1nmo4HG0VrsAELMoqfsgH9HUnHPsaBeIzQoOF7ThaYgGEbxo4HdhJ0/w58hTjSaeWc52R8AYy/AkqxKRXJOK3U7ZTDnpEqxgiFDC4SDki8V9TAJcwpAtrbmChAahoZH5qKHJVWGJDeuwFCOqnsbrpO/gQpsUznmc4kIbDLxoGZN5zEWls/aJWjtYEEXNFED7WaM1n7apWyUOn24QjvS11jfZIb+6RsUoAEA1FNzpN9yh0kVwHBx82vMJmn6tp+seIOStEJyd4Ay/wemqoQrsjer20GP99gLUCHi/CTOwLqC1ofRAIoBcotEH6NJ/0DXLolAlGDUoBjhlABoJUGS47psIFt4ciOF+NhYEeCThjUfnAiO5qKJJrWnw5oWjEbZUKGsAWdoQLne6kN5wwPfsCVtORVRZTmLt7FsggiUIGtXpJkjgHW4d/VWjTu5lXu5mbuYO/seyNcPnlkNdKJamTscamUSGNKafYgYk3EaK+i61cGs/yEzcmN/+SM4/oOJGYl93plUAjK1xRsdDsAItFofxPOD8zKk/4qofCsBOEVon+Aq5Xu+cZUJtnurtTiHiPhLTLOMuKyKCtzAzQGczQmMqdQ5gSnNIP+cKO4TYsiZwq+BpkDWHPS6DvgabPxYsYNJhMxi1zJhu3sUxLlYxKtB3u5btP/ik1vBNkTZ4eBNZrVCjRA1vG38yJE8yZV8yZm8yZ38yaE8yqV8yqm8yq38yrE8y7V8y7m8y73cIIp5ur/c5WqlAap5zHGOnOkmQlVsFHXVQN68Q34NM0DBum2td3LRDJbZKpZiz8/1oanRF3+YDUKcvsR13f5EGGucTfrMwqM1zt+AZCxcjN0E0jnxpr1AJivYHWOiYA8SUDV0PTxqp0iqepBDH0UKYpdAOvr5OBrEVq4DpfKVOsIiSh42jGL9gUdDnTMDkRGWQ1RyCVqy1eVCM47/Q6j6OTYWEl5zwz4qBKd+KFwlktUaeJ0Nmn8TY1/ND6/BQCZxmExw0iblMifl5NmrwLAgJabTxyYFq9wHc7JSy07UfVayuwmghaRmK0suZE3gnbGOuFlUC4Y/CCgFHjs07LMG0xLc8kotZSyxgLUC/Cn2ar/3Ui2n82OP+KKnsrpINsGZjttpnTG10zE5E7Ik02m0omuxuL/CdjJitby8dmin+i7U9r0WNmkhI+aLcWkWdsjsVDcnjI4MYaqB05ZSDV5os8X+vUJxhog3dYDKmJAfY2kj8LOBoSawk+khV1XotjvRC0JLqzkzZ1amBuwFNzTHXjOCAcjQ8m0Npxmx/2J2akfDW1XFylPolR4yFBSq87NXRgys23hCV+eNB4g+6yVui9VDCwdE9WBFWqi0GLm9Mrtrk+XOBjk0J18zKC0VEOV66uLyUUiFLM3Ff15J8Z6QOaYk+T6tjXQ+t7vQWPwOGoHwy0ZHXSgdjdVMeQjdYjnIiOdN8d0WRsS2SSoBkkXZ0o16rfi3K0ozTok+jE3WXFX5qSeYeC10dujn6fSDZYWViB9UV79ITFsKpJJDVSwYmHdSE8poaH+JDvVHOEnM0XwdTo3L0oFW539Z56ehixsIAMIhsWg8IpPKooERKBiW0im1ar1is9ott+v9gsPiMblsPqPT6jW77X7D4//yOR2QEAzq8wHh7IhuGQzw+UUZ9A396S0yNsoJKAwU5DmuGSAInAVQaiUwKBxo5ikObVaeoqZ6FYQmOKieKQgwDDUEBDQUCdg6ECiYJoQeJAgZLAQ8ACAvLIQSOdzmAggELACWcg5RKxAQZAoJdP9+Jxg8ZA8wM+QFA6QvrMPKz9MTIQgNBNSLQRBAATQhMKwIAmLMDjRRlicfgAMMDiUL0OuBgiK5CDA48GABQGnYijjIZAvAQ4C0JgEIqYwBniEHWPnLs+nlgZj7buJkdM+dvpxcGnB88OoAhHNGdgr4ds8UQ6FEmPYcMgAahAEJCpQzYooIhKQC7lEEoKAcS0j/+rYOcapQoVq0Pt/CTQMBH8e4WBQ4KUCroYACUYUgVbqWYdKnC/82+MfUAcsibgEgGDQIAMbKkiRHeVx47abNj+2CDr1lQS4HyXJ6Ta06W5F+QqAcCEVg55DAgAGQtqNvwN7Mh4kIeBXzEICRhh2fBvSrIgEIgHxb7Ilyk3GUoq9jt2LAbwBE2ZMATevg5RNi9sAJ5h3gFzi/HKES8VdtUuIn11JC+DeEwIICBepe4sx2T2TymQMFKDDdKAha952DD0IYoYQTUlihhRdimKGGG3LYoYcfghiiiNfdZ6EgAzizxF9VrKiFAa9kcaJ3XJAyoo1mDEPbhetRA+NRtWWh/+MVDPHUyScpcuEWkTcyycUAX2loymxCQIOLO5gQg4AtFVE2jhDlGAVkcdVE4ct6fVBjDXAsDRIANadVKc0u62nFWjsDTUMmQMdI80482rCpGyhNElqFkBWaklBxlGV0QGRRFIQbMSipFECgQAIlEAP8JdOAORwZ4JEdkxzAGx8ZLYpRKJEuYN5HxzUFagM0ETATTA2OimICCxDAW6G/LnEohU9YCshUAVQFmZhJNZEUe5/ds4AsswygAGmtYFUikUQuhmweth0Hqz5XZfWAm9QI0BY6PS1ASQAlAhuvshlu0lwUiUFHW2CXDQIdQcqcM0gfCSiQ7FSNSdUTtwPgu/8WuK9+tC1jzkp2gGfrCrHVZ/L+Kmw9qoHcEhKJ9hMcZSghgEhg9haz1r8C1CUQJSERZxw+BeDTU2fCoYyeY6zlloA+NW+yaTHVoYMzAE5hxDHHQiMQgKuIUnIVef3l0dcrtg1YQIGszXvgExZzR0B9+pUi9cLyYT3vZlTmd5967J0dxVVPlMYga7ck4It/ojoduOCDE1644YcjnrjiizPeuOOPV6iRAPBOeCLlQxgTQGxHbK5EjUckMPUWLVLR6wCXX/Ei5Bw6kEADf1rIY4KXP0RA6KATs7HLSLyNhb5aHICX6FosedvqF/Y+LCUB7WnlAFhO5vpB7qD4SSZmfkP/HSUMA3e9l3mqaYuVUmEJ2ZZf3kIOUM0UUXxD5rUjvpxnUpbmX88LQMw7YB9/ndQYokUBD6DVTB5VGIkQICxJ8YdRKPU144zPZw7cSEcCgichOOp0kDGI/vrQKmVMhEsJa5/OTrepgahkJCoRGhEyaACHxAZV/csOCwHIiaSYKyluctvXinTAPDTLLGtp1F60Mbmy/IJcUSBKmM5jvMJYzFI9dB8VS8hESnQlKfdwjft28oBvpGuG2LnKjKg2BAU0ABIV4+Fg9PFDd0yiX2uhiGl0gYc4avBgmSDbin43DQE4JBdvrCIJM5YHPkJGMt/K2b/+6DMxhoaMcAnZapKw/5WruMNoAGEjfA54Eee0TEoM0KQRWQYQom1uSvZQGXokIQRZtLGQRNjOyVAkm6UkBwAosRlg+kBLZaAOkjdBAHd8hCi/IAgRdytALmzTSZH4BSDI7KFYjOmzru0CmS9Epui0xsYEVWOKf9kOBKzZH6yRByuU6c9/pCmtFXmzL14TJj1FI8N64jOfYCCYPvvpz38CNKACHegiJMc/CRGHMsEESRQ+B4ahWZOg+GydJAA3oa24Twmm0B3vvqGEe2RUovms4462p4/g6WkYT3KHOmTCsO2JKh30Sx+S4nSbkIpUmAdwADcAOC32IMQk7oDAAgB5K5dCUFQvXFpFFBCJGf9dBFUgJV1OIdmrCCIqYOb60i+mKgR1DTGGRUhgf9zoUalQZZE4rSok1/ogjOqDp6sqkiM5kwc6nmYIBXjAVetaC8WolapsPR4lIOETSqbmoC5jiJUcRVekrQUjpOylbqZhTZPZxKuDpSc7eWVDRjZBIppNid5cpoCIemI9J/XLNdjWM7duNrYbuqdsa8s4fto2t7rdLW9769vfAje4wh0ucYtr3OMiN7nKXS5zm+vc50I3utKdLnWra93r1tOg2N0uLCjKTO6CNxUkRYLpSiTYK9wOcxHtxPC+oLo8tbcSxDlvEtLLBfsqNLxJ2GlP9yu8Rnqhd7CtQvLAwJBdUWb/Horw2BIKTIXN9O69b+CoSK9qUVna43wsPZMBzKORLu0QOE59V5Fk2lOG/SJUdALxN1AaYm3wwkx3dUY5MvcNW6iJsW5K0Z2IMYw3fWl9ztgGIrZxLz3ZGMQ9tek0LDaMuQ7wS9fA02kyEZxfUALHS7wDMhyz4yubYiAoxigzAAm++7Qjj0DkEzjO5xBYDiHNUZgMIAGJUvgJuX4Sia/hYJtRVhFjqRQhylcr4kDg8MoAc2GIoCtCDYRAgIO6HEUmUALn2hikGQlRSXPslcDi8MohfXUqIQxZ4nWoCoQJrEgK41qRUGVK1M759AI6dS9GrWrHprgHp12DKQiUyo2a/0tIrDdlqlSf8amPTghhhk0LWk2CgqHqnjIqYqua7JqDDMzGAa39rR2j+oMIDMsK6eu0wnLJzEb4s8/IGs0PZiSI7DGiIRnibrM+8YjOepfSkgeuezjEDhVhgAMIIa2krIMwZ43lwmKZRSj5GjfTWgfBCWGtWeEjrfNyWENogVtsyOIBX6xrtCbeJlPTm+Q+FIy6lEjC4OFsLjlEFydZkw+YA2Au8zKAwt7zGy6am2OdVRn/2O3IvfY1HzyHI2aorRCGIF3h+ebX6Yjk70fupFX/IGs/kCGZviYPPg2HT2Qks3GAfZ3rAysYwwC78V0LQeslSld3pJU1wXhdYA1P+f9mvNr3ui4GYUMoSgMcMBI1DmKujvwM4Q3fk51s6yy/gXzQHWf0wqSssiT5nynvU5jmFCnzLPz7Hzvf6ZQs/N/4cAI+XvOkmAXbr3HPBQvH/psub/J/AIGZEGTm+pklhWeLNDXkWc+EveKm34LhPWVivzvLYn3lt0Ea0YpwDGlmgjeIgJTPsBr3oc1z464JI3x2WXnGkdOatkntvB9QRGyuCW9FYj++2Qj/q5S5kaQniTTYCSOxsYLUEcHc7EYJxRJ/+Aeo3IKVAOAB+N80lI1rDR/HCQEDXBiwaR7pNeDeYRBr/Z0A7sSB4EXb2UcRhAVJVA0yNZPP1IcJcsmf0Eb/YiRTLG0HM5yfflFBwEVOEZ0CItAWLCiTCOHgF4yFhRRhKuQFn51CanXHEDrhE0LhZmnXhSwVPpSRHvDCEUhYFXROFIpXAlTUhbwO+rgBhXVcN4wQXUnBZuCXF4pXXiEKMZSElinZFQYZM3gD7u0POJDJmy2c0AzKLIjMNLBJPgBZ8wAOTUXP+uRhcrCZG74Bf9lhhBCFA7xCsXFKcVzOuE2CqsAQDElbA2wbEexKr3gcqcQZqRxbo8CEW5CaNxTIRHQiK2KbYkFiGVhYhsyCB5ncxSHJz9DVJozcNDyAyz0fbriLIKxI5BnSzL1YXQ1SCTnjwt2iGgzYd3BLwBAC/8EkyxHAh0JAWPZNzDFqzMkNoMKUEOKhiNNFoyGp4y9Woxmg22EhVlLYotXBHvC5QyL+hkL80rtUn/cxDS1QkdIsjPa1jDbASDs+nSYtVDx+wdBlyJI0YF/cggeJzjeagjxBUwm24H4kyHdlFN803DKJCnkYAEMCgwpCpEDxYEvCJBZ8WEzSZE3a5E1WleQ8ZHZUoTtMYh1koRFsYQ7CI06mQeu8ji1+xxhqXiWImncw4xSwoRIa5Rk4WIT8zxzqiZn0lxHIj56Fwz6mmIZhjxEAYigI4g0VopvgXuYk4o4tIh4eoltWZRjonoVU4iWG2qbUmiZq4QkRAywZ1rJFmv+kTBrqkSKv+MpVrOOXqCKq0WKtZMMrHpAsnkpstKJS1uUU1BCG7KLEIVy1XAsSXJEQ6FzOqdwfydtftEvGKKMsLcw0sqM4NeO5PONmYoEkTaTOaOPadaMRINLvkJ494tF9lCMhBeOTRELizWYsgeNyNiZu5mYB/OQ81KM9KgE+9l6pUEn2neQt4UYupENqLhAobZJ4MIoa3gwjNeT2AcdC0mZ7JqR0XgEx3cJ6SQhFIhMfNeEHuQQ3AcQCRsFwZgL8geTfqGfGqI0BmmQLeWB8rqT80SfkvOSE0uRMWmiGauiGcihCaYgBAAIB7CQaZE6H3kSORAkG4hSDjUHtXKX/iVbCk7AohLhJRRDJWV5J/mCOhyVDWdqBOaSRNswIjuKP0OyYj0oP+8CoHszoW93cgSnmsz2KS+hcWByaFF0GHCWmKTbEo7zilYbQkjJplAxCJOhDawLT2cWdHCIEEkkeV4nF1KApiXGNmzqnmM5BkzrIRrFQOaopTywd1flLzikaMFJgYQjqneJpHOhpKlznINZJJunDQFJWETgBMXTe7giiCQrHXiCFcJgndFzjopIB1NylGSmDPvjNd0GgNbkf5kzT7jhKGa2qNOwESsLfN5JqcX3crkLhD/pqsArrsHboHWjmd4Bo740osVqIGuHKsKjoDTLrhLCCHeAnjRrWvI2uR1G22YqVZYdhUDLQZZOp27SeAuXZkOZAKZciAaAdZkgQGlMR0LeVq7k6ArqWVLUwxJxeTmCspmFmhGw2qr3Ggc6NZ0kpQ5+6y0HtS3ECqhtBp+IR7CnkxnjdxKMqFlOwHqX+qP6FQ6hW4P8g5CYN7MS6wYA0IcKmapcgaM79ItfE6tIUUYOWrMkGlDHYLHY1wLHmbM/67M8CbdAK7dASbdEa7dEibdIq7dIybdM67dNCbdRK7dQGaxAAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: JL Cox, JM Holden, R Sagovsky. Department of Psychiatry, University of Edinburgh.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_43_34495=[""].join("\n");
var outline_f33_43_34495=null;
